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The human T-cell leukemia virus type-1 (HTLV-1) infects CD4+ T-cells and is the
etiological agent of adult T-cell leukemia/lymphoma (ATL), an aggressive and often-fatal
lymphoproliferative neoplastic disease. The major transactivator protein, Tax, drives proviral gene
expression and replication and plays a key role during the early-stage immortalization of T-cells
by HTLV-1. Tax has also been shown to regulate many host cellular signaling pathways, including
CREB/ATF, SRF, and NFκB. Another accessory viral protein p30II acts as a latency-maintenance
factor and negatively regulates proviral gene expression and replication. The p30II protein counters
Tax-dependent gene expression at the transcriptional and posttranscriptional levels. HTLV-1 Tax
constitutively activates the NFκB pathway. Intriguingly, the stathmin or OP18 (Oncoprotein-18)
gene, a microtubule-destabilizing protein, is negatively regulated by p53/Sin3/HDAC1 repressor
complexes and was recently shown to interact with and stabilize the p65RelA subunit of NFκB.
Stathmin is associated with an aggressive disease phenotype in pancreatic cancers. Our lab has
recently shown that p30II induces the expression of p53 dependent pro-survival genes such as
TIGAR (Tp53 induced glycolysis and apoptosis regulator). In approximately half of all cancers,
p53 is either mutated or functionally inactivated. However, in the majority of ATL patient isolates,
the wildtype p53 protein continues to be expressed at high levels. My studies have demonstrated
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that the HTLV-1 p30II protein inhibits Stathmin expression in Tax-expressing HTLV-1 infected
cells and ultimately suppresses NFκB hyperactivation. My research studies have revealed that
Stathmin/Op-18 might act as an important co-factor for NFκB-activation in HTLV-1 associated
oncogenesis and highlights the cooperative role of the latency-maintenance factor, p30II, with the
viral transactivator by preventing Tax-induced cytotoxicity and genomic instability and may allow
for the continued proliferation of HTLV-1 transformed cells and conceivably aid in disease
progression. Overall my research work reveals a mechanistic link between NFκB inflammatory
signaling and genomic instability that may contribute to oncogenesis and transformation in certain
human cancers.
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CHAPTER I
INTRODUCTION AND BACKGROUND

1.1 Significance and hypothesis
The human T-cell leukemia virus type-1 (HTLV-1) is an oncogenic retrovirus and is the
etiological agent of adult T-cell leukemia/lymphoma (ATL) in humans. My dissertation focuses
on an interplay between the cellular and viral proteins that could possibly lead to the development
of ATL.
The viral transactivator and oncoprotein, Tax, is considered to play a central role in the process
leading to ATL. Tax is a highly promiscuous viral protein containing a number of interesting
domains allowing it to interact with a myriad of cellular factors and thus affecting a large number
of cellular functions. Tax is also a potent activator of a variety of transcription pathways and has
been shown to be sufficient to immortalize T-cells in vitro and thus plays an important role in
cellular transformation. Persistent activation of NFkB by Tax is one of the characteristic features
of ATL. Tax immortalizes primary human T-cells in a manner highly dependent on its ability to
activate NFkB. However, a complete mechanism for Tax-mediated oncogenesis remains to be
fully elucidated. The expression of Tax alone has been shown to be cytotoxic and also induces
apoptosis and senescence. One possibility is that the other viral genes of pX region cooperate with
Tax. HTLV-1 p30II is a latency-maintenance factor which negatively regulates HTLV-1
replication and counters Tax-dependent gene expression at the transcriptional and
posttranscriptional levels. Previous studies from our lab have shown that p30II cooperates with
1

cellular oncoproteins and induces aberrant lymphoproliferation through the activation of p53dependent pro-survival genes. The p53 gene is mutated or functionally inactivated in nearly half
of all cancers, however, in HTLV- 1-induced ATL the p53 gene is usually wild-type. Interestingly,
Stathmin – a p53 regulated protein has been reported to act as a cofactor for NFkB signaling by
stabilizing the p65RelA protein in aggressive pancreatic cancers. Stathmin is a microtubule
destabilizer which stimulates MT transition from elongation to shortening and is referred to as a
catastrophe promoter. HTLV-1 Tax oncoprotein which activates NFkB signaling is also
responsible for DNA damage and genomic alterations. This led us to investigate the p65RelA and
Stathmin molecular interactions with regard to Tax-induced NFkB hyperactivation and genomic
instability.
The objective of my dissertation research is to discover the molecular mechanism(s) for how
HTLV-1 p30II and host cellular factors p65RelA and Stathmin may modulate Tax-induced NFκB
activation and promote tumorigenesis during HTLV-1-induced carcinogenesis.
1.2 HTLV-1 AND ATL
Adult T-cell Leukemia/Lymphoma (ATLL/ATL) was first described as a new type of adult
onset T-cell leukemia by Uchiyama et al in 1977 even before the discovery of Human T-cell
lymphotropic virus (HTLV-1). One of the striking aspect of the disease was epidemiological
clustering of affected individuals in certain areas of Japan, indicating towards involvement of a
transmissible agent in this disease (Uchiyama et al. 1977). ATL spectrum was divided into five
types depending on the clinical features: pre-ATL, chronic, smoldering, acute T- cell leukemia and
lymphoma-type. The acute form of ATL comprises 55–75% of all ATL, with chronic and
cutaneous forms comprising the remaining 25% (Takatsuki et al. 1985; Yamaguchi et al. 1983;
Yamaguchi & Takatsuki 1993).
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Human T-cell lymphotropic virus (HTLV-1) was the first infectious human retrovirus reported
to be the etiological agent of cancer and was first isolated in a patient with cutaneous T-cell
lymphoma and was soon correlated with ATL (Poisez et al. 1980; Yoshida et al 1982). Two years
later, HTLV-2 was identified in a patient diagnosed with hairy cell leukemia (Kalyanraman VS et
al. 1982). Over years, HTLV-1 has been deemed to be more clinically significant of the two and
has been proven to be the etiological agent of multiple disorders including two major diseases:
adult T-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-1-associated
myelopathy (Osame M et al. 1986). Other conditions associated with HTLV-1 infection are uveitis,
rheumatoid arthritis/Sjogren syndrome, bronchioalveolar pneumonitis, autoimmune thyroiditis
and infective dermatitis (Manns A et al. 1999; Jones K.S. et al. 2008; LaGrenade L et al. 1990).
HTLV-1 is a complex deltaretrovirus that infects and transforms CD4+ T-lymphocytes. It is found
in clusters of endemic infection in parts of Southeast Asia, including Japan, Taiwan, Malaysia,
Africa, Caribbean and parts of Central and South America, the Middle East, and Melanesia (Poisez
et al. 1980; Matsuoka M et al. 2005). There are about 10-20 million people estimated to be HTLV1 carriers worldwide (Gessain A et al. 2012). Almost 90% of carriers remain asymptomatic
throughout their lifetime and only 3-5% individuals develop disease with the average age of
clinical onset between 40-60 years (Datta et al. 2007; Matsuoka 2003; Green et al. 2001). The
cumulative risks of developing ATL among HTLV-1 carriers are approximately 6.6% for males
and 2.1% for females (Proietti FA et al. 2005).
Viral Transmission and Infectivity
The most important route of HTLV-1 transmission is from mother to child, predominantly
through breastfeeding. It has been shown that approximately 10-25% of breast fed infants of
HTLV-1 positive seropositive mothers are also seropositive (Gessain A and Connor O. 2012).
3

There is also a <3% risk of HTLV-1 vertical transmission from mother to child through
transplacental route or during delivery. It is also transmitted horizontally by sexual course and
through blood transfusion (Carnerro-Proietti AB et al. 2014). Since the virus by itself is very poorly
infectious, effective transmission requires live infected T-lymphocytes such as T-cells in breast
milk, in semen and in blood of HTLV-1 carriers (Taylor GP et al. 2005). Viral infectivity is
primarily cell to cell and is mediated through a virological synapse. In the incidence of contact
between an infected and uninfected cell, polarization of microtubule organizing center (MTOC)
occurs at the cell to cell junction and a virological synapse is formed (Igakura T et al. 2003).
Following the synapse formation, HTLV-1 Gag complex and viral genomic RNAs accumulate and
are sent to the uninfected cell. HTLV-1 utilizes the ubiquitous vertebrate glucose transporter Glut1, as well as neuropilin (NPR1) and surface heparin sulfate proteoglycan receptors to infect and
transform their primary target, that is, CD4+ T-helper lymphocytes (Manel et al. 2003; Takenachi
N et al. 2007). Later it was shown to also infect other immune substrates including CD8+
lymphocytes, CD14+ macrophages, and dendritic cells. More recently, it was shown that HTLV1 virions can efficiently infect dendritic cells, and these cells can then rapidly infect CD4+ T cells
(Lepoutre et al. 2009).
HTLV-1 Proviral Genome
The HTLV-I virus was the first human retrovirus to be identified and was initially isolated in
1978 by Gallo and Poiesz from the T lymphocytes of a patient with a cutaneous T-cell lymphoma
(Poisez BJ et al. 1980; Gallo RC et al. 1982).
HTLV-1 is a virus with a single-stranded RNA genome of approximately 9 kb. The viral
genome encodes structural and enzymatic proteins and tandem long terminal repeats (LTRs) at the
3’ and 5’ end of the genome which are divided into unique region 3’ (U3), repeated region (R),
4

Figure 1. HTLV-1 proviral genome and its products. HTLV-1 has four genomic regions namely
gag, pol, env and a unique pX region that encodes its regulatory and accessory genes. hbz is
encoded from the minus strand of the mRNA (Malu et al; 2019, submitted)

unique region 5’ (U5) that allow the proviral transcription through the U3 region as well as mRNA
termination, polyadenylation and strand transfer during reverse transcription (Zhao LJ and Giam
CZ 1992; Lairmore et al. 2011; Green et al. 2001; Johnson et al. 2001). Moreover, there are three
imperfect twenty-one base pair repeats termed Tax Responsive Elements or TREs which are
necessary for transcriptional activation by the Tax protein and also act as an active site for
chromatin remodeling (Lairmore et al. 2011). Similar to other retroviruses, HTLV-1 has the
structural proteins group-specific antigen (gag), protease (pro)/polymerase (pol), and envelope
(env) genes are coded from unspliced/singly spliced mRNAs (Lee TH et al. 1984). The Gag (p55)
polyprotein is cleaved by viral proteases into Capsid (p24), Nucleocapsid (p15), and Matrix (p19),
which are required for packaging (Franchini GV. 1995). In addition to the structural genes, the
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HTLV-1 genome contains a unique pX region at the 3′ end, which encodes regulatory proteins.
The two regulatory genes tax and rex are encoded by open reading frames (ORF) IV and III,
respectively, and are synthesized from a doubly spliced mRNA. The pX ORFs I and II produce
alternatively spliced forms of mRNA, which encode four accessory proteins, p12I, p27I, p13II, and
p30II. HBZ is encoded on the minus strand of the provirus and transcribed from the 3′ LTR. Other
viral genes are transcribed as sense transcripts from the 5′ LTR. Transcription from the 5′ LTR is
highly inducible by Tax, in which CREB and p300/CBP are involved (Nyborg JK et al. 2010).
Orf-I (p8/p12): The orf-I products are 2 accessory proteins p12 and p8 made from singlyspliced mRNA. HTLV-1 infected individuals exhibit a cytotoxic T-lymphocyte (CTL) response
towards orf-I products. Proteolytic cleavage of p12 protein precursor removes a non-canonical
endoplasmic reticulum (ER) retention/retrieval signal at its amino-terminus to yield the p8 protein
(Fukumoto R et al. 2009). The orf-I mRNA has been detected in all ATL patient isolates (Ding et
al, 2002; Edwards et al, 2011). The 12-kD precursor protein (p12), is a 99 amino acid long
hydrophobic protein which resides in the endoplasmic reticulum (ER)/Golgi (Johnson JM et al.
2001; Koralnik IJ et al. 1993). The HTLV-1 virus usually maintains lifelong infection once an
individual is a carrier, and in doing so it constantly evades the host immune responses. One such
mechanism is decreased expression of major histocompatibility complex (MHC) class I,
intercellular adhesion molecule 1 (ICAM-1) and ICAM-2, on cell surface and protecting the
CD4+ HTLV-1–infected cells by natural killer cells. p12 binds to the heavy chain of MHC class I
in the ER and sends it to cytosol for proteasome mediated degradation thus inhibiting recognition
of infected cell by the CTLs (Johnson JM et al. 2001). In the ER, p12 protein interacts with the
interleukin-2 receptor (IL-2R) γ and β chains (Mulloy et al. 1996) and increases signal transducer
and activator of transcription 5 (STAT5) phosphorylation leading to an increase in STAT5
6

activation (Van Prooyen N et al. 2010; Nicot C et al. 2001) and increases the production of IL-2
(Nicot C et al. 2001; Ding W et al. 2003). p12 also causes an increase in release of calcium and
calcium-dependent proteins (calnexin and calreticulin; ER proteins that regulate calcium storage)
from the ER, and also results in activation of Nuclear Factor of Activated T-cells (NFAT), a
cellular transcription factor in order to promote T-cell activation and proliferation. This increase
in intracellular calcium levels and calcium-dependent signaling during early infection not only
promotes proliferation but can also trigger other cellular pathways, including those important for
viral transmission. Both these functions of p12 further underscore its importance in T-cell
activation (Ding et al, 2001; Albrecht et al, 2000; Van Prooyen et al, 2010). Altogether, the ERassociated functions of p12 seem to promote the proliferation of infected T-cells and protect them
from host immune recognition.
The loss of the p12 N-terminus allows p8 protein to go to cell membrane lipid rafts (Van
Prooyen N et al. 2010). The p8 protein is recruited to immunological synapse by trafficking to
lipid rafts at the site of TCR ligation and downregulates TCR proximal signaling through decreased
phosphorylation of Linker of Activation for T-cells (LAT) (Fukumoto R et al. 2009) and increases
lymphocyte function-associated antigen-1 (LFA-1) clustering by colocalization (Van Prooyen N
et al. 2010). Furthermore, p8 has been shown to have the ability to be transmitted from cell-to-cell
through cellular conduits and it increases HTLV-1 transmission by increasing T-cell adhesion and
formation of cellular conduits (Van Prooyen N et al. 2010).
Orf-II (p30II/p13II): The orf-2 encodes for two proteins p30II and p13 which are produced
through alternative splicing. The larger protein, p30II, is encoded by a doubly-spliced message
including the first and second exon of Tax spliced to the acceptor site, whereas the smaller protein,
known as p13, contains the C-terminal 87 amino acids of p30II and is produced from a singly7

spliced message by splicing of the first Tax exon directly to the splice acceptor at position 6875
(Ciminale V et al. 1992). CTLs and antibodies for ORF-II products have been isolated from
HTLV-1-infected carriers and ATL patients (Chen et al. 1997; Pique et al. 2000; Lairmore et al,
2011). ORF-II products have been shown to be necessary to maintain a high proviral load and to
allow for the development of latency and disease (Silverman et al, 2004; Lairmore et al, 2011).
Bartoe et al showed that ablation of p30II expression resulted in a significant decrease in HTLV-1
proviral load in rabbit model (Bartoe JT et al. 2000). The p30II protein is intriguing because it is
reported to act as both a transcriptional and posttranscriptional regulator; a characteristic shared
by another nucleolar resident protein, nucleolin (Ciminale et al, 1992).

Figure 2. Diagram of HTLV-1 p30II accessory protein and its functional domains. HTLV-1
p30II contains a TIP60-binding domain (aa 99-154) and a Rex binding domain (RexBD) (aa 131164). TAD: transcription activation domain, NLS: nuclear localization domain, NoRS: nuc
nucleolar retention signal. The p13II peptide is encoded by the C-terminal domain (aa 155-241).

The p30II protein also known as Tax ORF-II (tof-II) is a 241 amino acid long protein which is
highly basic and has a net positive charge. This protein contains three nuclear localization signals
(NLS1, NLS2, and NLS3) and an arginine-rich nucleolar localization/retention (NoRS) domain
(Ghorbel S et al. 2006). In addition, p30II also contains a Rex-binding domain (RexBD), a p30IIbinding domain, and a DNA-binding domain (Baydoun HH et al. 2008). The p30II protein localizes
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within the nucleus and nucleolus. It is specifically located in a granular component which is the
site of assembly of ribosome subunits and de novo mRNA production. This localization explains
the ability of p30II to bind the 60s ribosomal subunit protein L18a and to retain the newly
transcribed tax/rex mRNA in the nucleus (Ghorbel S et al. 2006). p30II promotes virus latency by
retaining tax/rex mRNA within the nucleus to prevent its export to the cytoplasm, and by
downregulating Tax and Rex production p30II further plays a role in suppressing viral replication
(Nicot C et al. 2004). In instances of DNA damage, p30II interferes with DNA repair processes by
specifically delocalizing from the nucleoli to the nucleoplasm (Baydoun HH et al. 2011). The
localization of p30II within the nucleus and nucleolus suggests its possible role in mediating critical
cellular processes such as cell cycle progression, DNA repair, and mRNA export. Another
hypothesis suggests that p30II retention within nucleoli may serve as a reservoir where it is stored
until the protein is needed in the nucleus (Baydoun HH et al. 2011).
Post-transcriptional Regulation: The p30II protein controls viral gene expression at posttranscriptional level by binding to the tax/rex mRNA at the p30II mRNA-responsive element
(p30IIRE) and also to Rex at the RexBD (Sinha-Datta U et al. 2007). Rex and p30II are antagonistic
to each other since Rex plays a role in nuclear-cytoplasmic export of unspliced and singly-spliced
mRNA while p30II actually retains the tax/rex mRNA transcripts in the nucleus. Rex usually binds
to the Rex responsive elements (RexRE) at the 3’ end of viral mRNA and shuttles unspliced
gag/pol and singly spliced env transcripts to the cytoplasm. p30II interacts with Rex to inhibit Rexmediated nuclear export of double spliced viral mRNA, including tax transcripts. Rex is not
accessible to p30II when it is bound to mRNA transcripts and is able to shuttle transcripts to the
cytoplasm. However, viral mRNA-bound p30II still retains tax/rex transcripts in the nucleus
(Sinha-Datta U et al. 2007). This nuclear retention of viral mRNA is reversed by an excess of Rex,
9

which displaces p30II from the p30IIRE. By decreasing the translation of tax/rex mRNA; the two
positive regulators of viral replication, p30II promotes latency allowing the virus infected cells to
escape host immune surveillance and facilitates propagation through cell division and clonal
expansion of infected cells (Silverman et al. 2004; Edwards et al. 2011). Also, it was speculated
that this interplay between p30II and Rex can play an important part in establishing viral latency
(Sinha-Datta U et al. 2007). Furthermore, microarray studies showed that p30II is also capable of
regulating cellular gene expression at post-transcriptional levels. It was seen that in the presence
of p30II there was a decrease in cytoplasmic expression of genes involved in cell signaling,
transcription, translation, replication, cytoskeleton and metabolism while an increase in genes
involved in DNA damage repair, apoptosis and cell adhesion (Taylor et al, 2009).
Transcriptional Regulation: Owing to its nuclear localization signals and serine- and threoninerich regions, p30II shows distant homologies with the activation domain of cellular transcription
factors Oct-1, Oct-2, Pit-1, and POU-M1, p30II was proposed to have a transcriptional function
(Ciminale et al, 1992; Edwards et al, 2011; Taylor et al, 2009; Albrecht and Lairmore, 2002). It
was shown that the p30II protein colocalizes with Tax in cell nuclei and regulates gene expression
by binding to the KIX domain of CBP/p300 (Zhang et al, 2001). Furthermore, p30II was able to
disrupt CREB-Tax-CBP/p300 complexes bound to the viral 21-bp repeats (Michael B et al. 2006).
Altogether, these data suggest that p30II acts as a repressor of transcription by sequestering
CBP/p300 from the pool of available transcription factors. Therefore, at higher concentrations
p30II may serve to promote viral persistence by reducing viral gene expression and thus reducing
immune recognition of infected cells (Zhang et al., 2000).
Through microarray analyses by various groups, p30II has been shown to alter the expression
of a variety of gene families including those that have a role in transcription, translation, cell cycle
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progression, DNA replication and repair, cell signaling, angiogenesis, cell migration, and
apoptosis (Taylor M et al, 2009; Edwards et al, 2011; Awasthi S et al, 2005). p30II also selectively
activates genes involved in T cell signaling/activation and enhances transcription mediated by
NFAT, NFκB, and AP-1 (Michael et al, 2004). The ability of p30II to transcriptionally activate
cellular genes was reported in a study where p30II binds to and stabilizes the Myc/TIP60
transcriptional complex (Awasthi S et al., 2005). Furthermore, focus-formation assays showing
that p30II cooperated with Myc allude to p30II’s role in transformation by enhancing Mycresponsive genes (Awasthi S et al., 2005). The p30II protein contains a histone acetyltransferase
TIP60-binding domain spanning amino acids 99-154. Through this domain, p30II interacts with
cellular TIP60 and enhances cMyc associated transcriptional activity on the cyclin D2 promoter
leading to increase in cell-cycle progression and increased cellular transformation (Awasthi S et
al, 2005). It was seen that p30II is present in c-MYC-containing nucleoprotein complexes in
HTLV-1-transformed T-lymphocytes. Moreover, p30II leads to inhibition of apoptosis in
proliferating cells expressing c-MYC under conditions of genotoxic stress. These reports provide
new insight into the mechanism of cooperation between p30II and c-MYC and demonstrate its
possible cooperation with retroviral accessory proteins during HTLV-1-associated T-cell
transformation (Awasthi S et al, 2005; Romeo MM et al, 2015). Furthermore, p30II can interact
with the PU.1 transcription factor through its DNA binding domain leading to a decrease in the
DNA binding ability of PU.1. The PU.1 directly regulates cell surface expression of TLR4 and in
presence of p30II expression there is suppression of TLR4 leading to a significant decrease in proinflammatory cytokines TNF-a, MCP-1 and IL-8 and an increase in the expression of antiinflammatory cytokine IL-10 (Datta et al, 2006). The p30II protein cooperates with Tax and HBZ
and enhances their oncogenic potential in colony transformation/foci-formation assays. Hutchison
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et al showed that the HTLV-1 latency-maintenance factor p30II by inducing the TP53-induced
glycolysis and apoptosis regulator (TIGAR) promotes immune evasion and survival of HTLV-1
infected cells by countering the oxidative stress, mitochondrial damage, and cytotoxicity caused
by the viral oncoproteins Tax and HBZ. They further demonstrated that p30II cooperates with the
viral transactivator to promote oncogenic colony formation in vitro, by activating p53 dependent
pro-survival signals including the TIGAR and suppresses Tax-induced oxidative stress (Hutchison
T et al. 2018). Overall, these studies indicate that p30II regulates transcription of viral genes as
well as cellular genes and also regulates innate and adaptive immunity through influencing cellular
transcription, to create an environment that promotes viral gene expression and survival of infected
cells.
Cell-cycle Regulation: Cell-cycle control is a highly regulated pathway that ensures proper
cellular division and cell-cycle progression. Some studies have shown that p30II activates the
G2/M checkpoint by increasing the phosphorylation of Chk1 and subsequently the
phosphorylation of Cdc25 (Datta et al. 2007). p30II binds to and recruits TIP60 to Myc-responsive
promoters stabilizing the Myc/TIP60 interactions. The stabilization of Myc/TIP60 interactions by
p30II causes transactivation of the cyclin D2 promoter and progression to S-phase leading to
polyploidy and enhanced Myc-transforming activities (Awasthi et al, 2005). However, Baydoun
et al showed that p30II delays S-phase entry by binding to Cyclin E and Cdk2. This interaction
prevents the formation of active Cyclin E/Cdk2 complexes causing a decrease in Rb
phosphorylation and preventing the release of E2F, ultimately delaying the start of S-phase
(Baydoun et al, 2011).
DNA damage repair: Retrovirus integration leads to double stranded DNA damage response
where the DNA double strand breaks are highly toxic, and the cells must repair DNA damage in
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order to avoid apoptosis. Double-strand DNA break repair can be carried out by either homologous
recombination or non-homologous end joining (NHEJ). Under conditions of double-strand DNA
breaks, the cell activates ATM (ataxia telangiectasia mutated) leading to the autophosphorylation
of ATM followed by the phosphorylation of H2A.X, and finally activation of Checkpoint kinase
2 (chk2) (Anupam et al, 2011; Baydoun et al, 2011). Chk2 phosphorylates p53, stabilizing p53 and
preventing p53 turnover by MDM2, thereby allowing for the repair of the breaks or the induction
of apoptosis (Baydoun et al, 2011). p30II down-regulates ATM and favors non-homologous end
joining (NHEJ). p30II interacts with REGg - a nuclear proteasome activator, and targets ATM for
proteasome mediated degradation. Lowering the levels of ATM upon DNA damage decreases p53
mediated apoptosis and promotes the survival of infected cells (Anupam et al. 2011). Hence, by
preventing apoptosis, p30II confers a growth advantage to those cells with DNA-damage. p30II
also translocates from the nucleolus to the nucleus upon DNA damage and inhibits homologous
recombination while promoting non-homologous recombination. p30II inhibits homologous
recombination by disrupting the MRE11/Rad50/NSB1 (MRN) complex and pushing the cell to
instead utilize NHEJ which allows for more mutations (Baydoun et al, 2011).
The second product of HTLV-1 orf-II is the singly spliced 87 amino acid long protein made
from the C-terminus of p30II, known as p13II (Albrecht and Lairmore, 2002; Ciminale et al,1992).
p13II is localized in the inner mitochondrial membrane owing to its special N-terminus
mitochondrial-targeting signal (Edwards et al, 2011; Albrecht and Lairmore, 2002). p13 forms an
amphipathic alpha-helix across the inner mitochondrial membrane which triggers an inward K+
and Ca+ current causing mitochondrial membrane depolarization and activation of the electron
transport chain and enhancing reactive oxygen species (ROS) production (Silic-Benussi et al,
2010). When expressed at high levels, p13 localizes within the nucleus. In the presence of Tax,
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p13 is ubiquitinated and translocates to nuclear speckles (Andresen V et al, 2011). In the nucleus,
p13 decreases transcription of cellular and viral genes by inhibiting formation of Tax-CBP/p300
complex. p13 also increases the sensitivity of T-cells to pro-apoptotic stimuli such as Fas ligand
(FasL), C2 ceramide, and glucose deprivation (Andresen V et al, 2011; Hiraragi H et al, 2005).
This pathway also triggers translocation of Ras to mitochondria and requires Ras farnesylation.
Farnesylated Ras goes to mitochondria and directly binds Bcl-2 inhibiting the anti-apoptotic
effects of Bcl-2. (Hiraragi H et al, 2005). This effect is interesting because p13 was also shown to
bind to farnesyl pyrophosphate synthase which is an enzyme required for the synthesis of
precursors necessary for the farnesylation of Ras and other substrates (Lefebvre et al, 2002).
Localization of the p13 protein within mitochondria and the nucleus suggests that this protein may
modulate effects on apoptosis and transcriptional regulation.
Orf-III p21Rex and Rex (p27): Two products p21Rex and Rex (p27) are formed from doubly
spliced bicistronic mRNA from orf-III. The major Rex open reading frame (Rof) protein is Rex
however the splice variant p21Rex is also produced at detectable levels (Nakano and Watanabe,
2012; Koralnik et al, 1993; Baydoun et al, 2008). CTLs against both these proteins have been
detected in HTLV-I infected asymptomatic carriers, HAM/TSP and ATL patients (Pique et al,
2000).
HTLV-1 Rex is a major post-transcriptional regulator of viral expression. It is responsible for
active viral replication in the early phase of infection and for reduction of viral activity to establish
latency in the late phase of infection (Nakano and Watanabe, 2012). Rex is a 27kD phosphoprotein
that binds to and facilitates nuclear export of viral mRNA. Rex also binds to and exports unspliced
and singly spliced mRNA coding for viral structural protein. This critical nuclear-cytoplasmic
export function and post-transcriptional control of mRNA translation makes Rex indispensable for
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viral replication (Inoue et al. 1987; Hidaka et al. 1988; Gröne et al. 1996). Rex binds to the Rex
responsive element (RxRE) of the viral transcript with high affinity. The 255 nucleotides long
RxRE sequence is located in the U3 to R region of the 3′ LTR and forms a stable secondary
structure consisting of four stem loops (Ahmed et al., 1990). Since RxRE locates to the U3 and R
regions, all unspliced, singly spliced and doubly spliced HTLV-1 mRNA have RxRE. RxRE
allows Rex to selectively bind to unspliced and partially spliced HTLV-1 mRNA in the nucleus
and exporting them to the cytoplasm, preventing further splicing and enhancing their effective
translation (Hidaka et al, 1988; Adachi et al, 1990, 1992; Hamaia et al, 1997). Rex also has a very
basic arginine-rich N-terminal RNA binding domain which also serves as nuclear localization
signal (NLS) and as binding domain for p30II (Nakano and Watanabe, 2012; Baydoun et al, 2008;
Bai et al, 2012). This RNA binding domain allows for binding to the Rex responsive element and
additionally it allows for Rex to be imported into the nucleolus (Baydoun et al, 2008). Through
the leucine-rich nuclear export signal (NES) Rex binds to Exportin-1 (CRM1), a cellular nuclear
export protein, to facilitate Rex shuttling between the nucleus and cytoplasm (Nakano and
Watanabe, 2012; Baydoun et al, 2008; Bai et al, 2012). NES is very hydrophobic and is also
referred to as the Rex-activation domain. Through interactions with CRM1, NES can induce Rex
multimerization (Bai et al, 2012; Baydoun et al, 2008). Rex multimers are assembled at the RxRE
enabling Rex nuclear export (Bai et al, 2012; Baydoun et al, 2008, Nakano and Watanabe, 2012).
Rex also increases the expression of il-2rα mRNA, although the mechanism through which it
upregulates is not clear. IL-2Rα overexpression in HTLV-1-infected cells increases the cellular
response to IL-2. Rex is capable of stabilizing il-2rα mRNA up to fivefold (Nakano and Watanabe,
2012); this explains the overexpression of this gene in HTLV-1-infected and ATL cells, at least
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partly, by the function of Rex. Altogether it appears that Rex functions as a positive regulator of
viral gene expression and helps regulate the switch from viral replication to latency.
The N′-truncated form of p27Rex is p21Rex. p21Rex lacks 78 aa of the N-terminus region,
including RBD/NLS and the N′-multimerization domain (Kiyokawa et al., 1985). The p21Rex
transcripts are expressed in HTLV-1-infected cell lines and have also been detected in primary
peripheral blood mononuclear cells from HTLV-1 carriers and ATL patients (Orita et al, 1992). It
is hence speculated that p21Rex plays a role in the HTLV-1 life cycle as a dominant negative form
of p27Rex.
HBZ: HBZ was the first viral protein found to be encoded in the antisense ORF of HTLV-1.
There are two transcriptional isoforms of the HBZ: an unspliced (usHBZ) form and a spliced
(sHBZ) form. usHBZ was discovered in 2002 (Gaudray G et al, 2001) and early publications on
HBZ were exclusively based on usHBZ. The alternative transcript, sHBZ, was first reported in
2006 (Cavanagh MH et al, 2006). Since sHBZ is more abundantly expressed in infected cells
(Yoshida M et al, 2008), current studies are mostly focused on sHBZ. The half-life of sHBZ is
much longer than that of usHBZ (Yoshida M et al, 2008). HBZ expression has been correlated
with HTLV-1 proviral load (Saito M et al, 2009). HTLV-1-infected rabbits were studied for kinetic
analyses of the HBZ transcript which revealed that HBZ was detected at relatively low levels early
after infection and its expression gradually increased and stabilized, whereas other viral genes were
maintained continuously at a low level (Zhao T, 2016). Previous study demonstrated that the HBZ
gene was expressed in all ATL cells and that HBZ gene knockdown inhibited the proliferation of
HTLV-1-infected cells, indicating that HBZ may play a critical role in HTLV-1-mediated
oncogenesis. HBZ is localized in the nucleus (Hivin P et al, 2005) and contains an activation
domain (AD) at its N-terminus, a central domain (CD), and a basic leucine zipper (bZIP) domain
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at the C-terminus. The N-terminus of HBZ has transactivating potential when fused with the DNAbinding domain of GAL4 and therefore it was named as the activation domain (Gaudray G et al,
2002). HBZ was first identified as a binding partner for the cAMP-response element binding
protein-2 (CREB-2) by yeast two-hybrid screening (Hivin P et al, 2005).
Several studies have demonstrated that HBZ plays critical roles in ATL leukemogenesis and
promotes cell proliferation (Matsuoka M and Green PL, 2009). Satou et al. reported that the HBZ
mRNA enhances proliferation of T cells in culture and in transgenic mice (Satou et al, 2006). Also,
the growth-promoting activity of HBZ was observed only in the cells expressing sHBZ and not in
those cells expressing usHBZ (Yoshida M et al, 2008). Mitobe et al. reported that HBZ RNA
increased the number of CD4+ T cells and suppressed cell death by activating the transcription of
the surviving gene, which inhibits apoptosis (Mitobe Y et al, 2015).
HBZ can interact with the bZIP domain of Jun, AP-1, and ATF/CREB- family of cellular
transcription factors to suppress viral gene expression from the HTLV-1 5’ LTR (Hilburn et al,
2011; Lairmore et al, 2011; Satou et al, 2006). HBZ is known to interact with cAMP response
element-binding protein 2 (CREB-2) and suppresses Tax-mediated viral transcription through
dimerization with CREB-2 preventing CREB-2 from binding to a Tax-responsive element in the
5’LTR of HTLV-1 (Gaudray G et al, 2002). HBZ also represses CREB-dependent transcription of
cellular genes from a cellular cyclic AMP-responsive element (CRE) in the cyclin D1 promoter
through its bZIP domain (Ma Y et al, 2013). Furthermore, HBZ inhibits Tax-dependent viral
transcription by interacting with the KIX domain of p300/CBP through its LXXLL-like motifs
located in the amino-terminus of HBZ and disrupting the Tax and p300/CBP complex (Clerc I et
al, 2008). Additionally, HBZ can inhibit the NFκB signaling pathway by binding to the NFκB p65subunit (Satou and Matsuoka, 2012; Zhao and Matsuoka, 2012). HBZ can also bind AP1-family
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members (Activating Protein 1) including JunB, JunD and c-Jun to regulate both viral and cellular
transcription (Zhao and Matsuoka, 2012; Kuhlman et al, 2007). HBZ has been shown to suppress
AP-1 signaling pathway, which is mediated by c-Jun and JunB (Hivin P et al, 2005). However,
HBZ can also form heterodimers with JunD and activate JunD-induced transcription and JunDdependent cellular genes including human telomerase reverse transcriptase (hTERT) (Kuhlmann
AS et al, 2007). This activation of telomerase by HBZ may contribute to the maintenance of and
survival of leukemic cells (Zhao T, 2016). ATL, like other cancers, has up-regulated hTERT
expression which may play a role in leukemogenesis (Zhao and Matsuoka, 2012; Kuhlman et al,
2007). Moreover, HBZ suppresses the canonical Wnt pathway and increases the expression of
noncanonical Wnt5a which enhances the proliferation and migration of ATL cells which may be
associated with the leukemogenesis of ATL (Ma G et al, 2013). Lastly, HBZ can up-regulate
cellular proliferation genes while down-regulating apoptotic genes by interacting with Activating
Transcription Factor 3 (ATF3), a member of the ATF/CREB family of transcription factors. ATF3
is constitutively expressed in ATL cell lines and all ATL cases. HBZ allows ATF3 to promote the
proliferation of ATL cells by upregulating the expression of cell cycle regulatory genes (Hagiya
et al, 2011).
HBZ plays a pro-survival role by suppressing the apoptosis of ATL cells. HBZ has been
demonstrated to decrease cellular apoptosis by inhibiting the transcription of a proapoptotic gene
Bim. HBZ interacts with FoxO3a, transcriptional activator of the Bim gene, and attenuates its
DNA binding ability by epigenetic alterations and histone modifications in the Bim promoter
region (Tanaka-Nakanishi A et al, 2014). Furthermore, Zhao et al. reported that HBZ protein
selectively inhibits Tax-mediated classical NF-κB activation by inhibiting p65 DNA binding
capacity and by promoting expression of the PDLIM2 E3 ubiquitin ligase, which results in p65
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degradation. Thus, HBZ suppresses the onset of Tax-induced cellular senescence by downregulating NFkB signaling (Zhao T et al, 2009). HBZ inhibits p65 acetylation and leads to
repression of the classic NFκB pathway. Another study demonstrated that HBZ maintains viral
latency by down-regulating Tax-mediated NF-kB activation and by inhibiting Rex-induced
expression of viral proteins (Philip S et al, 2014). NF-kB signaling is a well-known mediator of
host immunity. Hence it is possible that HBZ-mediated suppression of the classical NFκB pathway
in ATL may facilitate escape from the host immune attack by decreasing the expression of genes
associated with innate immunity and inflammatory responses (Saitoh Y et al, 2008). This role of
HBZ also indicates towards a possible cooperative interplay between Tax and HBZ for the longterm development and maintenance of leukemic cells in ATL.
HBZ transgenic mice were found to have increased numbers of Foxp3+CD4+ T cells. This
population includes regulatory T cells (Tregs) which is a T-cell subset known to suppress effector
T cells (Zhao T et al, 2011). It was seen that HBZ forms a ternary complex of HBZ/Smad3/p300
by interacting with Smad2/3, key components of the TGF-β pathway, and leads to enhanced TGFβ/Smad transcriptional responses in a p300-dependent manner. The enhancement of TGF-β
signaling by HBZ results in the overexpression of Foxp3 in naïve T cells. Thus, HBZ induces T
cells to become Tregs by enhancing the TGF-β/Smad pathway and upregulating Foxp3. As a
mechanism, HBZ impairs the suppressive function of Treg cells by binding to Foxp3 and NFAT.
HBZ interacts with Smad3 in a fashion similar to several other viruses that seem to employ a
common strategy to nullify the TGF-β signaling by having their viral proteins bind to Smad
proteins (Zhao T, 2016). By impairing functions of conventional and regulatory T cells, HBZ
critically contributes to the development of inflammation (Zhao T, 2016).
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HBZ interacts with both viral and cellular factors and suppresses major HTLV-1 sense genes
including Tax, promotes T-cell proliferation, suppresses cellular apoptosis and senescence,
enhances viral infectivity, induces T-cell lymphoma and inflammation. Also, HBZ is the only
detectable protein in patient isolates suggesting that HBZ expression plays an important role in
HTLV-1- leukemogenesis (Zhao T, 2016; Yoshida et al, 2008; Satou et al, 2006). Taken together,
these observations indicate that the HBZ gene is essential for cellular transformation and
leukemogenesis of HTLV-1.
Orf-IV (Tax): The tax gene encodes 353 amino acids long, 40-kD nuclear phosphoprotein. Tax
is the potent transactivator of viral transcription. Tax has a nuclear localization signal at its amino
terminus and hence it is predominantly present in the nucleus (Smith MR et al, 1992). However, a
substantial portion of Tax is present also in the cytoplasm due to its leucine-rich (LR) nuclear
export signal (NES) (Alefantis T et al, 2003). Tax has also been shown to be localized at
extranuclear sites at the Microtubule-Organizing Complex (MTOC) (Semmes et al, 1996; Kfoury
et al, 2012). Tax exists as a dimer and was originally discovered as a transactivator of viral RNA
transcription from a promoter located at the 5'-LTR (Jin DY et al, 1997). Tax interacts with a
number of cellular proteins and modulates a wide variety of cellular signaling pathways leading to
transcriptional activation, proliferation and ultimately transformation. Tax also interacts with host
transcription factors including CREB and recruits coactivators such as CREB binding protein
(CBP) to the LTRs and regulates viral gene expression. Tax has pleiotropic functions and it
regulates several cellular signaling pathways such as CREB, AP-1, NFAT and NFκB (Jeang KT,
2001; Azran I et al, 2004). Tax also dysregulates cell cycle control and inactivates tumor
suppressors such as p53 and Rb (Jeang KT, 2001).
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Figure 3. Diagram of HTLV-1 Tax with its functional domains. HTLV-1 Tax is a 353 aa
long protein that contains a NLS: nuclear localization signal, NES: nuclear export signal, two
(LZ) leucine zipper like regions and a dimerization domain. The mutations M22, G148V and
M47 are also represented in the figure. It also contains p300/CBP binding domain and CREB
binding domain in addition to binding domains for several other transcription factors. (Malu
et al; 2019, submitted)

Several lines of evidence point towards the fact that Tax protein has the ability to initiate
cellular transformation and immortalization. Grassman demonstrated that using a nontransforming Herpesvirus saimiri vector when the pX region of HTLV-1 was introduced into
primary T cells, it resulted in the constitutive high-level expression of functional IL-2 receptors.
Unlike the normal activated T cells, these pX-expressing T-lymphocytes could be maintained in
continuous long-term culture in the presence of exogenous IL-2 (Grassman R et al, 1989),
suggesting that the HTLV-I pX gene products may deregulate the normal transient nature of the
T-cell growth response. Moreover, in the transgenic mice expressing the tax gene, multiple
mesenchymal tumors and neurofibromas were seen (Hinrichs S et al, 1987). When Tax is coexpressed with Ras, it induces the formation of cellular foci and these cells when injected into
nude mice led to tumor formation (Pozzatti et al, 1990). Similarly, when tax gene was stably
expressed in a rat fibroblast cell line (Rat-1), it resulted in cellular transformation and demonstrated
contact inhibition and anchorage independence in these cells (Tanaka A et al, 1990).
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Tax is highly immunogenic and is one of the principal targets of cytotoxic T cells (CD8+ T
lymphocytes). Hence, in order to evade the host’s adaptive immunity HTLV-1 uses multiple
mechanisms to downregulate viral antigens, including Tax, and enter a state of latency. The viral
regulatory proteins HTLV-1 basic leucine zipper factor (HBZ), p30II and Rex exert negative
effects on Tax expression and help in immune evasion (Nicot C et al, 2004; Anupam R et al, 2013).
The HTLV-1 Tax protein is required for oncogenic transformation of infected cells (Akagi T et al,
1995); however, tax transcripts are detected in only about 40% of all ATLs. Further studies of
HTLV-1 proviruses and tax transcripts in ATL cells revealed three ways in which cells can silence
Tax expression: genetic changes are seen in ~10% of ATL cases (nonsense mutations, insertions
and deletions in tax) (Furukawa Y et al, 2001; Takeda S et al, 2004); in ~15% of ATL cases DNA
methylation of the provirus leads to silencing of viral transcription (Takeda S et al, 2004; Koiwa
T et al, 2002; Taniguchi Y et al, 2005); and lastly, in ~27% of ATL cases deletion of 5′ LTR of
the provirus is observed (Tamiya S et al, 1996). While it seems likely that Tax may play a crucial
role in the development of ATL, Tax may not be required for the maintenance of this transformed
phenotype. Later it was accepted that Tax is needed in early stages of virus infection to initiate
transformation, but it is not required later for maintaining the transformed phenotype of ATL cells
(Tamiya S et al, 1996).
Activation of viral transcription by Tax: CREB/ATF transcription factors are involved in cell
growth, survival and apoptosis by regulating CRE- directed gene transcription in response to
growth factor signals or stress (Taylor G, 2007). The U3 region of the HTLV-1 LTR contains a
region known as Tax responsive element 1 (TxRE-1 or TRE1) composed of three discontinuous
21 base pair repeats (Seiki et al, 1983). The TRE element contains an octamer motif that is flanked
by a G-rich sequence at the 5’ end and C-rich sequence stretch at the 3’ end. This octamer shares
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homology with the consensus cAMP-responsive elements (CRE) 5’- TGACGTCA-3’ (Yin MJ and
Gaynor RB, 1996). Tax can form stable ternary complexes with cellular transcription factors
CREB and ATF-1 that contain a basic leucine zipper domain (b-ZIP). In these ternary complexes,
CREB/ATF-1 bind the CRE of the 21-bp repeats and Tax binds the b-ZIP domains of CREB/ATF1 (Adya N et al, 1994; Yin M et al, 1995; Baranger AM et al, 1995; Perini G et al, 1995) and makes
contacts with the DNA minor groove of the G/C-rich sequences that flank the CRE. This allows
for high DNA sequence specificity of LTR transactivation by Tax (Lundblad JR et al, 1998). Thus,
Tax increases CREB/ATF dimerization and their affinity for viral CREs by stabilizing the ternary
complex through direct contact with the GC-rich flanking sequences (Taylor G, 2007; Boxus M et
al, 2008; Yin MJ and Gaynor RB, 1996; Lundblad JR et al, 1998). Furthermore, Tax recruits the
co-activators CBP/p300 and P/CAF and facilitates transcription initiation, binds to CREB-binding
protein (CBP), and forms a bridge between CREB and CBP. This ternary complex consisting of
TAX/CREB/TRE is stabilized through Tax binding and the recruitment of the co-activators
p300/CBP and P/CAF resulting in histone acetylation, opening of the nucleosome and
transcriptional activation (Harrod R et al, 1998; Harrod R et al, 2000; Boxus M et al, 2008)
allowing positive regulation of viral promoter by Tax. A number of cellular genes contain a
consensus CRE element in their promoters which are activated by elevation in CAMP levels. The
elevated CAMP activates PKA which phosphorylates CREB and in turn, CREB binds to
CBP/p300. It is possible that Tax can activate the CRE located in cellular promoters in addition to
the viral CRE activation. There are some data that demonstrate that Tax uses the CREB/ATF
factors to repress the expression of certain genes including cyclin A, p53 and c-myc (Boxus M et
al, 2008). This activation of CREs by tax may play a role in initiation of oncogenic process by
dysregulating the cell cycle control and growth control.
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Tax-mediated NFkB activation: The NFkB family of transcription factors regulate the
expression of over 100 target genes and is known to regulate diverse biological processes and the
expression of genes involved in immune responses, development, cell proliferation, apoptosis and
survival (Ghosh S et al, 1998). Deregulation of NFkB has been associated with several human
diseases, specially cancers (Xiao F and Fu J, 2011). The NFkB pathway is a lucrative target to
viral pathogens because the activation of NFkB is a rapid immediate early (IE) event that occurs
within minutes following exposure to a stimulant and does not require any de novo protein
synthesis and yet it results in a strong transcriptional activation of many cellular genes as well as
early viral genes (Hiscott J et al, 2001). The NFkB family consists of Rel family members which
function as homo- and hetero-dimers and share a highly conserved 300-amino acid-long Nterminal Rel homology domain (RHD) which is also responsible for their dimerization, nuclear
translocation, DNA binding and interaction with the inhibitors of NFkB (IkBs). Rel family
includes five closely related DNA binding proteins: RelA (p65), RelB, c-Rel, NFkB1/p50 and
NFkB2/p52, which regulate transcription of genes containing kB motifs in their promoters (Xiao
G et al, 2006). The p50 and p52 proteins are generated from their precursors p105 and p100
respectively, by proteasome-mediated degradation. In resting cells, Rel proteins are sequestered in
the cytoplasm through their interactions with the inhibitory proteins IkBα, IkBβ, and IkBϵ, as well
as the precursor proteins p105 and p100. Upon stimulation, the IkB kinase (IKK) complex, which
is composed of 2 catalytic subunits, IKKα and IKKβ, and the scaffolding protein, NFkB essential
modulator (NEMO, also known as IKKγ) gets activated. The IKK complex phosphorylates
specific serine residues on the IkB proteins leading to their poly-ubiquitination and proteasomedependent degradation or processing (Baldwin AS Jr., 2001; Hayden MS and Ghosh S, 2004).
These released NFkB then translocates to the nucleus and regulates the expression of target genes.
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Moreover, the gene encoding IkBα is also under the control of NFkB and thus provides a negative
feedback loop to control the NFkB activation of its downstream cellular gene targets (Sun SC and
Ballard DW, 1999).
Persistent NFkB activation by HTLV-1 Tax is the key event for T-cell transformation and the
development of ATL (Qu Z et al, 2011; Zhang H et al, 2016). Despite the fact that the HTLV-1
proviral genome is integrated and NFkB is constitutively activated in ATL cells, Tax is expressed
in only about 40% ATL cells, however HBZ is consistently expressed in all ATL cells (Zhao T,
2016). This suggests the possible contribution of additional factors in order to sustain the persistent
activation of NFkB even in the absence of Tax in ATL cells (Matsuoka and Jeang, 2007). The
regulation of NFkB pathway by HTLV-1 Tax is discussed in further detail in a separate section of
this dissertation.
Cell-cycle deregulation and DNA damage by Tax: HTLV-1 Tax has been implicated to play a
crucial role in cell cycle control. By disrupting cell cycle check points, Tax prevents apoptosis/cell
death and promotes the proliferation of infected cells conferring an obvious advantage to the virus
infected cell. The interaction of Tax with cell cycle components often results in dysregulation
leading to cellular abnormalities including aneuploidy and immortalization of T-cells, all of which
play key roles in oncogenesis (Currer R et al, 2012). Cell cycle progression is tightly regulated by
cyclins and cyclin-dependent kinases (CDK). Passage from G1 phase and G1/S transition is carried
out by Cyclin D-CDK4/6 and Cyclin E-CDK2 complexes respectively. Tax has been shown to
activate G1/S entry. Specifically, Tax can disrupt the G1/S transition by its direct interaction with
CDK4 and CDK6 via its amino terminal domain. Through these interactions, Tax stabilizes the
cyclin D2/CDK4 complex and enhances its kinase activity, leading to hyperphosphorylation of
retinoblastoma protein (Rb) (Ohtani K et al, 2000; Jeang KT et al, 2004; Schmitt I O et al, 1998).
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G1/S progression can be inhibited by CDK inhibitors (CDKI) such as p15INK4b, p16INK4a,
p18INK4c and p19INK4d that bind to CDKs and make them unavailable for cyclin binding. Tax
associates with p15INK4b and p16INK4a and prevents it from binding to CDK4 and CDK6 (Low
KG et al, 1997). Finally, Tax has also been shown to directly bind to the hypo-phosphorylated
form of Rb and targets it for proteasomal degradation (Kehn K et al, 2005).
Another cell cycle checkpoint that the cell passes is while going from G1 to S phase and is
regulated by the tumor suppressor p53. p53 is mutated in approximately half of all human cancers,
but interestingly in ATL p53 is often wild-type (Mulloy et al, 1998; Pise-Masison and Brady, 2005;
Zane et al, 2012). In case of DNA damage, p53 is activated by ATM/ATR DNA damage
recognition pathways and signals for repair (Zhou and Elledge, 2000). Tax disables the p53mediated G1/S checkpoint, allowing cell cycle progression to occur even in the presence of DNA
damage (Haoudi and Semmes, 2003). Tax activates expression of the p53 target gene, p21waf1 in
a p53 independent manner (De La Fuente et al, 2000). The ability of Tax to induce p21waf1
expression in HTLV-1-immortalized cells is associated with resistance to apoptosis (Kawata et al,
2003). Tax may also inhibit the G1/S checkpoint by inactivating p53 (Mulloy et al, 1998; PiseMasison et al, 1998). Tax neither binds to p53 nor represses its transcription. However, it was
shown that in the presence of Tax expression there is nuclear stabilization of p53 (Cereseto et al,
1996). There are two major theories to explain the inactivation of p53 by Tax. In some studies, it
was shown that Tax and p53 compete for binding to the ubiquitous coactivator CBP/p300, thereby
decreasing the ability of p53 to activate target gene expression (Suzuki et al, 1999b; Van et al,
2001). Another mechanism of p53 inactivation is through NFκB signaling pathway (Pise-Masison
et al, 2000). Tax was shown to facilitate the formation of functionally inactive complexes
containing p65RelA and p53, and this interaction requires p53-phosphorylation on serine 15. This
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Ser-15 site was previously shown to be preferentially phosphorylated in Tax-expressing cells
(Jeong et al, 2004). Also, through repressing p53-dependent transcription, the p53-dependent gene
Bax is also repressed and inhibits the induction of apoptosis (Satou and Matsuoka, 2012; Kfoury
et al, 2012). By preventing several p53-dependent apoptotic pathways, cells can continue to
proliferate and may lead to a defective DNA damage response seen in Tax-expressing cells.
Anaphase promoting complex (APC) is a E3-ubiquitin ligase that functions to direct ubiquitinmediated degradation of anaphase inhibitors. A complex between the APC and its accessory factor
Cdc20p, known as APCcdc20p, ubiquitinates cyclin B1 as well as the Pds1p/securin protein and
targets them for degradation. Liu et al. demonstrated that Tax directly binds to and prematurely
activates APCcdc20p, leading to premature degradation of cyclin B and causing delayed cell cycle
progression. This also leads to an improper sister chromatid separation and contributes to
aneuploidy. This interaction between Tax and APC-related complexes may explain the mitotic
defects observed in Tax-expressing cells (Liu et al, 2003; 2005). Several cellular proteins including
the mitotic arrest defective (MAD) proteins 1 and 2 are responsible for securing this checkpoint.
MAD1 was identified as a binding partner of Tax, and it was observed that Tax binds to hMAD1
and causes prominent cytokinesis defects in the form of multinucleation Tax-expressing cells (Jin
et al, 1998).
HTLV-1 associated Pathogenesis
ATL is one the most aggressive disease associated with HTLV-1 infection. In addition to it
there are other HTLV-1 associated conditions including HTLV-1 associated myelopathy/tropical
spastic paraparesis (HAM/TSP), infective dermatitis associated with HTLV-1 (IDH) and an
inflammatory eye condition called HTLV-1 associated uveitis (HAU). HAM/TSP can manifest in
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about 3-5% of HTLV-1 infected individuals. It commonly affects women with an average age of
40 years at disease onset. HAM/TSP is a neurological condition manifested due to lesions in central
nervous system (CNS) as a result of infiltration of HTLV-1 infected CD4+, CD8+ T cells and
proinflammatory cytokines and chemokines into the CNS. It involves spasticity of lower limbs,
bowel and bladder disturbances and a slow and steady progression over several years. While ATL,
HAM/TSP, and ID are the major diseases associated with HTLV-1- infection, eyes, skin, joints,
and bone are also affected by HTLV-1. Some HTLV- 1-positive individuals develop Sézary
syndrome, a cutaneous T-cell lymphoma (Green et al, 2001). Autoimmune disorders, like Sjögren
syndrome may be associated with chronic lymphocytic infiltration in both salivary and lacrimal
glands, (Goncalves et al, 2008).
TSP/HAM: This is a chronic meningomyelitis of the gray and white matter in the spinal cord
with perivascular demyelination and axonal degeneration that usually begins in adulthood.
TSP/HAM is characterized by weakness and spasticity of the extremities, mild peripheral sensory
loss, and hyperreflexia (Cooper SA et al. 2009). The majority of TSP/HAM patients are
seropositive for anti-HTLV-1 antibodies (Osame et al, 1987) and polyclonal integration of proviral
DNA is common. There is presence of morphologically atypical lymphocytes in the peripheral
blood. There have been cases where HAM/TSP developed within months of infection by
contaminated blood products; this is significantly different from ATL, which usually develops
after an incubation period of decades. In a few cases however, ATL and TSP/HAM have been
known to occur in the same patient. HTLV-1 DNA can be found in blood and CSF lymphocytes
(Yoshida et al, 1987). High levels of HTLV-1 specific cytotoxic T-lymphocytes (CTLs) have been
detected in TSP/HAM patients that may contribute to the neurological damage (Johnson JM et al,
2001). It has been suggested that the central nervous system (CNS) damage may be due to the
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recognition of infected cells which are then lysed by the host's immune system. HTLV-1 can infect
neuronal cells in vitro and in vivo (Yoshida et al, 1987). An alternate way of damage may be
indirectly due to autoimmune or cytokine-mediated mechanisms since there is a marked increase
in levels of TNF-α, GM-CSF, IFN-γ, and IL-1 in TSP/HAM patients unlike those in asymptomatic
carriers (Watanabe et al, 1995). There is no curative treatment for TSP/HAM and the prognosis
depends on the individual immune response and proviral loads. Corticosteroids, IFN-α, and IFNβ1a have shown limited results (Nakagawa MK et al, 1996).
Infective Dermatitis associated with HTLV-1 (ID): HTLV-1 is often associated with
dermatological lesions. ID was the first pediatric syndrome associated with HTLV-1 infection. ID
is a severe recurrent childhood eczema with the first symptoms manifesting at approximately 18
to 24 months. Children with IDH are vertically infected through breast milk of HTLV-1
seropositive mothers (De Oliveira et al, 2010). It is characterized by a severe and relapsing
eczematous disease with lesions involving the scalp, neck, external ear, axillae, and groin (La
Grenade L et al, 1990). ID is a very important manifestation because cutaneous involvement in an
asymptomatic carrier has been considered an indicator of future ATL or HAM/TSP development
(Goncalves DU et al, 2010). Follicular papules and pustules on affected areas is seen. ID patients
yield positive cultures of Staphylococcus aureus and beta-hemolytic Streptococcus for nostrils or
skin (La Grenade L et al, 1990). An adequate response to systemic antibiotics and topical steroids
is usually obtained, although relapse is common (La Grenade L et al, 1990). IDH usually
disappears by adolescence; however, the patient may develop ATL or HAM/TSP in adulthood (De
Oliveira et al, 2010).
HTLV-1-Associated Uveitis (HAU): HAU is characterized by a granulomatous or nongranulomatous reaction accompanied by vitreous opacities and retinal vasculitis in one or both
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eyes (Mochizuki M et al, 1992). It can occur as the only HTLV-1 manifestation or can be
associated with HAM/TSP. HAU target population are either male or female HTLV-1-infected
middle-aged adults. “Flying flies” and acute or sub-acute visual blurring characterized by ‘floaters’
and foggy vision in the eye are characteristic symptoms associated with HAU (Mochizuki M et al,
1992; Goncalves DU et al, 2010). Uveitis was more frequent among those with an earlier onset of
HAM/TSP and in patients with severe motor disability (Goncalves DU et al, 2010). The immune
system of patients with HAU has abnormalities similar to those seen for patients with HAM/TSP
including high proviral load, overproduction of proinflammatory cytokines, and the presence of
HTLV-1 provirus in the spinal fluid. HAU can be either an independent inflammatory disease
associated with HTLV-1 or, perhaps, a predictor of HAM/TSP. HAU in the Caribbean and Brazil
areas is observed to manifest the corneal disease which was not described for Japanese patients
(Mochizuki M et al, 1992). The treatment of uveitis is based on topical and systemic
corticosteroids. Usually the response to therapy is satisfactory and the patients are able to get their
vision back to normal, although recurrence is also common. In order to prevent ocular
complications such as corneal ulcers lubricating drops are widely used (Goncalves DU et al, 2010).
Characteristics of ATL
HTLV-1 infection sometimes results in development of an aggressive non-Hodgkin’s
peripheral T-cell malignancy- ATL. Most of the HTLV-1 infected individuals remain
asymptomatic throughout their lifetime except about 5% that go on to develop ATL after a long
latency period of 40-50 years. The disease is associated with diverse clinical features including
lymphadenopathy, hepatosplenomegaly, skin lesions, blood and bone marrow involvement,
hypercalcemia and lytic bone lesions. Shimoyama classification (Lymphoma Study Group
classification) that takes into account lymphocytosis, tumor syndrome, hypercalcemia, and lactate
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dehydrogenase (LDH) values recognizes four ATL subtypes: acute and lymphoma aggressive
forms, chronic and smoldering indolent forms (Shimoyama M, 1991). Wattel E et al have
described the borderline state between healthy carriers of HTLV-1 and ATL patients as pre-ATL
(Wattel E et al, 1995). Pre-ATL is an asymptomatic phase and is characterized by the presence of
abnormal peripheral blood lymphocytes with characteristic ATL-cell morphology. From the preATL phase, a patient can either go back to normal or progress to one of the subtypes of ATL. The
clinical features of ATL are dependent on the disease type (Shimoyama M, 1991). Acute ATL
(so-called prototypic ATL) comprises 60% of all ATL cases and has a leukemic presentation.
Acute ATL presents with lymphadenopathy, hepatosplenomegaly, lytic bone lesions, skin lesions
and systemic multi-organ involvement. Hypercalcemia is frequently observed along with diverse
opportunistic infections due to general immunosuppression (Takatsuki K et al, 1985; Bazarbachi
A et al, 2011). 20% of all ATL cases are referred to as lymphoma type ATL and have lymph node
enlargement with < 1% of leukemic cells circulating in the peripheral blood. The lymphoma type
of ATL is considered to be a form of T-cell-type non-Hodgkin's lymphoma. These patients may
also present with hepatosplenomegaly, lytic bone lesions, skin lesions, gastrointestinal, and lung
infiltration which are usually less frequent than in acute-type ATL (Bazarbachi A et al, 2011). The
smoldering type ATL presents infiltration of skin or lung with no other visceral involvement, a
normal lymphocyte count, and about 1-5% abnormal lymphocytes in the peripheral blood
(Tsukasaki K et al, 2013; Bazarbachi A et al, 2011; Shimoyama M, 1991). Chronic-type ATL is
associated with high lymphocyte count and chronic peripheral lymphocytosis for several years
associated with skin and lung involvement, lymphadenopathy, and hepatosplenomegaly. Chronic
ATL however does not have any associated hypercalcemia or infiltration of the CNS,
gastrointestinal tract, or bones. Lactate dehydrogenase levels are normal or only slightly increased
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(Tsukasaki K et al, 2013; Bazarbachi A et al, 2011; Shimoyama M, 1991). Chronic-type ATL is
further sub-grouped into favorable and unfavorable. Unfavorable subtype is defined by low serum
concentration of albumin, high lactate dehydrogenase, and a high expression of Ki-67 antigen
(Shirono K et al, 1994; Yamada Y et al, 2001).
ATL patient serum contains antibodies to HTLV-1 and in most cases, the HTLV-1 provirus is
clonally integrated in the CD4+ CD25+ -activated T lymphocytes, which have the characteristic
flower shaped nuclei. Although the exact mechanism is not known but this appears to be the first
step in the multistep HTLV-1 related oncogenesis (Franchini G, 1995). ATL cells express the IL2
alpha receptor (IL2-R, CD25) and show a constitutive activation of NF-kappa B pathway.
Structural and numeric karyotypic abnormalities are seen more frequently in aggressive ATL cases
than in indolent ATL (Kamada N et al, 1992). The most frequent aberrations included gains at
chromosomes 14q, 7q, and 3p and losses at chromosomes 6q and 13q. (Tsukasaki et al, 2001). In
ATL cases, the gene deletions tend to cluster around cyclin dependent kinase inhibitors and cell
cycle regulatory genes such as p15 (INK4A), p16 (INK4B), p18 (INK4C), p19 (INK4D), p21
(WAF1), p27 (KIP1), as well as p53 and retinoblastoma (Rb) (Hatta and Knoeffler, 2002). The
p53 tumor suppressor is mutated in nearly half of all cancers, but p53 mutations are rarely observed
in ATL patient samples (Hatta and Knoeffler, 2002). However, it was observed that the p53 gene
was mutated in 10% to 50% of aggressive type ATL cases, whereas its frequency was much lower
in indolent-type ATL (Cesarman E et al, 1992). These studies indicate that mutations in the cell
cycle-related genes are more likely to be associated with more severe stages of ATL than with
earlier clinical stages of this malignancy.
Furthermore, ATL cells have an intrinsic resistance to various chemotherapies. All these
factors taken together result in very poor prognosis for ATL disease, and a median survival of 6.2,
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10.2, and 24.3 months for acute, lymphoma, and chronic subtypes, respectively (Shimoyama M,
1991).
Current Therapies and Treatment of ATL
ATL is diagnosed by testing the sera for anti-HTLV-1 positivity and checking the presence of
a mature T-cell malignancy. To confirm the diagnoses, identification of monoclonal integration of
HTLV-1 proviral DNA in tumor cells is done by Southern blot analysis ATL (Shimoyama M,
1991). The treatment strategy for ATL is universally based on certain factors including clinical
subtypes, prognostic factors and response to initial therapy (Utsunomia A et al, 2015). Patients
with aggressive ATL (acute and lymphoma types and chronic type with poor prognostic factors)
are recommended intensive chemotherapy regimens such as VCAP-AMP-VECP (vincristine,
cyclophosphamide, doxorubicin, and prednisone; doxorubicin, ranimustine, and prednisone;
vindesine, etoposide, carboplatin, and prednisone) or AZT/IFN-α combination therapy
(zidovudine/interferon α), except for in cases with lymphoma. In cases of indolent ATL
(smoldering type and chronic type without poor prognostic factors), either waiting with careful
observation or AZT/IFN-α combination therapy is recommended until disease progression is seen.
In both United States and Europe, leukemic-type ATL is treated using AZT⁄ IFN-α antivital
therapy. However, for lymphoma-type ATL, the overall survival with AZT⁄ IFN-α alone is very
short hence chemotherapy is the first-line therapy in such cases (Bazarbachi A et al, 2010). A
small-scale study has also reported the efficacy of the combination of AZT/IFN-α and arsenic
trioxide in chronic ATL patients (Kchour G et al, 2009). Moreover, the addition of arsenic trioxide
was shown to induce Tax degradation in vitro (Dassouki Z et al, 2015). Due to mutations in
multidrug resistance (MDR) genes and tumor suppressor genes like p53, there is approximately
10% reduction in long term treatment success making ATL very resistant to therapy (Taylor and
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Matsuoka, 2005; Matsuoka, 2003; Bazarbachi et al, 2011). More recently other strategies such as
hematopoietic stem cell transplantation for relatively young patients with aggressive ATL are also
being applied (Utsunomia A et al, 2015).
Animal Models of HTLV-1 and ATL
Researchers started to develop animal models to understand the biology of HTLV-1 infection
shortly after the discovery of HTLV-1. Animal models are of great use as they can help to develop
vaccines, study the disease progression and test new therapies. HTLV-1 can infect animals, such
as rabbits, rats, and monkeys (Akagi et al, 1985; Nakamura et al, 1987). HTLV-1 infected rats
were shown to develop a chronic progressive myeloneuropathy which was similar to HAM
(Kasai et al, 1999). Over years several animal models for ATLL have been described and
developed in rats and rabbits (Ohashi et al, 1999; Simpson et al, 1996). However, it was seen that
although leukemic cells can be transplanted in these models, leukemia of rat or rabbit origin does
not develop in these animals. Transgenic animals are being used more recently to examine the
effect of single or multiple viral genes, particularly the viral transactivator Tax, on HTLV-1
associated leukemogenesis. Tax has been shown to play an important role in the induction of
tumors in transgenic mice (Hinrichs et al, 1987; Grossman et al, 1995; Yamada et al, 1995).
Rabbit Models: It has not been easy to establish a clinical HTLV-1 disease model in rabbits.
Although, infectivity in rabbits was demonstrated early in the mid-1980s using intravenous
inoculations of an ATL patient T-cell leukemia cell line known as the MT-2 cell line (Akagi et al,
1985), and a rabbit lymphocyte cell line derived from cocultivation of rabbit lymphocytes with
MT-2 cells, called the Ra-1 cell line (Miyoshi et al, 1985). This initial study also demonstrated
that HTLV-1 was transferable via blood transfusions in rabbits (Miyoshi et al, 1984; 1985) and
that cell-free plasma was not capable of transmitting the virus to rabbits (Kotani S et al, 1986). In
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most of these studies, rabbit infection has been like the asymptomatic infection of humans. Some
groups have tried to reproduce an ‘ATL-like disease’ via intraperitoneal or intravenous injection
of HTLV-1-transformed cells; however, this required a huge number of cells and death occurred
within the first few weeks of inoculation (Lairmore MD et al, 2005). The early studies in rabbits
helped verify routes of transmission of HTLV-1 (e.g. blood, semen, milk) (Kotani et al, 1986).
Infectious molecular clones of HTLV-1 were first developed in the mid-1990s (Kimata et al,
1994). The molecular clones were used to immortalize human PBMCs to create the ACH cell line,
which was then used to infect rabbits to demonstrate that the lethally irradiated ACH cell line could
successfully establish infection in the PBMCs of rabbits (Collins et al, 1996). Later, mutant ACH
molecular clones disrupting some HTLV-1 accessory genes within the ORF, including, p12I, p13II,
and p30II, were generated and inoculated into rabbits to analyze their importance during in vivo
infection (Silverman et al, 2004). The regulatory gene, Rex, and accessory genes, p12 and p30II,
have all been demonstrated as dispensable for viral immortalization in vitro (Lairmore MD et al,
2005).
Rat Models: Rats as experimental models for HTLV-1 infection were first established in 1991
(Suga et al, 1991). It was established that there were considerable differences in the response of
various rat strains to HTLV-1 infection (Lairmore MD et al, 2005). The HTLV-1-infected WistarKing-Aptekman (WKA) strain of rats were concluded to produce an antibody response to HTLV1 and was established as a model for TSP/HAM (Yoshiki T, 1995). Moreover, rat models have
been proven to be a valuable tool for studying mother-to-child transmission of HTLV-1 by vertical
transmission as well as intrauterine transmission (Lairmore MD et al, 2005). Immunodeficient rats
were inoculated with some specific HTLV-1-immortalized cell lines to develop an ‘ATL-like
lymphoproliferative disease’ model (Ohashi T et al, 1999).
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Non-human Primate Models: Miyoshi et al in 1984 first reported that HTLV-1 infection is
possible in non-human primates by intravenous inoculation of HTLV-1 producing Ra-1 cell line
into Japanese monkeys which resulted in antibody production and seroconversion (Miyoshi et al,
1984; 1985). Squirrel monkeys were also inoculated with a HTLV-1 producing cell line and
although no signs of ATL development were observed until two years after inoculation, peripheral
lymphocytes, spleen, and lymph nodes were verified as major reservoirs for HTLV-1 virus during
the early phase of infection (Kazanji M et al, 2000). It was later reported that, HTLV-1 infection
in squirrel monkeys begins through reverse transcription of the virus genome, followed by clonal
expansion of infected cells, a process similar to that seen in humans (Mortreux et al, 2001). HTLV1 infection in macaques can lead to human-like manifestations of disease including arthritis,
uveitis, and polymyositis (Beilke MA et al, 1996) and various combinations of rash, diarrhea,
lymphadenopathy, and lymphopenia (McGinn TM et al, 2002). Many studies used cynomolgus
and squirrel monkeys, Japanese macaques for testing vaccines and passive immunization
(Lairmore MD et al, 2005).
Mouse models: Similar to rabbit and rat models, HTLV-1 doesn’t efficiently infect murine
cells either. Hence in order to maintain persistent infection, mouse models were manipulated by
using intra-peritoneal inoculation. The inoculation of immunocompetent mice is similar to in vivo
human infection in several ways. A broad spectrum of infected cell types were seen in infected
mice including CD4+, CD8+, B cells, and granulocyte fractions, similar to those observed in
HTLV-1-infected individuals. Furthermore, infected mice present polyclonal proliferation of
spleen infected cells and lymphatic tissues that act as a reservoir for infected and proliferating cell
clones. Apart from one report of tumor induction, immunocompetent HTLV-1 carrier mice have
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not provided any significant evidence of the in vivo spread of infection and any apparent disease
after infection (Panfil AR et al, 2013).
In 1992 Ishihara et al successfully used severe combined immunodeficiency (SCID) mice to
model the proliferative and tumorigenic potential of ATL cells in mice. They found that some of
the mice developed tumors at or near the injection site, which were positive for detection of viral
p19 and also proviral DNA. Repression of SCID mouse NK cells using an anti-murine IL2 receptor
beta chain monoclonal antibody followed by injection with ATL patient cells resulted in tumor
and leukemia development in about 5–7 weeks after inoculation. Moreover, they identified the
proliferating leukemic cells in the mouse as deriving from the original inoculating ATL cell clone.
They also saw the infiltration of ATL cells into various mouse organs which was similar to what
is observed in ATL patients (Ishihara S et al, 1992). Ohsugi et al demonstrated successful
tumorigenesis from MT-2 cell engraftment in SCID mice with normal NK cell function as opposed
to the previous experiments that utilized reduced NK cell function to establish tumors (Ohsugi T
et al, 2004).
Tax transgenic mice: Nerenberg et al in 1987, first described HTLV-1 promoter (LTR)-Tax
transgenic mice (Nerenberg M et al, 1987). In these mice, Tax protein expression efficiently
induced mesenchymal tumors and had tissue-specific expression patterns. Iwakura Y et al
developed Tax Tg mice that has Tax expression in the brain, salivary gland, spleen, thymus, skin,
muscle, and mammary gland tissues (Iwakura Y et al, 1995). It was observed that these Tg mice
had a higher incidence of mesenchymal tumors and adenocarcinomas with activated c-Fos and cJun expression in the tumors. In other Tg mice, Tax expression was restricted to the lymphoid cell
compartment by the use of alternative promoters. Tax was over expressed under the human
granzyme B promoter to target expression to the mature T-lymphocyte compartment which
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resulted in large granular lymphocytic leukemia/lymphomas in mice. These Tax Tg mice also
spontaneously developed hypercalcemia, high frequency osteolytic bone metastases, and enhanced
osteoclast activity, symptoms frequently associated with ATL development (Grossman WJ et al,
1995). Under the control of the Lck proximal promoter, Tax expression is restricted to developing
thymocytes and this model was able to demonstrate lymphomas characterized by constitutive
NFkB activation and increased cytokine and growth factor expression (Hasegawa H et al, 2006).
These studies in various transgenic mice confirm HTLV-1 as a transforming virus and Tax as its
oncogenic protein.
1.3 Role of NFkB inflammatory signaling in HTLV-1 infected cells
HTLV-1 is an animal oncoretroviruses that does not carry host-derived oncogene, neither does
it activate a cellular oncogene through proviral integration. HTLV-1 encodes a regulatory protein
Tax which is the primary oncogenic mediator. Tax does not bind DNA directly, instead it induces
cellular target genes indirectly by its pleiotropic control on host cellular pathways (Smith MR and
Greene WC, 1991). Among those host machineries, NFkB signaling plays a pivotal role in Taxmediated transformation and ATL leukemogenesis (Ballard DW et al, 1988).
In normal T-cells NFkB activation is tightly regulated and occurs transiently in response to
immune stimuli, playing an important role in T-cell proliferation and survival. Moreover, under
normal conditions, following stimulation by an antigen, T-cells predominantly stimulate the
canonical NFkB pathway ensuring a rapid but short-lived nuclear expression of NFkB responsive
genes (Ballard et al, 1988; Xiao et al, 2001). T cell receptor (TCR and its proximal signaling
molecules are downregulated shortly after antigen stimulation, preventing persistent signaling
through the cell surface receptor (Jang and Gu, 2003). There is also a negative feedback
mechanism through which the activated NFkB indices increased expression and synthesis of
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inhibitory IkBa molecules that curb the further NFkB pathway activation (Sun et al, 1993).
However. In case of HTLV-1 infection, the virus induces persistent activation of NFkB, leading
to deregulation of an array of NFkB responsive antiapoptotic, proliferation, and cell cycle
progression genes (Fochi S et al, 2018). Constitutively high NF-kB activity has typically been
observed in human hematopoietic cancer cells, including adult T-cell leukemia (ATL), Hodgkin
lymphoma, and multiple myeloma cells.
The NFkB family
Nuclear factor-kappa B (NFkB) is a family of transcription factors involved in regulation of
immune response, cell proliferation, survival and development. Several human diseases,
particularly cancers, have been associated with deregulated NFkB (Xiao G and Fu J, 2011). The
NFkB family consists of five DNA binding proteins that share a 300 amino acid long N-terminal
Rel homology domain (RHD) and contain kB motifs in their promoters: RelA (p65), RelB, c-Rel,
NFkB1/p50 and NFkB2/p52 (Ghosh and Hayden, 2008). The RHD allows nuclear translocation,
DNA binding, interaction with the inhibitors of NF-kB (IkBs), formation of homo- and
heterodimers in these proteins. RelA, RelB and c-Rel are directly synthesized in their mature form
and contain a C-terminal transactivating domain (TAD) whereas p50 and p52 are generated from
large precursor proteins, p105 and p100, respectively. p100 and p105 can also function as NFkB
inhibitors since they contain IkB-like sequences in their C-terminal (Rice NR et al, 1992).
In resting cells, Rel proteins are sequestered in the cytoplasm through their interactions with
the inhibitory proteins IkBα, IkBβ, and IkBϵ, as well as the precursor proteins p105 and p100.
Upon stimulation, the IkB kinase (IKK) complex, which is composed of 2 catalytic subunits, IKKα
and IKKβ, and the scaffolding protein, NF-kB essential modulator (NEMO, also known as IKKγ)
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gets activated. The IKK complex phosphorylates specific serine residues on the IkB proteins
leading to their poly-ubiquitination and proteasome-dependent degradation or processing
(Baldwin AS Jr, 2001; Hayden MS and Ghosh S, 2004). These released NF-kB then translocates
to the nucleus and regulates the expression of target genes.
Canonical and Non-Canonical NFkB pathways
The NFkB signaling pathways can be activated by variety of signals through two distinct
pathways: the canonical and noncanonical pathways. Generally, the canonical pathway regulates
inflammation and cell survival, whereas the noncanonical pathway regulates lymphoid
organogenesis and B-cell survival and maturation and bone metabolism (Sun SC, 2011). The
canonical NF-kB pathway is activated by diverse stimuli, including the pro-inflammatory
cytokines tumor necrosis factor-α (TNF-α) and IL-1, antigen receptors or exposure to pathogens
like viral and bacterial products. The induction by various stimuli leads to phosphorylation of the
IkBs by the IKK complex, which is composed of the catalytic subunits IKKα and IKKβ and a noncatalytic scaffolding subunit IKKγ/NEMO, leading to ubiquitination and degradation of IkBs, and
the nuclear translocation of the Rel-heterodimers (Silverman and Maniatis, 2001). The
noncanonical NFkB pathway is activated in response to TNF superfamily ligands leading to
activation of NFkB inducing kinase (NIK) which phosphorylates IKKα, which in turn
phosphorylates the precursor p100 and its cleavage by the proteasome to p52 (Xiao G et al, 2001).
NIK stability, and hence p100 processing, is regulated by an E3 ubiquitin ligase complex
consisting of TRAF2, TRAF3, cIAP1 and cIAP2 (Zarnegar BJ et al, 2008).
The pro-inflammatory canonical pathway is NEMO or IKKγ dependent, while the noncanonical pathway depends on NFkB inducing kinase (NIK) and functions independent of IKKγ.
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The non-canonical pathway is activated in response to tumor necrosis factor (TNF) receptors
during lymphoid development (Sun SC, 2011). The crucial role of NFkB proteins in regulation of
these pathways is the reason that cancers and viral pathogens exploit NFkB to enhance
proliferation, cell survival, and evasion of immune responses.
HTLV-1 Tax deregulation of NFkB and leukemogenesis
A characteristic feature of ATL is the increased expression of lymphokines and lymphokine
receptors (products of genes controlled by NFkB) (Arima et al, 1996; Maruyama et al, 1987;
Siekevitz et al, 1987). Tax deregulates the expression of NFkB target genes that play a key role in
T-cell growth and survival shortly after establishment of HTLV-1 infection and proviral
integration. These genes include growth cytokines like IL-2, IL-15 and they receptors as well as
anti-apoptotic genes like BclXL, survivin etc (Sun SC and Ballard DW, 1999). Tax also stimulates
NFkB to induce cell-cycle regulators such as cyclin D2 and Cdk6 causing irregular cell-cycle
progression. Taken together when these factors are induced continuously in the infected cells, it
results in an unstable genomic environment that predisposes them to leukemic transformation.
Tax plays a very important role in HTLV-1 associated leukemogenesis by driving cellular
proliferation, cell cycle dysregulation, enhancing cell survival and promoting genetic instability.
Mouse models with tax expression in their lymphocyte compartment have constitutively active
NFkB and reproduce many aspects of HTLV-1 pathogenesis (Nerenberg MI, 1990). It has been
seen that tax expression alone without any other viral factors is sufficient to activate the NFkB
pathway and cause leukemia, lymphoma, solid tumors, splenomegaly, and osteolytic disease. In
1990, Nerenberg identified that NFkB is involved in tumor growth in a transgenic mouse model
and Tax under the regulation of the HTLV-1 LTR, leads to the development of neurofibromas
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(Nerenberg MI, 1990). Another manifestation of LTR driven Tax expression and NFkB pathway
activation in mouse models was chronic inflammation, hence in order to better understand ATLlike malignancies, other promoters were used in transgenic constructs to restrict tax expression in
the lymphoid compartments. Transgenic mice with Granzyme B promoter had tax expression
selectively in activated T-cells and NK cells and developed leukemia/lymphoma and tumors
associated with high levels of NFkB and NFkB-regulated genes. This animal model demonstrates
that expression of Tax in the lymphocyte compartment is sufficient for the development of
leukemia (Grossman WJ et al, 1995). Furthermore, it was shown in two independent studies that
Tax expression using an Lck-promoter leads to constitutively elevated NFkB and an ATLL-like
malignancy in transgenic mice (Hasegawa H et al, 2006). The persistent expression of NFkB
responsive genes in the presence of Tax has been considered to lead to initiation and/or
maintenance of the malignant phenotype in HTLV-1 infected cells. It was seen that the inhibition
of NFkB activity by using antisense arrest curbs the growth of Tax transformed cells in vitro and
in vivo (Kitajima et al, 1992). Most of the studies using Tax mutants defective for either NFkB or
CREB/ATF activation were able to prove the association between Tax activation of NFkB and Tcell transformation. And finally, HTLV-1 molecular clones with a single point mutation in Tax
oncogene that render it unable to activate NFkB pathway were used to demonstrate that such
mutant clones disrupt the ability of the virus to transform primary cells (Robek M and Ratner L,
1999). These data confirmed the role of NFkB in Tax-mediated transformation and also establish
that constitutive activation of the NFkB pathway is essential in the process of Tax-mediated
oncogenesis.
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Mechanism of Tax activation of NFkB
Tax acts at multiple levels to induce NFkB activation. Tax is known to stimulate persistent
nuclear expression of Rel/NFkB members including p50, p52, Rel-A and c-Rel (Arima et al, 1991).
Initially, immunoprecipitation experiments were conducted to show that Tax interacts physically
with members of Rel/NFkB and IkB families (Suzuki et al, 1994; 1995). These experiments led to
the idea that Tax either dissociates or disrupts the assembly of the p50/RelA/IkB complex. In line
with the the dissociation model, Watanabe et al showed that p105 acts as an IkB inhibitor and
sequesters p50 and p65 in the cytoplasm and that Tax inhibits the IkB activity of p105, leading to
increased nuclear localization of p50 and p65 (Watanabe et al, 1993). Tax also potentially binds
to IkBa and dissociates IkBa/NFkB complex and after site-specific phosphorylation and
ubiquitination of IkBa targets it to 26S proteasome for degradation thus preventing its inhibitory
action on RelA and c-Rel (Suzuki et al, 1994; 1995; Sun SC and Ballard DW, 1999). Moreover,
the mutants of IkBα lacking Ser-32 and Ser-36 are completely resistant to Tax-induced degradation
and are able to repress Tax. The two serines Ser-32 and Ser-36 are phosphorylated for targeting
IkBα to the proteasome in cells activated with the pro-inflammatory cytokines TNFα or IL-1. Thus
it can be elucidated that by a phosphorylation-dependent mechanism Tax converts both IkBα and
IkBβ into degradable proteasome substrates and lead to persistent NFkB activation. (Sun SC and
Ballard DW, 1999).
Three observations led to deduction that cytokine-responsive IKKs are the primary cellular
targets of Tax in the NFkB pathway. First, Tax associates with constitutively active IKKs to form
dissociation resistant higher order complexes in vitro. Second, it was seen that the kinase-inactive
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forms of IKKa and IKKb interfere with Tax-mediated NFkB activation. Finally, the mutants of
Tax that are unable to interact with IKKs do not activate NFkB (Hiscot J et al, 2001).

Figure 4. Schematic representation of the possible mechanisms by which Tax activates NFkB
pathway. Tax interacts with and recruits NEMO (IKKg) and then recruits TAK1 and NIK to the
IKK complex to initiate the canonical pathway and to some extent also the non-canonical pathway.
Tax recruits TAK1 to IKK possibly by K63-linked poly ubiquitination, however if NIK is recruited
by K63 poly ubiquitination is not clear. Nuclear localization of p65/RelA and IKK induces
chromatin remodeling and target gene activation along with NFkB activation, possibly leading to
senescence. (adapted from Yik-Khuan Ho et al, 2012)

In the cytoplasm, the Tax dimers activate IKK by interacting with the non-catalytic subunit
IKKg (NEMO) which allows the recruitment of Tax to the catalytic subunits IKKa and IKKb.
This interaction and activation of IKK by Tax depends on its conjugation to Ub-K63 chains formed
by Ubc13 and removed by USP20. The first evidence linking IKKγ and Tax emerged from genetic
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complementation experiments where an IKKγ-deficient rat fibroblast line fails to express
constitutively active forms of NFkB in the presence of Tax. This loss of NFkB signaling correlated
with a reduced molecular size of IKK complexes and overexpression of IKKγ was able to rescue
the phenotype, suggesting that IKKγ is required for the proper assembly of the Tax-responsive
IKK complex (Yamaoka et al, 1998). Moreover, inhibition of IKKγ by antisense approach in
human T-cells inhibited Tax-mediated activation of NF-kB but did not affect CREB/ATF (Hiscot
J et al, 2001). Mutant T-cell lines deficient in IKKγ expression had no NFkB activation when
stimulated by both T-cell costimulatory signals and HTLV-1 Tax but the NFkB signaling was
restored with exogenous IKKγ (Harhaj EW et al, 2000). Overexpression of Tax, IKKγ and either
IKKa or IKKb in vivo leads to a measurable IkB kinase activity but in the absence of IKKγ there
is no induction of its kinase activity showing the indispensable role of IKKγ as a molecular adaptor
that provides a site for Tax binding and the assembly of Tax/IKK complexes (Hiscot J et al, 2001).
Tax can also interact with upstream kinases such as MEKK1, NIK, optineurin, TAK1, and
PIN1 and activate IKK by phosphorylation, ubiquitination and proteasome mediated degradation
of IkBs (Kafoury Y et al, 2010). This IkB-degradation exposes the NLS of NFkB dimers, allowing
their rapid translocation to the nucleus and NFkB activation. Tax can also disrupt the Ubc13/A20
complex through the interaction with Tax1BP1 making Ubc13 available for its ubiquitination
(Shembade et al, 2008; 2010). The phosphorylation, ubiquitination and proteasomal degradation
of IkBa play a key role in activation of NFkB pathway by Tax. Tax has no kinase activity of its
own and it binds to the IKK complex (Sun SC and Ballard DW, 1999), causing a direct interaction
with the IKKg - the IKK regulatory subunit NEMO (Kafoury Y et al, 2010). This direct interaction
allows the recruitment of catalytic IKKa and IKKb subunits. In order to activate the non-canonical
NFkB pathway, Tax requires NEMO and IKKa and forms a complex with p100 causing
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phosphorylation dependent ubiquitination and processing of p100 to p52 (Xiao et al, 2001). Thus,
by targeting different IKK complexes, Tax activates both canonical and non-canonical NFkB
pathways.
In ATL cells, just like in normal T-cells, NFkB activation has been shown to prevents
apoptosis. Thus, constitutive activation of NFkB pathway by HTLV-1 Tax leads to aberrant
growth and cytokine gene expression. A large body of data indicates that this constitutive NFkB
activation by the virus is required to maintain and/or induce the transformed phenotype of HTLV1 infected cells.
1.4 Genomic instability and DNA damage repair pathways in HTLV-1
Cancer is a genetic disease. DNA damage leads to errors during DNA synthesis causing
mutations that may lead to cancer. In eukaryotic organisms a DNA damage response pathway has
been developed to protect against such insults to the genome. The DNA damage response causes
cell cycle arrest and allows for DNA repair functions in cells with minor damages which ultimately
survive. However, the cells with severe DNA damage are directed to undergo apoptosis. Tax is
expressed at low levels in ATL cells and has a weak oncogenic activity, but the genomic and
genetic instability caused by Tax plays a key role in the development of ATL (Baydoun H et al,
2012). In HTLV-1 transformed cells and Tax expressing cells clastogenic DNA damage including
point mutations, deletions, substitutions, translocations and rearrangements, are frequently seen
(Marriott S et al, 2002). Tax has the ability to not only suppress DNA repair, but in addition it can
stimulate cell cycle progression and block apoptosis resulting in the introduction of mutations into
the genome. Owing to these combined biological effects of Tax, a 2.8-fold increase in genomic
mutation frequency had been demonstrated (Miyake H et al, 1999).
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HTLV-1 Tax can inhibit the cells ability to repair DNA damage resulting in accumulation of
mutations in infected cells (Jeang KT et al, 1990; Marriott S et al, 2002; Kao S-Y et al, 1999). It
is common for most cells to acquire DNA damage as they transit the cell cycle. However, in most
normal cells, the DNA damage that exists in the first growth phase, G1, of the cell cycle can be
repaired by DNA repair mechanisms such as base excision repair (BER), nucleotide excision repair
(NER), recombination and direct repair of nicks by DNA ligation. In 1990, Jeang et al, for the first
time alluded that HTLV-1 suppresses DNA repair through Tax which decreses BER by repressing
the expression of DNA-polymerase b (Jeang KT et al, 1990). HTLV-1 Tax was shown to suppress
NER in rat fibroblasts exposed to UV irradiation (Kao S-Y et al, 1999). UV irradiation of cells
usually leads to NER which uses DNA polymerases δ and ϵ and a cofactor PCNA (proliferating
cell nuclear antigen) for its repair activity. Tax can cause excess PCNA synthesis by inducing its
up-regulation by transactivating the PCNA promoter (Lemoine FJ et al, 2000). In presence of
excess PCNA, DNA pol δ inappropriately synthesizes excess new DNA going past the template
lesion resulting nucleotide mis incorporation (Lemoine FJ et al, 2000; Marriott S et al, 2002).
An early DNA double-strand breaks sensing mechanism is the activation of ataxia
telangiectasia mutated (ATM) kinase. ATM kinase sends the DNA damage signal to cell cycle
checkpoint control which facilitates DNA damage repair by activating repair proteins. In the
presence of Tax expression, ATM kinase activity is prematurely attenuated and doesn’t allow
recruitment of MDC1 to the DNA repair site rendering ATM inactive. Thus, in Tax expressing
cells, ATM is not able to facilitate DNA damage repair, resulting in premature DNA replication
along with the present genomic lesion leading to accumulation of mutations (Chandhasin C et al,
2008).
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Preneoplastic cells proliferate at a high rate in order to accumulate genetic mutations and
acquire a transformed phenotype. Each cell division involves progressive shortening of telomeres
which can initiate senescence and irreversible cell cycle arrest or cell death after a finite number
of cellular divisions. This mechanism can suppress tumor development. In about 90% of cancers,
tumor cells overcome this barrier by reactivating telomerase enzyme (Chlichlia K and Khazaie K,
2010). Telomerase activity is increased at the post-transcriptional level by AKT, the p65 subunit
of NFkB, SHP2, 14-3-3 protein, and PKC-mediated phosphorylation. Since there are high levels
of AKT and NFkB in HTLV-I cells, it is possible that these pathways could be very important in
maintaining the high telomerase activity seen in these cells (Bellon M and Nicot C, 2015).
Normally, telomeric repeats at the chromosomal ends prevent aberrant end-to-end chromosomal
fusions, stabilize de novo double strand chromosomal breaks, and also protect them from
degradation by endonucleases. Recent evidence also suggests that Tax represses the transcription
and expression of human telomerase (hTERT) resulting in telomerase inactivation in Tax
expressing cells. Tax prevents the addition of telomeric repeats to new double-stranded breaks and
potentially interferes with a protective mechanism used to prevent inappropriate chromosomal
breakages-fusions (Jeang KT et al, 2004). On the contrary, it was also shown that in the absence
of exogenous mitogenic stimulation, Tax is able to stimulate the hTERT promoter through the
NFkB pathway which may result in transient genetic instability during mitosis (Gabet A-S et al,
2003). Even when the mitogenic effect has vanished, this tax mediated activation of hTERT gives
long term proliferative advantage to these cells that have acquired chromosomal abnormalities.
The sum of effects of Tax on BER, NER, DNA end stability, telomerase, and cell cycle progression
lead to a compromised state of DNA damage repair in the cells termed as the mutator phenotype
and is a critical component of cellular transformation.
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Figure 5. Schematic representation of Tax expression in cells leading to either apoptosis or cell
cycle progression and contributing to transformation (adapted from Chlichlia K and Khazaie K,
2010)

In order to maintain the diploid state in human cells, it is required that a precise and
reproducible equal chromosomal division occurs from mother to two daughter cells. Majority of
cancers and transformed cells typically present numerical chromosomal changes including loss or
gain of entire chromosomes (aneuploidy) owing to unequal chromosomal division, in addition to
other structural chromosomal alterations. ATL cells are no different in this respect and have highly
lobulated “flower” shaped nuclei. Mitotic spindle assembly checkpoint (MSC) is the cellular
mechanism that guards against chromosome missegregation and maintains the state of euploidy
(Marriott S et al, 2002). Several ATL cell lines were found to be deficient in MSC function (Kasai
T et al, 2002). At least seven genes have been identified for MSC function in yeast and mammals
including Mps1 (monopolar spindle), BUB 1, 2 and 3 (budding uninhibited by benomyl) and MAD
1, 2 and 3 (mitotic arrest deficient) (Marriott S et al, 2002). In events of spindle damage or
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segregation anomalies the MSC is activated to arrest metaphase to anaphase transition and prevents
cell division and initiates apoptosis curbing the propagation of chromosomal abnormality. MAD2
is the distal effector protein of metaphase-anaphase checkpoint. MAD2 binds to CDC20 and
inhibits the function of APC (anaphase promoting complex). Tax binds human MAD1 (hsMAD1)
which is an integral constituent of MSC. hsMAD1 is required to direct MAD2 to kinetochores in
the nucleus where it is critical to carry normal MSC function. This association between Tax and
hsMAD1 causes MAD1 and MAD2 to translocate to the cytoplasm from the nucleus leading to
loss of MSC function and M phase to proceed uninterrupted ultimately resulting in aneuploidy.
(Kasai T et al, 2002). Tax also interacts with TAX1BP2, a centrosomal protein which normally
blocks centriole replication, and causes multipolar mitosis which is another common cause of
aneuploidy (Ching YP et al, 2006). Furthermore, Tax interacts with RANBP1 during mitosis and
causes fragmentation of spindle poles, thereby promoting multipolar mitosis and asymmetrical
chromosome segregation (Peloponese JM et al, 2005). These mechanisms involving Tax
interactions with TAX1BP1 and RANBP1 explain the frequent occurrence of aneuploidy and
multipolar spindles in ATL cells.
Baydoun et al showed that Tax-mediated NFkB activation is important for inhibition of
homologous recombination (HR) DNA repair. They used the ACH clones (ACH.wt and
ACH.p30II) and also Tax mutants M47 and M22 and saw that M47 which is defective for NFkB
pathway activation significantly inhibited HR but not the M22 mutant which can activate NFkB
robustly (Baydoun HH et al, 2012). This study concluded the role of Tax in inhibiting the DDSB
HR repair through activating the NFkB pathway.
It is possible that NFkB may also contribute to oncogenesis through DNA damage and
induction of mutations indirectly through inflammation-mediated production of reactive oxygen
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and nitrogen species (ROS and RNS) (Xiao G and Fu J, 2011). More recently, it was shown that
HTLV-1 infected T-cells and cells expressing Tax exhibit high levels of intracellular nitric oxide
(NO). NO and its product peroxynitrite are highly reactive molecules that cause DNA damage.
iNOS is the enzyme that catalyzes the production of NO in T-cells, macrophages and neutrophils.
Tax activates iNOS and induces DSBs through the induction of NO by the classical NFkB and
JAK/STAT pathways, which are persistently activated in the proliferation of HTLV-1 infected Tlymphocytes (Baydoun HH et al, 2015). Chaib-Mezrag et al showed that Tax induces DDSBs
through activation of NFkB pathway and by stimulating intracellular NOS. They also showed that
in the presence of Tax, the replication forks are slower leading to genomic defects and increased
DDSBs (Chaib-Mezrag H et al, 2014). Taken together, Tax targets proteins involved in DNA
replication, DNA damage and repair, centrosome duplication, and cell cycle checkpoints leading
to genomic instability and acquisition of mutations, paving the way for leukemogenesis.
1.5 Stathmin – Oncoprotein 18 (OP18)
Stathmin also known as oncoprotein 18 (OP18), is a 149 aa long cytosolic phosphoprotein
integrating several intracellular pathways involved in cell division, cell motility and intracellular
transport (Curmi AP et al, 1999). Stathmin expression is very high in early embryonic stages in
the undifferentiated cells but it strongly decreases in the adult tissue except in nervous system and
in testis (Curmi AP et al, 1999). However, stathmin overexpression has been reported in several
types of cancers including acute leukemia, lymphomas, cervical cancer, breast cancer, prostate
cancer, lung cancer, osteosarcoma, and gastrointestinal tumors including pancreatic cancer (Lu Y
et al, 2014). Microtubules exist as long polymers and form the cytoskeleton of eukaryotic cells.
Stathmin has been found to interact with tubulin and control microtubule dynamics. It can
destabilize microtubules by sequestering tubulin heterodimers and directly promoting catastrophes
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leading to a decrease in the amount of free tubulin for microtubule assembly (Charbaut E et al,
2001). Microtubule disruption may lead to formation of abnormal mitotic spindle, inaccurate
chromosomal segregation, attenuated cell motility and possibly facilitate cancer development.
Some previous studies have confirmed the oncogenic role of stathmin in promoting cancer cell
proliferation, differentiation, migration and invasion (Lu Y et al, 2014). Any mutation or aberrantly
expressed protein that compromises the fidelity of spindle assembly increases chromosomal
instability and is considered to be aneugenic since such defects contribute to aneuploidy. A
hyperactive Q18E Stathmin mutant, or overexpression of wildtype Stathmin, has been reported to
cause aneugenic effects and chromosomal instability linked to ploidy changes in leukemic cells
(Holmfeldt et al, 2006). Overexpression of wild-type Op18 results in aneugenic activities, leading
to aberrant mitosis, polyploidy, and chromosome loss. It was seen that the aneugenic activity of
Op18 was dramatically increased by the somatic Q18→E missense mutation (Holmfeldt et al,
2006). Tubulin assembly studies in vitro have determined that the N-terminal nonhelical region of
Op18 is essential for catastrophe promotion, whereas the tandem helical repeats are required for
tubulin-sequestering activity (Howell et al, 1999). Human Op18 can be inactivated to various
degrees by differential phosphorylation at four Serine residues (Ser-16, -25, -38, and -63) by cell
cycle–regulating and signal-transducing kinase systems. Although Op18 is phosphorylated at
multiple sites during mitosis, it exists predominantly in its unphosphorylated active form during
interphase (Brattsand et al, 1994; Larsson et al, 1997).
Stathmin is transcriptionally repressed by wild-type p53. p53 forms a transcriptional repression
complex with HDAC and mSin3a where mSin3a binds to the promoter of stathmin and reduces its
association with acetylated histone H3 resulting in repression of transcription in the presence of
wild-type p53 (Murphy M et al, 1999). In normal cells, p53 tumor suppressor protein is critical in
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cellular response to stress and leads to increased p53 protein levels which translocates to the
nucleus to act as a transcription factor activating genes associated with either growth arrest or
apoptosis (Levine et al, 1997). The mutation or loss of p53 activity is one of the most frequent
events in human cancer (Hollstein et al, 1994). Unlike most cancers however HTLV-1 positive
ATLL clinical isolates mostly have a high level of wildtype p53 (Zane L et al, 2012). HTLV-1
latency maintenance factor p30II has been shown to interact with MYST-family acetyltransferase
TIP60 resulting in inhibition of K120-acetylation of the p53 protein (Romeo MM et al, 2018)
leading to regulation and expression of p53 regulated pro-apoptotic genes (Sykes SM et al, 2006).
Murphy et al proposed a possibility that in addition to contributing to trans-repression of genes
like stathmin and Map4, the HDAC–mSin3a–p53 association may also result in the deacetylation
of p53 and have a role in the regulation of this protein (Murphy M et al, 1999). This alludes to the
possibility that in ATL, with majority of wildtype p53, the p53-target genes are subverted
selectively to promote oncogenesis (Romeo MM et al, 2018).
Successful chemotherapy treatments such as using paclitaxel and vinblastine are believed to
act by targeting microtubules. They disrupt the spindle function, activate spindle assembly
checkpoint and induce cell death. More recently, novel chemotherapy targets such as microtubule
regulatory proteins including stathmin/OP18 have received attention (Rana S et al, 2008).
Moreover, high stathmin or phosphorylated stathmin level in tumor tissues predicts a poor overall
survival and was described as a potential biomarker for metastasis or local recurrence in some
human cancers (Lu et al, 2014). p27kip1 is a cell cycle inhibitor and also a regulator of cell motility
(Belletti B et al, 2010). p27 gets phosphorylated on threonine residue T198 which allows it to bind
stathmin in the cytoplasm and inhibits its microtubule destabilizing activity (Schiappacassi M et
al, 2011). In the absence of p27, there is a decrease in microtubule stability which promotes
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increased motility and invasive potential of cells. Interestingly, HTLV-1-transformed cells have
very low levels of p27 (Kuo YL and Giam CZ, 2006) which may allow abundant stathmin binding
to and destabilizing microtubules and aberrant mitosis leading to genomic instability in ATL cells.
Lu et al found a correlation between stathmin and NFκB pathway in pancreatic cancer. They
established that stathmin expression correlated with poor prognosis of pancreatic cancer and
stathmin promotes pancreatic cancer cell proliferation through its interaction with p65RelA. In this
study they confirmed that NFκB/p65RelA was downregulated when stathmin was knocked-down
and the CoIPs showed an interaction between Stathmin and p65RelA suggesting a novel oncogenic
role of stathmin in aggressive pancreatic cancer (Lu et al, 2014).
1.6 Lipid Rafts – Stathmin – TIGAR
Lipid rafts are cholesterol- and sphingolipid-rich, detergent-resistant plasma membrane
microdomains. Lipid rafts are synthesized from the Golgi and are recycled between the Golgi and
the plasma membrane (Rocks O et al, 2005). These lipid raft microdomains are crucial membrane
structures and often serve as signal transduction platforms for mediating kinase activation in TCR
signaling (Cheng H et al, 2010). Some researchers have proposed lipid rafts to be associated with
cytoskeleton from experiments conducted in rat forebrain extracts and in human smooth muscle
cells (Dremina ES et al, 2005, Kawabe J et al, 2006). In fact, some reports indicated that when
microtubule disrupting agents such as cholchicine were used on glias or cardiomyocytes, it resulted
in the loss of signaling molecules from lipid rafts (Jin S et al, 2011).
The persistent activation of NFkB by HTLV-1 Tax is a characteristic feature of ATL and plays
a crucial role in T-cell transformation and ATL development. Tax has been shown to induce NFkB
activation through several different mechanisms. One of those is through the recruitment of IKK
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signalosome to the lipid raft microdomains. Tax is considered to be a lipid raft modulator that
hijacks IKKs to the lipid rafts for the activation of NFkB through physical interaction with IKKg
and promotes T-cell proliferation (Huang J et al, 2009). Ren T et al showed that Tax can also
utilize this IkB kinase dependent NFkB activation in lipid rafts to promote autophagy by recruiting
the autophagic complex to the lipid raft microdomains. Their research further suggests the possible
role of Tax in utilizing lipid rafts as signaling platform to recruit IκB kinases and autophagy
molecules into these lipid raft microdomains and activating NFκB and autophagy pathways (Ren
T et al, 2015). It is however known that Tax does not contain a consensus lipid raft signal peptide
and it is plausible that Tax may interact with a cellular lipid raft-associated protein for targeting to
the lipid raft domains.
Microtubules provide a polarized network in the cells that allows organelle and protein
movements. Microtubules have been shown to regulate membrane trafficking and lipid raft
localization of certain signaling components (Head BP et al, 2006). Lipid raft components have
been shown to move throughout the cell cytoplasm via cytoskeletal structural scaffold and can
contribute to dynamic organelle structural remodeling (Sorice M et al, 2010). Moreover, it was
observed that disruption of microtubules leads to loss of lipid raft caveolae and redistribution of
lipid raft resident proteins and may ultimately lead to disruption of certain signaling pathways
associated with lipid rafts (Head BP et al, 2006). Interestingly, stathmin is a microtubule associated
protein which, if uninhibited, is involved in disrupting tubulin polymers and can cause microtubule
catastrophe (Curmi PA et al, 1999). Belletti et al also showed that p27kip1 and stathmin interaction
regulates lipid raft trafficking and control cell migration, invasion and division (Belletti B et al,
2010). Stathmin activity has also been linked to vesicular trafficking regulation in T-helper cells
where it plays a role in controlling interleukin-4 receptor recycling (Tanaka et al, 2007). This
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alludes to a possible role of stathmin in disrupting lipid raft associated signaling by microtubule
regulation and leading to dampened NFκB activation in the lipid rafts microdomains of HTLV-1
infected T-cells.
TIGAR (TP53-induced glycolysis and apoptosis regulator), is a p53-target gene that affects
ROS by modulating the glycolytic pathway and protects the cell against oxidative stress (Bensaad
et al, 2006). TIGAR protein has similarity to the bisphosphatase domain of phosphofructo-2kinase/ fructose-2,6-bisphosphatase (PFK-2/FBPase-2). PFK-2 plays an essential role in
glycolysis regulation. Li and Jogl showed that TIGAR can hydrolyze fructose 2,6-bisphosphate
and fructose 1,6-bisphosphate resulting in their decrease and ultimately reducing glycolysis in cell
(Li and Jogl, 2009). In addition to the reduction in glycolysis, TIGAR expression also redirects the
glycolytic metabolic intermediates to the oxidative branch of pentose phosphate pathway resulting
in an increased production of NADPH. Increased NADPH can scavenge ROS by reduced
glutathione leading to decreased intracellular ROS and lower apoptosis resulting due to oxidative
stress (Bansaad et al, 2006). TIGAR overexpression has been linked to decreased ROS levels and
inhibits autophagy (Bensaad K et al, 2009).
Autophagy is a catabolic process and occurs in response to metabolic stress by sequestering
and degrading cellular proteins and organelles in autolysosomes (Baudhuin P, 1966). Autophagy
is considered mainly pro-survival and thus autophagy is also known to contribute to chemotherapy
resistance (Ren T et al, 2015). Furthermore, in certain tumorigenic viruses autophagy is necessary
for their replication and induction of oncogenesis (Ren T et al, 2015). In Hepatitis C virus (HCV)
infection autophagy promotes initiation of viral infection, and inhibition of autophagy represses
viral replication (Dreux M and Chisari FV, 2009). Latent membrane protein 1 (LMP1) of EpsteinBarr virus (EBV) induces early or late stage autophagy depending on its expression levels (Lee
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DY and Sugden B, 2008). Inhibition of autophagy in EBV-infected cells suppresses its
transforming potential. Also, Hepatitis B Virus (HBV) sensitizes cells to starvation-induced
autophagy by increasing Beclin1 (BECN1) expression (Tang H et al, 2009). In Hepatitis C virus
(HCV) infected cells, an association between lipid rafts and autophagosomes has been confirmed,
which the virus uses for its RNA replication (Kim JY et al, 2017). Lipid rafts are associated with
autophagy associated molecules and contribute to autophagosome morphogenesis. A recent study
by Matarrese et al found that GD3 ganglioside, a key lipid raft constituent, actively contributed to
the biogenesis and maturation of autophagic vacuoles in human and murine primary fibroblasts
(Matarrese P et al, 2014). Furthermore, the viral LMP1 protein from EBV associates with the lipid
raft microdomains where it activates NFκB and also induces autophagy (Lee DY and Sugden B,
2008). Ren T et al found that Tax-deregulated autophagy is associated with the lipid raft
recruitment of the autophagic molecular complex containing Beclin1 and Bif-1 which increases
LC3+ autophagosomes and promotes autophagy. They also confirmed that Bif-1 and BECN1,
together with IKK and Tax, were constitutively present in the lipid raft fraction in Tax-expressing
T cell lines (Ren T et al, 2015). It was also recently demonstrated that p30II activates p53 and
induces the expression of p53-regulated pro-survival signals, including TIGAR, increasing the
oncogenicity of the HTLV-1 (Romeo M et al, 2018; Hutchison T et al, 2018).
Although the exact role of lipid rafts in autophagy induction is presently not clear but there
seems to exist a potential association between the two. As mentioned earlier, TIGAR
overexpression has been seen to inhibit autophagy (Bensaad K et al, 2009). The possibility that
p30II induces p53 which in turn upregulates TIGAR in HTLV-1 infected cells leading to
suppression of autophagy by TIGAR further leads to inhibition of IKK signaling in lipid rafts and
hence dampens Tax induced NFkB activation needs to be addressed.
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CHAPTER II
EXPERIMENTAL RESULTS AND DISCUSSION

2.1 HTLV-1 latency maintenance protein p30II inhibits TIP60 dependent K120-acetylation
of p53 and represses Stathmin/OP18 expression
Rationale: The mutation or loss of p53 activity is one of the most frequent events in human
cancer (Hollstein et al, 1994). However, unlike most cancers, HTLV-1 positive ATLL clinical
isolates mostly have a high level of wildtype p53 (Zane L et al, 2012). The p53 transcription factor
gets activated in response to stimuli such as DNA damage, hypoxia or cellular and viral oncogenes.
In response to these stimuli, p53 either induces or represses a set of p53-response genes and
regulates the expression of various pro-survival or pro-apoptotic pathway genes (Murphy M et al,
1999). p53 post-translational modifications can modulate its functions and can dictate its response
to various cellular signals. Acetylation of p53 protein increases its stability, activation, binding,
antiviral activities and also plays a role in DNA damage checkpoint response and oncogene
activation response (Murphy M et al, 1999). In general, p53 acetylation is mediated by two
different acetyltransferases, p300/CBP/PCAF or Tip60/MOF/MOZ on one or more seven Cterminal lysines, leading to p53-dependent activation of apoptosis and senescence (Brooks C and
Gu W, 2011). This indicates that acetylation is a critical regulator of p53 anti-cancer functions.
Previous studies from our lab have shown that the HTLV-1 latency maintenance factor p30II
protein cooperates with cellular oncoproteins and induces activation of p53-dependent prosurvival genes leading to aberrant lymphoproliferation (Romeo M et al, 2014). HTLV-1 p30II has
been shown to interact with MYST-family acetyltransferase TIP60 resulting in inhibition of K12058

acetylation of the p53 protein (Romeo MM et al, 2018) which causes expression of p53 regulated
pro-apoptotic genes. To take this further we tested whether p30II can cooperate with cMyc to
inhibit TIP60 mediated K120 acetylation of p53 and activate pro-survival pathways in HTLV-1
infected cells.
Stathmin is a microtubule-destabilizing factor and has been shown to play an oncogenic role
in a range of invasive cancers (Lu et al, 2014). The stathmin gene is transcriptionally repressed by
wild-type p53 through formation of p53/mSin3a/HDAC1 repressor complexes (Murphy M et al,
1999). In aggressive pancreatic tumors Stathmin has been shown to interact with the p65RelA
subunit of NFkB and it acts as a cofactor for NFkB-signaling by stabilizing the p65RelA protein
(Lu et al, 2014). Since HTLV-1 infected cells have a high level of wild-type p53 and Stathmin is
negatively regulated by p53, there is a possibility that p30II, through its induction of p53 (Romeo
M et al, 2014) suppresses Stathmin. This prompted us to investigate whether HTLV-1 p30II
inhibits Stathmin/OP18 and p65RelA-Stathmin/Op-18 molecular interactions owing to the
negative regulation of Stathmin by p53-repressor complexes.
Result and Discussion: HTLV-1 p30II can interact with the histone acetyl transferase (HAT)
TIP60 (Awasthi S et al, 2005; Romeo M et al, 2015). Awasthi et al (2005) showed that in the
presence of HTLV-1 p30II, c-Myc is acetylated by the HAT TIP60. Romeo et al (2015) confirmed
that p30II enhances c-Myc-induced cellular transformation which is dependent on lysine
acetylation through the cofactor TIP60. Moreover, Romeo et al (2014) showed that p30II activates
the expression of p53 in the presence of c-Myc oncoprotein. In order to assess the effect of p30II
and c-Myc cooperation on p53 K120 acetylation, co-immunoprecipitation studies were performed
in 293 HEK cells. 293 HEK cells were transfected with wild-type FLAG-tagged c-Myc and an
empty vector control and showed high p53-K120 acetylation through immunoblotting (Fig. 6b).
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In the assay, 293 HEK cells were also transfected with wild-type FLAG-tagged c-MYC and CMVHTLV-1 p30II-Green fluorescent protein fusion (p30II-GFP) showing no acetylation through the
immunoprecipitation with the anti-acetyl-K120-p53 antibody (Fig. 6b). This experiment revealed
that HTLV-1 p30II protein activates p53 and inhibits TIP60-mediated K120 acetylation of p53
(Fig. 6b). This inhibition of K120 acetylation of p53 can differentially regulate p53 dependent proapoptotic gene expression and promote aberrant lymphoproliferation in ATL cells (Sykes SM et
al, 2006). Since Stathmin/Op18 is one of the few genes that are negatively regulated by p53
(Murphy M et al, 1999), we wanted to see the effect of p30II expression on stathmin. 293 HEK
cells were transfected with increasing concentrations of either the empty vector or p30II-GFP.
Clearly, the p30II-GFP protein inhibited Stathmin protein expression as compared to empty CbS
vector in 293 HEK cells (Fig. 6c). The p30II-GFP was detected by immunoblotting and relative
Actin protein levels were also detected for comparison (Fig. 6c). Since Stathmin has been shown
to interact with the p65RelA subunit and acts as a cofactor for NFkB-signaling by stabilizing the
p65RelA protein (Lu et al, 2014), we tested whether p30II might affect p65RelA stability by inhibiting
the cofactor stathmin. 293 HEK cells were transfected with either empty vector, p30II-GFP,
HTLV-1 Tax or phytohemagglutinin (PHA)-stimulated. PHA is a known NFkB activator in human
cells. 293 HEK cells were also co-transfected with HTLV-1 Tax and CbS vector, HTLV-1 Tax
and HTLV-1 p30II-GFP and HTLV-1 p30II-GFP and PHA stimulation. The results in figure 6d
indeed showed that repression of Stathmin also destabilized the NFkB subunit p65RelA in cells
expressing CMV-HTLV-1 Tax or in PHA-stimulated cells (Fig. 6d). These findings are consistent
with Lu et al’s study (Lu et al, 2014) confirming the role of Stathmin as a cofactor for p65RelA.
Overall these results indicate that HTLV-1 p30II inhibits TIP60 mediated p53-K120 acetylation
leading to subversion of p53 pro-apoptotic pathways. p30II also inhibits Stathmin/OP18 owing to
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its negative regulation by p53 and this repression of stathmin by p30II also destabilizes p65RelA
subunit of NFkB. This alludes to the possibility that HTLV-1 p30II might counter the Tax-induced
hyperactivation of NFkB-signaling.
a

b

c

d

Figure 6. The p30II protein inhibits p53-K120 acetylation and represses Stathmin/OP18
expression. a. The p53 protein forms co-repressor complexes with mSin2a and HDAC1 and
transcriptionally represses stathmin gene promoter (Murphy et al, 1999). b. p30II inhibits the
K120-acetylation of p53 induced by oncogenic expression of c-Myc. c and d. The p30II protein
inhibits Stathmin expression which results in reduced levels of p65RelA in cells expressing the viral
transactivator Tax.
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2.2 HTLV-1 p30II suppresses Tax-induced NFkB transactivation
Rationale: Tax drives proviral gene expression and replication by inducing CREB/ATFdependent transcription from three Tax-responsive elements (TREs) within the U3 region of the
HTLV-1 5’ long terminal repeat (LTR) (Zhao L and Giam C, 1992). Although NFκB pathway is
tightly controlled in normal T-cells, it is constitutively activated in both HTLV-I-transformed Tcell lines and freshly isolated ATL cells (Sun SC and Yamaoka S, 2005) suggesting its critical role
in mediating the development of ATL. Activation of NFκB by Tax is mediated by direct binding
of Tax to the regulatory subunit of IκB kinase (IKK), NFκB essential modulator (NEMO), also
known as IKKγ. This interaction results in constitutive activation of IKKα and IKKβ, degradation
of the IκBs, and activation of both classical and alternative NFκB pathways (Sun SC and Ballard
DW, 1999; Kafoury Y et al, 2010). Tax is also known to inhibit p53 function through NFkB
signaling (Qu Z and Xiao G, 2011). Thus, by constitutive NFκB activation, Tax induces NFκB
target genes expression to promote cell growth and survival as well as suppresses the expression
of p53 target genes involved in DNA repair and cell cycle checkpoint regulation. Both these
functions of NFκB likely contribute to the induction of T-cell transformation. Although NFκB
transactivation is essential for the proliferation and survival of HTLV-1-transformed lymphocytes
(Zhang H et al, 2016), the Tax induced hyperactivation of NFκB-signaling leads to DNA-damage,
cytotoxicity and oxidative stress that can cause cellular senescence and apoptosis (Baydoun HH et
al, 2015; Zhi H et al, 2011). Hutchison et al showed that HTLV-1 p30II inhibits Tax-induced
cytotoxicity by activation of p53-regulated pro-survival signals such as TIGAR, which suppress
Tax-induced oxidative stress (Hutchison et al, 2018). We therefore hypothesize p30II influences
the ability of Tax to interact with IKK signaling components and might counter the
hyperactivation of NFkB-signaling by the Tax transactivator protein.
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Results and Discussion: The viral transactivator drives viral gene expression and replication
by interacting with the cellular transcription factors, CREB/ATF-1, and activates 21- bp-repeat
Tax-responsive elements within the U3 region of the HTLV-1 LTR (Zhao LJ and Giam CZ, 1992).
293HEK cells were co-transfected with an HTLV-1 LTR luciferase reporter plasmid (Giebler HA
et al, 1997; Harrod R et al, 1998) and increasing amounts of CMV-HTLV-1 Tax or a pcDNA3.1GFP control. The HTLV-1 Tax, GFP, and Actin proteins were detected by immunoblotting (Fig.
7a). In order to determine if p30II inhibits NFκB transactivation by Tax, a κB responsive E-Selectin
gene luciferase reporter promoter construct (Hong S et al, 2007) or a ΔTAR/SP1 mutant version
of the HIV-1 promoter which contains only the κB-responsive elements and three SP1-binding
sites with a deletion of the U-rich trinucleotide bulge of the TAR of the HIV-1LAI promoter were
transfected in 293HEK cells along with expression constructs for HTLV-1 Tax, p30II-GFP, or an
empty CbS vector control (Figs. 7b and 7c). These findings indicate that p30II could significantly
inhibit Tax-dependent NFκB transactivation from the E-Selectin and HIV-1 κB-LTR (ΔTAR)
promoter-reporter plasmids. Phorbol 12-myristate 13-acetate (PMA), also known as 12-Otetradecanoylphorbol 13-acetate (TPA) is a specific activator of Protein Kinase C (PKC) and of
NF-κB signaling (Holden NS et al, 2008). It has been previously demonstrated that PMA, and Tax
can activate the promoters of several genes by causing the transcription factor NFκB to translocate
from the cytoplasm to the nucleus and bind κB sites within the promoters of responsive genes to
stimulate transcription. Thus, I have shown transactivation by different concentrations of PMA in
293HEK cells (Fig. 7d). p30II-GFP also suppressed NFκB transactivation induced by stimulating
the cells with PMA (Fig. 7d).
The transactivation from the E-Selectin promoter through NFκB was impaired upon using the
Tax mutants, Tax-M22 and -G148V, which are defective for NFκB activation (Smith MR and
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Figure 7. HTLV-1 p30II inhibits NFkB hyper-activation by the viral oncoprotein Tax. a.
Transcriptional activation of an HTLV-1 LTR-luciferase reporter gene by CMV-Tax, as compared
to a GFP control. b and c. 293 HEK cells were cotransfected with either an E-Selectin promoterluciferase reporter plasmid or DTAR/SP1Mut version of an HIV-1 LTR-luciferase reporter
plasmid which contains only its kB-responsive enhancer elements and increasing amounts of
CMV-HTLV-1 Tax, CMV-HTLV-1 p30II-GFP, or a CbS empty vector control. d. 293 HEK cells
were treated with PMA and NFkB transcriptional activation was observed on an E-Selectin
promoter.
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Greene WC, 1990; Yamaoka S et al, 1996), unlike the Tax-M47 mutant defective for CREBdependent transactivation, but which supports NFκB-signaling (Smith MR and Greene WC, 1990)
(Fig. 8a).
Furthermore, these results demonstrated that p30II inhibits NFκB activation by the M47 Tax
mutant (Fig. 8a). Immunoblotting was performed to detect the wildtype Tax and the Tax-M22, M47 and -G148V mutant proteins, as well as p30II-GFP (Fig. 8a). The Tax-dependent NFκB
activation from the E-Selectin promoter was also impaired when 293HEK cells were cotransfected with the dominant-negative deletion mutants of IκKβ subunit: IκKβΔ9 and IκKβΔ34
(Sylla BS et al, 1998) (Fig. 8c), or the “super repressor” S32A/S36A mutant of IκBα which is
defective for serine-phosphorylation and proteasome-mediated degradation (DiDonato J et al,
1996) (Fig. 8b).
Since HTLV-1 infects CD4+ T-cells, I have further shown Tax induced transactivation of
NFκB, and the repression by p30II in Jurkat T-cells (Fig. 8d). The HTLV-1 bZIP factor (HBZ),
which is encoded by an mRNA of the opposite polarity of the viral genomic RNA, is involved in
both T-cell proliferation and suppression of Tax-mediated viral gene transcription (Clerc I et al,
2008), suggesting that HBZ cooperates closely with Tax. It has been shown that HBZ specifically
suppresses NFκB–driven transcription mediated by p65 (the classical pathway), without inhibiting
the alternative NFκB signaling pathway (Satou and Matsuoka, 2012; Zhao and Matsuoka, 2012).
Furthermore, the selective suppression of the classical NFκB pathway by HBZ renders the
alternative NFκB pathway predominant after activation of NFκB by Tax or other stimuli (Zhao T
et al, 2009). My results demonstrate that HBZ is not able to significantly activate NFκB
transactivation on E. Selectin promoter and that p30II suppresses the minimal activity that HBZ
has on this promoter (Fig. 8d). Consistent with figure 8a, NFκB transactivation in Jurkat T-cells
65

a

d

b

c

e

Figure 8. Tax-G148V mutant and dominant-negative mutants of IkBa or IkKb inhibit Taxinduced NFkB transactivation. a. Luciferase activity was measured on an E-Selectin promoterluciferase reporter in 293 HEK cells that were co-transfected with the luciferase reporter construct
and either CMV-HTLV-1 Tax (wild-type) or the Tax mutants, M22, M47, or G148V. The cells
were also co-transfected with the M47 Tax mutant in the presence of increasing amounts of CMVHTLV-1 p30II-GFP. b. Immunoblots to detect protein expression in “8a”. c and d. The NFkBdependent transactivation from the E-Selectin gene promoter by HTLV-1 Tax was demonstrated
by co-transfecting the cells with CMV-HTLV-1 Tax in the presence of dominant-negative mutants
of the IkKb catalytic subunit: IkKbD9 and IkKbD34 (Sylla et al,1998), or pRc-IkBa-S32A/S36A,
a “super repressor” mutant of the IkBa inhibitor, defective for Ser34/Ser36-phosphorylation and
degradation (DiDonato et al, 1996). e. Jurkat T-lymphocytes were cotransfected with an E-Selectin
promoter-luciferase reporter plasmid and either CMV-HTLV-1 Tax (wild-type) or the Tax
mutants, M22, M47, or G148V and relative luciferase values were determined.
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demonstrated that Tax mutants M22 and Tax-G148V were impaired, whereas Tax-M47 induced
NFκB-dependent transcriptional activation at levels comparable to wildtype Tax (Fig. 8d).
2.3 Stathmin and p65RelA interact in HTLV-1 transformed T-cell lines and knockdown of
Stathmin destabilizes NFκB/p65RelA subunit
Rationale: Lu et al demonstrated a correlation between stathmin and NFκB pathway in
pancreatic cancer. In pancreatic cancer environment, it was previously demonstrated that
microtubule disruption contributed to an enhanced chronic hypoxia and microtubule
destabilization induced a significant Hypoxia-inducible factor 1-alpha (HIF1-α) up-regulation
through an NFκB-dependent pathway (Jung YJ et al, 2003). Lu et al proposed that it is possible
that stathmin played its oncogenic role also by utilizing a potential NFκB mediated pathway in
pancreatic cancer. They found that stathmin binds to and stabilizes the p65RelA subunit of NFκB
and also confirmed that p65RelA was downregulated when stathmin was knocked-down suggesting
a novel oncogenic role of stathmin in aggressive pancreatic cancer (Lu Y et al, 2014). Lu et al also
found that silencing of Stathmin inhibited the prancreatic cancer cell proliferation in vitro and in
vivo (Lu Y et al, 2014). Given this novel oncogenic role of Stathmin, we sought to determine the
effect of depleting Stathmin upon Tax-induced NFκB transactivation using the E. Selectin
luciferase construct (Fig. 9b). The NFκB pathway plays a crucial role in HTLV-1 associated
oncogenesis (Hiscott J et al, 2001). We hypothesize that there is an underlying connection
between Stathmin and NFκB/p65RelA where Stathmin participates in Tax-induced NFκB
transactivation through an interaction with p65RelA subunit.
Results and Discussion: In order to determine whether stathmin knockdown can affect Taxinduced NFκB transactivation, 293HEK cells were co-transfected with siRNA oligonucleotides
targeted against stathmin transcripts (siRNA-stathmin) or a non-specific RNA (nsRNA) as
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Figure 9. Stathmin interacts with the NFkB p65RelA subunit in HTLV-1-transformed ATLL
cells and Stathmin knockdown inhibits Tax-induced NFkB transactivation. a. 293 cells were
cotransfected with an E-Selectin luciferase reporter plasmid and expression constructs for wt Tax
or p30II-GFP. Some samples were transfected with wt Tax and increasing amounts of non-specific
RNA (nsRNA) negative control or an siRNA targeted against stathmin transcripts (siRNAstathmin). Relative luciferase values were determined. b. Immunoblots to detect siRNAknockdown of Stathmin protein expression. Stathmin depletion destabilized p65RelA and Actin is
shown as a control. c. Co-immunoprecipitation of Stathmin and p65RelA in 293 HEK cells
stimulated with increasing concentrations of phorbol 12-myristate 13-acetate (PMA). d. Effects of
HTLV-1 p30II upon p65RelA-Stathmin interactions in Tax-expressing 293 cells. Input blots
depicting protein expression for Tax and p30II-GFP are shown. e. Co-immunoprecipitaion for
Stathmin and p65RelA in cultured activated hu-PBMCs and in the HTLV-1+ve MJG11 and SLB1
T-cell lines. Heat-denatured Anti-p65RelA antibody was included as a negative control (lower
panel). f. Kockdown of Stathmin expression in SLB1 lymphoblasts using siRNA-stathmin
destabilized p65RelA and Stathmin-p65RelA complexes were significantly reduced.
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negative control. We used two different siRNAstathmin oligonucleotides (#1 and #2) and observed
that they both significantly inhibited Stathmin expression and also destabilized the p65RelA protein
(Figs. 9a and 9b). Relative actin levels are shown by immunoblotting (Fig. 9b). Next, we observed
that targeted knockdown of Stathmin could also inhibit Tax-mediated NFkB transactivation (Fig.
9a). Since the NFκB signaling pathway is widely associated with the regulation of cell survival,
inflammation, and cell proliferation, it was logical to test and verify whether stathmin could play
its oncogenic role by activating an NFκB pathway. In order to assess this, we performed western
blots and co-immunoprecipitation assays in PMA activated 293 HEK cells which activates NFκB
signaling in these cells. We observed an increased expression of the p65RelA protein compared to
the relative input levels of Actin (Fig. 9c). Co-immunoprecipitation of Stathmin/Op-18 and p65RelA
complexes was seen using Protein-G-agarose and AntiStathmin/Op-18 or Anti-p65RelA antibodies
in PMA-treated cells (Fig. 9c). Since we earlier saw that HTLV-1 p30II suppressed Stathmin (Fig.
6c and 6d), we wanted to see the effect of p30II on Stathmin-p65RelA complexes in cells with Taxinduced NFκB activation (Fig. 9d). We used Anti-p65RelA antibody to coimmunoprecipitate
p65RelA protein with Stathmin and saw that p30II-GFP, either alone or in combination with Tax,
inhibited their co-immunoprecipitation (Fig. 9d). The input levels of Tax, p30II-GFP, Stathmin,
and Actin are shown (Fig. 9d).
Next, we used ATLL tumor cell-lines that express high levels of the Tax oncoprotein to study
the interaction between p65RelA and Stathmin using an Anti-p65RelA antibody and extracts prepared
from the HTLV-1-transformed lymphoma T-cell-lines, MJG11 and SLB1, and cultured human
PBMCs as control cells (Fig. 9e). The results in figure 9e demonstrate that the NFκB/p65RelA
subunit was coimmunoprecipitated in Stathmin-containing complexes indicating a stable
interaction between p65RelA and Stathmin in HTLV-1-transformed T-cell lines which was
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significantly higher than the control lane with hu-PBMCs (Fig. 9e). Heat-inactivated monoclonal
Anti-p65RelA antibody was used as a negative control in co-immunoprecipitation reactions (Fig.
9e, bottom panel). Further, the targeted knockdown of Stathmin using si-RNA oligonucleotide
(#2) inhibited the formation of p65RelA-Stathmin immune-complexes in the SLB1 HTLV-1transformed lymphoma T-cell-line, as compared to nsRNA negative control (Fig. 9f).
It has been reported in other studies that Stathmin/Op-18 binds to the NFκB subunit p65RelA
and functions as a cofactor by stabilizing the p65RelA in aggressive pancreatic cancers (Lu Y et al,
2014). The coimmunoprecipitation of Stathmin and p65RelA in stable complexes (Figs. 9c, 9d, 9e
and 9f) and the inhibition of these immune-complexes either in the presence of HTLV-1 p30II (Fig.
9d) or upon targeted knockdown of Stathmin (Fig. 9f) clearly demonstrate a possible role of
Stathmin in stabilizing NFκB/p65RelA subunit and subsequent activation of NFκB pathway in
HTLV-1 transformed T-cells.
2.4 HTLV-1 p30II represses Stathmin through a p53-dependent mechanism
Rationale: Stathmin is a gene negatively regulated by p53 tumor suppressor, being
transcriptionally repressed by p53/mSin3a/HDAC1 complexes (Murphy M et al, 1999).
Additionally, our lab has demonstrated that HTLV-1 latency protein p30II activates p53 (Romeo
M et al, 2018). In the previous figures I was able to show that the p30II protein inhibits Stathmin
(Figs. 6c and 6d) and also destabilizes Stathmin-p65RelA complexes (Fig. 9d). Unlike most other
cancers, the p53 tumor suppressor is rarely mutated in HTLV-1 associated oncogenesis (Zane L et
al, 2012) alluding to a possible role of p53-regulated mechanism in HTLV-1 pathogenesis.
Together these findings led us to explore whether using a p53-dominant negative transcriptional
mutant will affect the ability of p30II to inhibit Stathmin.
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Figure 10. Coexpression of the dominant-negative R175H DNA-binding mutant of p53
prevents the suppression of Stathmin expression by HTLV-1 p30II. a. 293 HEK cells were
cotransfected with various combinations of HTLV-1 p30II-GFP, pCEP4-wildtype-p53, pCEP4p53-R175H mutant, or an empty CbS vector control plasmid, and the expression of p30II-GFP,
wildtype and R175H mutant p53, and Stathmin proteins was detected by immunoblotting. Actin
levels are shown as a control for protein loading. b. To determine the effects of the dominantnegative p53-R175H mutant upon Tax-dependent NFkB transcriptional activation, 293 HEK cells
were cotransfected with an E-Selectin luciferase reporter plasmid and expression constructs for
HTLV-1 Tax, p30II-GFP, the p53-R175H DNA-binding mutant, or an empty CbS vector control.
Relative luciferase values were measured by normalizing to total cellular protein.

Results and Discussion: A dominant-negative DNA binding-defective mutant of p53; p53R175H (Hermeking H et al, 1997) was used to assess the effect of p30II on Stathmin expression.
293 HEK cells were co-transfected with various expression constructs for HTLV-1 p30II-GFP,
wildtype p53, p53 mutant p53-R175H, or an empty CbS vector control. The expression of the
Stathmin, p30II-GFP, p53 and Actin proteins was detected by immunoblotting (Fig. 10a). We
observed that as compared to the untransfected control or the CbS vector control, p30II-GFP
significantly inhibited the expression of Stathmin (Figs. 10a and 10b). Since p53 is a negative
regulator of Stathmin and transcriptionally represses its expression, we expected that wildtype p53
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overexpression might also suppress Stathmin protein. Indeed, as expected, the overexpression of
wildtype p53 also inhibited Stathmin protein expression (Figs. 10a and 10b). Moreover, the
dominant-negative DNA-binding mutant of p53, p53-R175H, led to increased levels of Stathmin
and also countered the ability of p30II-GFP to repress Stathmin (Figs. 10a and 10b). To study the
effect of p53-R175H on Tax-induced NFkB transactivation, 293 HEK cells were co-transfected
with E-selecting luciferase construct and either CbS vector control, HTLV-1 Tax, p30II-GFP or
p53-R175H expression constructs (Fig. 10b). It was found that the p53-R175H mutant inhibited
Tax-induced NFkB transactivation from the E-Selectin promoter (Fig. 10b). This could be
explained by the possibility that the p53-R175H mutant binds to and interferes with p65RelA
transcription complexes (Jeong SJ et al, 2004; Pise-Masison CA et al, 2000). Another possibility
could be that the p53R175H mutant might hinder Tax from interacting with the IkK-g subunit of
the IkK complex (Yamaoka S et al, 1998; Pise-Masison CA, 1998). These results confirm that the
HTLV-1 latency protein p30II represses Stathmin/Op18 in a p53-dependent manner.
2.5 The role of p30II in Tax-induced NFkB-signaling in context of the full-length HTLV-1
provirus
Rationale: We have demonstrated that HTLV-1 p30II suppresses Tax-induced NFkB
transactivation in 293 HEK cells transfected with expression constructs for HTLV-1 Tax, HTLV1 p30II and various NFkB-transactivation mutants of Tax (Figs. 7b, 7c, 7d, 8a, 8d). In order to put
this finding in perspective of the full-length HTLV-1 provirus with all its regulatory and accessory
proteins we used HT1080 clones containing the infectious HTLV-1 ACH.wildtype or ACH.p30II
mutant provirus, defective for p30II production (Kimata JT et al, 1994; Robek MD et al, 1998;
Bartoe JT et al, 2000; Romeo M et al, 2018; Hutchison et al, 2018). We sought to extend our
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findings that HTLV-1 p30II represses Tax-induced NFkB transactivation in context of fulllength HTLV-1 provirus.
a

b

Figure 11. HTLV-1 p30II suppresses NFkB transactivation in ACH.wildtype proviral clones
when compared to ACH.p30II mutant. a. Infectious HT1080/HTLV-1 ACH.wildtype (wt) or
ACH.p30II mutant proviral clones (defective for p30II production) were cotransfected with a fixed
concentration (0.25µg) of tk-renilla-luciferase plasmid and increasing amounts of an E-Selectin
promoter-firefly-luciferase. Dual luciferase assays were carried out and the relative NFkBdependent firefly-luciferase activities were quantified and normalized for equivalent renillaluciferase levels. b. HIV-1 kB-LTR (DTAR)-firefly-luciferase reporter plasmid was used in
increasing amounts against a fixed concentration of tk-renilla-luciferase and dual luciferase assay
was carried out in the same way as (11a).

Results and Discussion: HTLV-1 p30II protein suppresses the expression of Stathmin and
destabilizes p65RelA and inhibits Tax-induced NFkB transactivation (Figs. 6, 7, 8 and 9). So far,
we conducted our experiments in 293 HEK cells, hence to observe the effect of p30II in context
of full-length HTLV-1 provirus we used infectious HTLV-1 ACH.wildtype or ACH.p30II mutant
(defective for p30II production) clones. Dual luciferase assays were performed in ACH clones
which were co-transfected with a tk-renilla-luciferase plasmid and increasing amounts of a kB73

responsive E-Selectin-firefly luciferase (Fig. 11a) or HIV-1 kB-LTR (DTAR)- firefly-luciferase
reporter plasmid (Fig. 11b). The relative values of kB-responsive firefly-luciferase activities
were normalized to equivalent renilla luciferase levels which revealed that NFkB-dependent
transactivation was greater in the HT1080 clones expressing the HTLV-1 ACH.p30II mutant
provirus, compared to wildtype ACH. It is however to be noted that the mutation in ACH.p30II
provirus also results in an in-frame insertion of eight amino acids (YLEEESRG) after the
activation domain of the antisense HBZ protein (Robek MD et al, 1998; Clerc I et al, 2008) this
insertion however is not likely to disrupt HBZ. Nevertheless, the possibility that the ACH.p30II
mutant provirus could also impair HBZ functions cannot be ruled out. In fact, previous studies
have shown that HBZ also inhibits Tax-induced NFkB transactivation (Zhi et al, 2011). Hence, it
can also be possible that the inactivation of both p30II and HBZ could produce a combined effect
upon NFkB-signaling. Nonetheless, these findings are in consensus with our previous results
that the viral latency protein p30II dampens Tax-induced NFkB-signaling.
2.6 HTLV-1 p30II suppresses Tax-induced microtubule (MT) destabilization and genomic
instability
Rationale - Tax has a weak oncogenic activity in ATL cells but the genomic instability caused
by Tax plays a key role in the development of ATL (Baydoun H et al, 2012). Clastogenic DNA
damage including structural and numerical chromosomal rearrangements are frequently seen in
HTLV-1 transformed T-cells and Tax expressing cells (Marriott S et al, 2002). Several studies
have pointed to the role of NFkB signaling in genomic instability by different mechanisms such
as double-strand DNA breaks, disruption of centrosome assembly, and interference with cellcycle, to name a few. Tax-induced constitutive activation of NFkB signaling increases the
expression of iNOS and NO production causing dsDNA-breaks in HTLV-1-infected cells
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(Baydoun et al, 2015). Chaib-Mezrag et al showed that Tax induces DDSBs through activation of
NFkB pathway and by stimulating intracellular NOS (Chaib-Mezrag H et al, 2014). The direct
binding of kB-responsive elements in the plk4 gene promoter (Polo-like kinase 4) regulate the
expression of Polo-like kinase 4 (PLK4) and may disrupt the assembly of centrosomes during the
cell cycle (Ledoux AC et al, 2013). Stathmin interacts directly with tubulin and can destabilize
microtubules by sequestering tubulin heterodimers leading to a decrease in amount of free tubulin
available for microtubule assembly and hence promoting catastrophes (Charbaut E et al, 2001).
This microtubule disruption induced by stathmin may lead to formation of abnormal mitotic
spindle and inaccurate chromosomal segregation and is considered to be aneugenic since such
defects contribute to aneuploidy. Previous studies have shown that stathmin plays an oncogenic
role in promoting cancer cell proliferation, differentiation, migration and invasion (Lu Y et al,
2014). Stathmin is upregulated in several cancers and overexpression of wild-type Op18 results in
aneugenic activities, leading to aberrant mitosis, polyploidy, and chromosome loss (Holmfeldt et
al, 2006). In addition to structural chromosomal aberrations, majority of cancers typically present
numerical chromosomal changes including loss or gain of entire chromosomes (aneuploidy) owing
to unequal chromosomal division. ATL cells have highly lobulated characteristic “flower-shaped”
nuclei (Johnson JM et al, 2001) suggesting altered MT dynamics. Our results confirm the
interaction between p65RelA and Stathmin (Figs. 9c-f), which also implies that this interaction could
alter MT dynamics controlled by Stathmin and lead to genomic instability in HTLV-1 associated
leukemogenesis. We propose that the interactions between p65RelA and Stathmin due to Taxinduced NFkB signaling leads to MT- and genomic-instability which can be suppressed by
HTLV-1 p30II or inhibitors of NFkB transcriptional signaling.
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Figure 12. HTLV-1 p30II protein inhibits Tax-induced multinucleation in the ACH proviral
clones. a. BrdU labeling was done on nocodazole treated HT1080/HTLV-1 ACH.wt and
ACH.p30II mutant proviral clones. Flow cytometry to determine the relative percentages of diploid
cells in the G1, S, and G2-phases, as well as the total percentage of aneuploid cells using the
ModFit LT 3.0 cell-cycle algorithm. b. and c. Immunostaining on HT1080/HTLV-1 ACH.wt and
ACH.p30II mutant proviral clones, treated with or without nocodozole. Anti-Tubulin primary
antibody and a rhodamine red secondary antibody were used along with DAPI nuclear stain.
Percent multinucleate cells per field were determined by in triplicate visual fields using confocal
immunofluorescence-microscopy.

Results and Discussion: HTLV-1 Tax plays a crucial role in cell cycle control, Tax can prevent
apoptosis and promote cell proliferation by disrupting cell cycle check points in virus infected
cells. Tax interacts with cell cycle components and often results in dysregulation causing cellular
abnormalities, aneuploidy and immortalization of T-cells which ultimately lead to ATL (Currer R
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et al, 2012). Stathmin has been shown to compromises the fidelity of spindle assembly, increase
chromosomal instability and is considered to be aneugenic (Holmfeldt et al, 2006). Stathmin can
interact with p65RelA and possibly affect MT dynamics and promote genomic instability in HTLV1 infected cells. We addressed this possibility by performing flow-cytometry for cell-cycle analysis
in the infectious HTLV-1 ACH.wildtype or ACH.p30II mutant (defective for p30II production)
clones labeled with bromodeoxyuridine (BrdU), in the absence or presence of nocodozoletreatment (Fig. 12a). We used the ModFit LT 3.0 algorithm to calculate the relative percentages of
cells in the G1, S, or G2-phases, or those with aneuploidy. We discovered that the ACH.p30II
mutant proviral clones exhibited significant aneuploidy in the absence of nocodazole and even
bypassed nocodozole-induced metaphase-phase arrest showing an increased percentage of
nocodazole-treated cells in the S-phase (Fig. 12a). Next, we treated the HTLV-1 ACH.wt and
ACH.p30II proviral clones with nocodozole and then stained with DAPI and a primary antibody
against Alpha-Tubulin and a fluorescence-conjugated secondary antibody. The results were then
analyzed by immunofluorescence-confocal microscopy and the number of multinucleate cells per
field were quantified in triplicates. This experiment further confirmed our findings that the
ACH.p30II mutant clones (lacking a functional p30II protein) exhibit higher percentage of
multinucleate cells, even in the absence of nocodozole-treatment when compared to ACH.wt
clones (Figs. 12b and 12c) where the p30II protein possibly represses Stathmin and NFkB
dependent transactivation. We expected ACH.wt clones to have repression of Stathmin by p30II
protein, compared to ACH.p30II mutant clones (lacking p30II) and indeed that’s what we observed
by immunoblot analysis (Fig. 12d). Thus, we next wanted to determine if the HTLV-1 ACH.p30II
mutant exhibits more MT-instability than the ACH.wt clones.

77

In order to assess this, the parental HT1080 cells, or HT1080/HTLV-1 ACH.wt or ACH.p30II
mutant proviral clones, were transfected with p30II-GFP, or pcDNA3.1-GFP and inhibitors of
a

b

c

d

Figure 13. HTLV-1 p30II protein inhibits Tax-induced MT-destabilization in the ACH
proviral clones. a. and b. Immunostaining using Anti-Tubulin primary antibody and rhodaminered-conjugated secondary antibody (red) and DAPI-nuclear stain (blue) were performed on
HT1080/HTLV-1 ACH.wt and ACH.p30II mutant proviral clones transfected with HTLV-1 p30IIGFP, or dominant-negative mutants: IkBa-S32A/S36A, IkKbD9, or IkKbD34, and co-transfected
with pcDNA3.1-GFP. As a control, HT1080 cells were transfected with pcDNA3.1-GFP. The
relative percentages of GFP-positive cells with cytoplasmic tubulin aggregates (indicated by
arrows in 13.b) were quantified in-triplicate by confocal immunofluorescence imaging. c.
Immunoblots to detect Stathmin protein expression in the HT1080/HTLV-1 ACH.wt and
ACH.p30II mutant proviral clones, compared to control HT1080 cell-line. Actin protein was
detected for loading control. d. Immunoblots to detect levels of acetylated Alpha-Tubulin in
HT1080 cells or HT1080/HTLV-1 ACH.wt and ACH.p30II mutant proviral clones, ± nocodozoletreatment and bottom panel shows total Alpha-Tubulin as control.
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NFkB - various expression constructs for the IkBa-S32A/S36A (DiDonato J et al, 1996), IkKbD9,
or IkKbD34 mutants (Sylla BS et al, 1998).
The relative percentages of transfected GFP-positive cells containing cytoplasmic tubulin
aggregates were quantified using immunofluorescence-confocal microscopy. Upon quantification,
the ACH.p30II mutant clones exhibited much higher number of cytoplasmic tubulin aggregates
relative to the ACH.wt clones (Figs. 13a and b; arrows in Figs. 13b) indicating aberrant MT
dynamics in ACH.p30II mutant clones which can be attributed to Stathmin overexpression in the
absence of p30II protein. I then transfected ACH.p30II mutant clones with either p30II-GFP or
dominant-negative inhibitors of NFkB in order to suppress the NFkB signaling in these clones and
quantified the cytoplasmic tubulin aggregates by immunofluorescence-confocal microscopy (Figs.
12c and 13b). The results demonstrated that inhibition of NFkB signaling leads to suppression of
cytoplasmic tubulin aggregates in these cells (Figs. 13a and b). The quantification of tubulin
aggregates is shown in the micrograph in figure 13a and indicates that the suppression of NFkB
transcriptional signaling causes suppression of aberrant MT dynamics and tubulin aggregates in
ACH.p30II mutant GFP-positive cells expressing IkBa- S32A/S36A, IkKbD9, or IkKbD34
mutants. Acetylation of alpha-tubulin on lysine K40 is considered to be an indicator of microtubule
stability (Howes SC et al, 2014). We sought to determine the acetylation levels of alpha-tubulin in
HT1080 cells and the HT1080/HTLV-1 ACH.wt and ACH.p30II mutant proviral clones, either in
the absence or presence of nocodozole-treatment by immunoblotting and using an antibody against
acetyl-tubulin which we compared to total tubulin levels in these cells (Fig. 13d). The results
clearly demonstrate that alpha-tubulin acetylation was significantly lower in the ACH.p30II mutant
clones, as compared to ACH.wt clones.
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Figure 14. Tax-G148V NFkB defective mutant exhibits reduced genomic instability and
p65RelA-Stathmin molecular interactions. a. HT1080 cells ± nocodazole treatment were
transfected with expression constructs for wt Tax or Tax-G148V mutant. Immunostaining was
performed with Anti-Tubulin primary antibody and rhodamine red-conjugated secondary antibody
and DAPI nuclear stain. Percent multinucleate cells per field were calculated by quantification of
each visual field in triplicates using confocal immunofluorescence. b. HT1080 cells were cotransfected with pcDNA3.1-GFP and either wt Tax or Tax-G148V mutant and immunostained as
described in 14a. Tubulin aggregates were quantified in GFP-positive cells (used as transfection
control). c. and d. Representative images displaying tubulin aggregates are shown. Arrows in fig
c. indicate tubulin aggregates. The quantification graphs in fig d. at right depict the relative
fluorescence-intensities for the corresponding micrographs (drawn and analyzed using Zen 2.5D
spatial analysis tool Carl Zeiss Microscopy). e. Immunoblots to determine the levels acetylated
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tubulin as compared to total alpha-tubulin in HT1080 cells treated with nocodozole and transfected
with expression constructs for wt Tax or Tax-G148V mutant. Untransfected HT1080 cells were
used as control. f. Co-immunoprecipitation assay to study Stathmin- p65RelA complexes in 293
HEK cells transfected with wt Tax or Tax-G148V mutant. Input levels of proteins Stathmin,
p65RelA, Tax, and Actin are shown in the upper panels.

In order to assess whether the aforementioned genomic-instability and aberrant MT dynamics
are a result of Tax-induced NFkB transactivation, I used the Tax-G148V mutant which is defective
for NFkB transactivation (Yamaoka S et al, 1996), in the presence or absence of nocodazole
treatment. HT1080 cells were co-transfected with pcDNA3.1-GFP and wt-Tax oncoprotein or TaxG148V and stained using a primary antibody against alpha-tubulin and a fluorescent secondary
antibody and DAPI nuclear stain. Using immunofluorescence-confocal imaging, I quantified the
relative percent of GFP-positive (transfection control) cells with multinucleation or tubulin
aggregates in untrasfected HT1080 cells or HT1080 cells expressing either wt-Tax oncoprotein or
the Tax-G148V (Figs. 14 a-d). The results in figures 14 a-d demonstrate that the wt-Tax induced
significant tubulin aggregates/genomic-instability and multinucleation, even in the absence of
nocodozole as compared to untransfected cells or the NFkB defective Tax-G148V. Upon studying
the acetylated-tubulin levels by immunoblotting, we found that Tax-G148V mutant expressing
cells had higher amounts of acetyl-tubulin compared to either wildtype Tax-expressing or
untransfected cells (Fig. 14e), indicating much more stable MTs in NFkB deficient group. To
detect the p65RelA-Stathmin/Op-18 complexes in the NFkB deficient Tax-G148V expressing cells,
I performed co-immunoprecipitation assay in these cells with untransfected HT1080 cells and wtTax expressing cells as controls (Fig. 14f). The results demonstrated diminished p65RelA-Stathmin
interactions in Tax-G148V as against wt-Tax (Fig. 14f). These experiments establish a possible
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link between p65RelA-Stathmin/Op-18 interactions as a result of Tax-induced NFkB transactivation
and altered MT-dynamics and genomic-instability in Tax-expressing HTLV-1-infected cells.
2.7 Tax-induced cytotoxicity can be countered by inhibition of NFkB-signaling
Rationale: HTLV-1 Tax is the major oncogene responsible to drive HTLV-1 associated
oncogenesis. Studies using Tax mutants defective for NFkB activation, defined that Tax-induced
immortalization is highly dependent on its ability to constitutively activate NFkB dependent
transcription (Smith MR and Green WC, 1990). Moreover, inhibition of NFkB was seen to prevent
Tax-mediated cellular transformation and blocks the growth of HTLV-1 Tax-transformed cells
and ATL cells, both in culture and in SCID mice (Yamaoka S et al, 1996; Satou Y et al, 2004).
Together, these studies confirm that NFkB activation plays a crucial role in HTLV-1 Tax-mediated
transformation in vitro. However, the constitutive NFκB activation by Tax also triggers a
senescence and apoptosis response (Ho YK et al, 2012; Baydoun HH et al, 2015; Chaib-Mezrag
H et al, 2012), suggesting that only those T-cells that are capable of overcoming NFκB-induced
senescence and apoptosis can selectively undergo clonal expansion after HTLV-1 infection. Faulty
apoptosis has been characterized as a major causative factor in cancer development and
progression. HTLV-1 has been shown to suppress apoptosis in virus infected cells by viral protein
interactions with host cellular factors (Saggioro D et al, 2009). In fact, HBZ has also been shown
to suppress Tax-induced senescence by inhibiting NFkB signaling (Zhi et al, 2011). Together,
these observations allude towards HBZ to modulate Tax-mediated viral replication and NFκB
activation, thereby allowing HTLV-1-infected cells to proliferate and persist. HTLV-1 p30II and
HBZ are both negative regulators of viral expression and transcription (Nicot C et al, 2004,
Matsuoka M and Green PL, 2009), suggesting that there is a possibility that like HBZ, the HTLV1 latency maintenance protein p30II also modulates Tax-induced NFκB activation and suppresses
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Tax-induced cytotoxicity. This led us to investigate whether p30II cooperates with the viral
transactivator Tax and inhibits Tax-induced senescence and apoptosis and also investigate if it
does so by repressing Stathmin and the NFkB-signaling pathway.
a

b

c

Figure 15. HTLV-1 p30II counters Tax-induced cellular senescence. a. HeLa cells were cotransfected with expression constructs for HTLV-1 p30II-GFP, wt Tax, CMV-HBZ and/or a CbS
vector control, and then stained using X-Gal to detect senescence-associated Beta-galactosidase
(SA-b-Gal; blue) after five days. The numbers of senescent SA-b-Gal-positive (blue) cells per well
were quantified by counting each well in triplicate using color and DIC phase-contrast microscopy.
Immunoblots were also performed to detect the expression of the HTLV-1 Tax, HBZ (Myctagged), p30II-GFP, and Actin b. Representative images (SA-b-Gal + DIC) are shown. c.
Senescence staining was also performed on HT1080 fibrosarcoma cells that were co-transfected
with HTLV-1 p30II-GFP, wt Tax, and/or a CbS empty vector control and the number of SA-bGal-positive cells per well were quantified in triplicates by microscopy.
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Results and Discussion: Several studies showed that Tax-induced NFκB hyper-activation leads
to over-expression of the cyclin-dependent kinase inhibitors, p21 and p27 which promotes an arrest
of cell proliferation that triggers senescence. They propose that in HTLV-1 infected cells with
impaired p21/p27 functions, the downregulation of NFκB by HBZ may suppress the senescence
induced by Tax and hence promote clonal expansion of the infected cells (Kuo and Giam, 2006;
Zhang et al, 2009; Zhi et al, 2011). We expounded upon this idea and investigated whether the
latency protein p30II and/or HBZ could prevent Tax-induced cellular senescence. HeLa cells were
cotransfected with various expression constructs for HTLV-1 Tax, p30II-GFP, HBZ (Myc-tagged),
or an empty CbS vector control. The senescent (blue) cells were visualized by using senescenceassociated Beta-galactosidase (SA-b-Gal) and staining the cultures with an X-Gal solution. The
relative numbers of senescent (blue) cells per well were quantified by microscopy (Fig. 15a). It
was observed that p30II-GFP suppressed Tax-induced cellular senescence more effectively as
compared to the antisense HBZ protein under these experimental conditions (Fig. 15a).
Immunoblotting was performed to detect the Tax, p30II-GFP, and HBZ (Myc-tagged) proteins
(Fig. 15a, lower panels). Quantification of senescent cells was done by counting each sample in
triplicates and representative micrographs for the same are provided in figure 15b. Additionally,
we sought to replicate this experiment in HT1080 cells and demonstrated that p30II-GFP inhibited
Tax-induced cellular senescence in cotransfected HT1080 cells (Fig. 15c).
Tax-activation of NFκB may also lead to cell death/apoptosis which is largely mediated by
TNF-related apoptosis-inducing ligand (TRAIL) and requires an intact NFκB pathway activation
(Rivera-Walsh I et al, 2001). However, it is unclear as to how the Tax-induced apoptosis is
suppressed and converted to pro-tumorigenic for ATL development and progression. Hence, we
sought to determine if the HTLV-1 latency maintenance protein p30II cooperates with the viral
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transactivator by preventing Tax-induced apoptosis. For this experiment Jurkat E6.1 Tlymphocytes were cotransfected and fluorescent terminal deoxynucleotidyl transferase dUTP nick
end-labeling (TUNEL) assays were performed. Certain samples were permeabilized and treated
with ribonuclease-free deoxyribonuclease I (RNAse-free DNAse I) to consider as a positive
control. The percent TUNEL positive cells were counted in triplicates using confocal-fluorescent
imaging (Fig. 16) and representative microscopy images are shown in figure 14e. The results in
figure 16 demonstrate that HTLV-1 Tax induces programmed cell-death and also HBZ induces
apoptosis to a lesser extent. Indeed, as hypothesized, both p30II (HA-tagged) and HBZ effectively
countered Tax-induced apoptosis in cotransfected cells (Fig. 16).

Figure 16. HTLV-1 p30II inhibits apoptosis in Jurkat T-lymphocytes. TUNEL staining was
performed to study apoptosis in Jurkat T-lymphocytes co-transfected with expression constructs
for wt Tax, HBZ, or p30II-GFP, or a CbS empty vector. Staining was performed using a Click-iT
Alexa Fluor 594 TUNEL kit (Invitrogen). Representative microscopy images showing DAPI
nuclear stain and TUNEL positive red staining are shown (left panels). Quantification of relative
percentages of TUNEL-positive apoptotic cells per field was done by counting each field in
triplicates using confocal microscopy (right panel).
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Tax-G148V, the tax mutant defective for NFkB activation, is a very good system to determine
if the apoptotic effect of wild-type Tax is dependent upon Tax-induced NFkB transcriptional
activation. We used Annexin V-FITC and propidium iodide (PI) staining to compare the relative
levels of apoptosis in 293 HEK cells expressing either the wt-Tax oncoprotein or the Tax-G148V
mutant, and/or p30II-HA, or an empty CbS vector (Fig. 17a). As a positive control, some samples
were treated with Staurosporine. The results were quantified as shown in figure 17a and
representative microscopy images are shown in figure 17c. As is evident, the Tax oncoprotein
induced more apoptosis (i.e., percentages of Annexin V-FITC and/or PI-positive cells) than the
NFkB-defective Tax-G148V mutant or the p30II expression construct. Infact, the p30II protein
countered the induction of cellular apoptosis by the viral transactivator Tax (Figs. 17 a and c).
These results in figure 17, strongly suggest that apoptosis in HTLV-1 infected cells can be
attributed to Tax-dependent NFkB signaling and that the viral latency protein p30II cooperates
with Tax and counters Tax-induced cell death.
This revelation led to the next logical step to determine whether p30II counters Tax-induced
apoptosis by repression of Stathmin. Hence, in order to determine whether inhibiting Stathmin
could prevent Tax-induced cytotoxicity, 293 HEK cells were co-transfected with wt-Tax and a
siRNA-stathmin oligonucleotide or nsRNA as a negative control, and then stained with Annexin
V-FITC/PI and subsequently analyzed by confocal-microscopy. These results demonstrate that the
inhibition of Stathmin levels countered Tax-induced apoptosis when compared to the nsRNA
control (Figs. 17 b and c). Taken together, these results indicate a strong possibility that Taxinduced NFkB hyperactivation leads to cytotoxic effects such as cell death and senescence and
that HTLV-1 p30II cooperates with Tax to suppress the Tax-induced cytotoxicity through inhibiting
Stathmin - a p53 dependent cofactor of NFkB/p65RelA. This cooperation between the viral
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transactivator Tax and the latency protein p30II is imperative for ATL disease development in
HTLV-1 infected cells.
a

b

c

Figure 17. HTLV-1 p30II and Tax-G148V-NFkB defective mutant counter Tax-induced
cytotoxicity by suppressing NFkB signaling and repression of Stathmin. a. Quantification of
percent apoptotic 293 HEK cells determined using Annexin V-FITC and propidium iodide (PI)
staining. 293 HEK cells were co-transfected with wt Tax, Tax-G148V mutant, or p30II (HAtagged) or a CbS empty vector and stained for apoptosis studies. Staurosporine treated cells were
used as a positive control. Percentage of apoptotic cells were quantified by counting Annexin VFITC and/or PI-positive cells in triplicates for each well by confocal microscopy. b. Apoptotic
cells were also quantified in 293 HEK cells that were co-transfected with wt Tax and either a
siRNA-stathmin or nsRNA control. c. Representative microscopy images are shown and DIC
phase-contrast is provided in the merged image for the Tax-G148V mutant which exhibited
reduced apoptosis.
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2.8 HTLV-1 p30II induces TIGAR to suppress Tax-induced NFκB transactivation
Rationale: Ubiquitination is an important post-translational modification that plays a key role
in regulation of NFκB activity (DiDonato J et al, 1996). Several studies have shown that Tax
activates NFκB by activating the IκB kinase complex by generating Lys63-linked polyubiquitin
chains. The IkK complex-associated Lys63/Met1-linked (K63/M1) hybrid polyubiquitin chains
are generated through the Tax-mediated recruitment of linear ubiquitin chain assembly complex
(LUBAC) to the IkK complex which results in trans-autophosphorylation-mediated IkK activation
(Shibata Y et al, 2017). In fact, in one study, it was demonstrated that Tax recruits IkK complex
to golgi associated compartments which is highly dependent on its ubiquitination and interaction
with IkKg (Harhaj NS et al, 2006). Another study recently showed that Tax induces generation of
K63 and M1 chains by recruiting LUBAC to the IkK complex, leading to the formation of the
active IkK complex (Shibata Y et al, 2017). Interestingly, Tang Y et al (2018) showed that TIGAR
(Tp53-induced glycolysis and apoptosis regulator) suppresses NFκB-signaling by directly
inhibiting LUBAC (linear ubiquitin chain assembly complex). They demonstrated that TIGAR
competes with NEMO for association with the LUBAC and in doing so, prevented linear
ubiquitination of NEMO which is essential for activation of IkKβ and other downstream targets
resulting in potent inhibition of NFκB–dependent gene expression (Tang Y et al, 2018). Our lab
recently demonstrated that p30II activates p53 and induces the expression of p53-regulated prosurvival signals, including TIGAR, which is required for its cooperation with cellular (e.g., c-Myc)
and viral (Tax and HBZ) oncogenes (Hutchison et al, 2018; Romeo et al, 2018). We surmised that
there is a possibility of p30II induction of TIGAR which leads to suppression of Tax-induced
NFkB signaling in HTLV-1 infected cells.
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Figure 18. TIGAR suppresses Tax-induced NFkB transactivation in 293 HEK cells and
Jurkat T-lymphocytes. a. 293 HEK cells were co-transfected with an E. Selectin luciferase
construct and various expression constructs for wt Tax, TIGAR (flag-tagged), and a CbS vector
control and relative luciferase activities were measured in triplicates and normalized to total
cellular protein. b. Jurkat T-cells were co-transfected with an E. Selectin luciferase construct and
various expression constructs for wt Tax, HTLV-1 p30II-GFP, TIGAR (flag-tagged), and a CbS
vector control and relative luciferase activities were measured in triplicates and normalized to total
cellular protein. c. Protein expression for wt Tax, HTLV-1 p30II-GFP, TIGAR (flag-tagged) was
detected by immunoblotting and normalized to Actin.

Results and Discussion: TIGAR has been found to be overexpressed in several tumor cell types
and cancers including colon cancer, breast cancer, nasopharyngeal carcinomas, adenomas,
glioblastomas, and the hematological malignancy multiple myeloma (Lee et al, 2014) suggesting
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that TIGAR may function to promote cancer development. According to the Warburg effect,
cancer cells require higher amounts of glucose and have an increased glycolysis owing to an
increase in proliferation rate which requires large amounts of ATP, NADPH, and other
metabolites, such as dNTPs (Jiang et al, 2013). However, increased cell growth and proliferation
also leads to increased ROS meaning more oxidative stress and damage. This oxidative stress can
be prevented by TIGAR which has been shown to reduce the amounts of fructose-2,6-bisphosphate
leading to an accumulation of glucose-6-phosphate. The increase in glucose-6-phosphate shunts
to the pentose phosphate pathway (PPP) and produces ribose-5-phosphate, a nucleotide precursor,
and NADPH which is a ROS reducing agent (Bensaad et al, 2006; Bensaad et al, 2009; Jiang et al,
2013). TIGAR can promote cell survival and proliferation by decreasing oxidative stress and
increasing the production of ribose for DNA and RNA synthesis. TIGAR was also reported to
protect cells from genotoxic drug induced DNA damage partly through the regulation of pentose
phosphate pathway products (NADPH and ribose) and reduction of reactive oxygen species (Yu
HP et al, 2015). All these studies point towards cyto-protective role of TIGAR which can also
protect HTLV-1 infected cells from Tax-induced cytotoxicity owing to constitutive NFkBsignaling by Tax and play an important role in HTLV-1 oncogenesis. In fact, Romeo et al (2018)
showed that the induction of TIGAR by HTLV-1 p30II prevents ROS accumulation and senescence
(Romeo M et al, 2018).
In order to assess if HTLV-1 p30II induction of TIGAR leads to suppression of NFκBtranscriptional activation by HTLV-1 Tax, we co-transfected 293 HEK cells and also Jurkat Tlymphocytes using an E. Selectin luciferase construct and various expression constructs for wt
Tax, HTLV-1 p30II-GFP, TIGAR (flag-tagged), and a CbS vector control and measured relative
luciferase activities were in triplicates. The luciferase reading was normalized to total cellular
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Figure 19. TIGAR knockdown inhibits p30II suppression of Tax-induced NFκB activation
and causes apoptosis in HTLV1 +ve SLB1 cells. a. 293 HEK cells were co-transfected with E.
Selectin luciferase reporter plasmid construct and various expression constructs for wt Tax, p30IIGFP and a siRNA-TIGAR or a non-specific scr-RNA in increasing concentrations. Relative
luciferase values were measured in triplicates and normalized to total cellular protein. b. SLB1 T
lymphocyte cells were transduced using lentiviral constructs for either an empty vector control or
siRNA TIGAR (provided by T. Hutchison). Annexin/PI staining was performed to study apoptosis.
Some samples were untreated SLB1 cells to use as control. c. Quantification of apoptosis from
19b. Annexin/PI stained samples were quantified by confocal microscopy and each field was
counted in triplicates.

protein. Indeed, as expected we saw that TIGAR inhibited Tax-induced NFκB-transcriptional
activation in a dose dependent manner (Fig. 18). Next, we knocked-down TIGAR protein
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expression using siRNA against TIGAR and used a non-specific scrambled RNA control in 293
HEK cells. These cells were co-transfected using E. Selectin luciferase construct and various
expression constructs for wt Tax, HTLV-1 p30II-GFP, TIGAR (flag-tagged), siRNA-TIGAR and
a CbS vector control and a ns scr-RNA control. The relative luciferase activities were measured
in triplicates and normalized to total cellular protein (Fig. 19). We observed that knockdown of
TIGAR expression in cell transfected with wt Tax and p30II GFP, rescued the p30II suppression of
Tax-induced NFκB activity on E-selectin promoter (Fig 19). Finally, infectious SLB1 T cells were
repeatedly transduced using lentiviral constructs for either an empty vector backbone or siRNA
against TIGAR. These cells were then adhered on polyL/ConA treated slides and stained using
Annexin/PI (BD Pharmingen) and subsequently observed by confocal imaging. Quantification of
percent Annexin and/or PI positive cells revealed that TIGAR knockdown in HTLV1-positive
SLB1 cells leads to much higher apoptosis and cell death when compared to untreated or vector
control transduced cells. These results in figures 18 and 19 allude to the possibility that in an
alternative mechanism, HTLV-1 p30II also suppresses Tax-induced cytotoxicity by induction of
TIGAR. One possibility for the mechanism could be that TIGAR competes with Tax for the
ubiquitination of IkKg and in doing so, prevents the Tax-IkKg interactions and suppresses NFkB
hyperactivation and the cytotoxicity associated with the same. Further studies are however
required to confirm these findings and deduce a possible mechanism.
2.9 HTLV-1 Tax targets the IkK complex to lipid rafts and p30II suppresses lipid rafts
Rationale: NFκB is sequestered in the cytoplasm in an inactive form by the family of IκB
proteins and in response to stimulation the NFκB/p65RelA gets rapidly activated and transports to
the nucleus where it activates T-cell proliferation and a wide variety of genes controlling cell
survival, development and differentiation. T-cell activation leads to the activation of NFκB in the
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membrane microdomains, termed lipid rafts for promoting T-cell proliferation (Huang J et al,
2009). Lipid rafts are cholesterol- and sphingolipid-rich, detergent-resistant plasma membrane
microdomains that are synthesized from the Golgi and recycled between the Golgi and the plasma
membrane (Rocks O et al, 2005). Owing to the presence of both nuclear import and export signal
peptides, the Tax protein is distributed between the cytoplasm as well as the nucleus (Alefantis T
et al, 2003). This distribution pattern of Tax allows for its two major activities: activation of IκB
kinases by the cytoplasmic Tax and in the nucleus it transactivates the HTLV-1 LTR through
induction of the CREB activity. Tax exhibits differential modes of IκB kinase activation. However,
it is still unclear whether Tax-mediated activation of NFκB is involved in lipid raft translocation
of IκB kinases. It has been shown that cytoplasmic Tax mediates activation of IκB kinases and a
portion of Tax was found to be in the Golgi where it recruits the IκK complex (Nejmeddine M et
al, 2005). Huang J et al (2009) showed that the Tax protein accumulates in the Golgi-associated
lipid rafts where it activates NFκB in both T cells and non-lymphoid cells by translocating IKK to
the microdomains and primarily targeting IKKγ (Huang J et al, 2009). We sought to determine
the presence of the IκK complex components in the lipid rafts in Tax expressing cells and also
determine the effects of p30II upon Tax-induced lipid rafts.
Results and Discussion: One of the several mechanisms through which HTLV-1 Tax can
induce NFkB activation is through the recruitment of IKK signalosome to the lipid raft
microdomains. Tax directs lipid raft translocation of IkK through selective interaction with IkKγ
and accordingly, depletion of IkKγ impairs Tax-directed lipid raft recruitment of IkKα and IkKβ
(Huang J et al, 2009). Ren T. (2015) suggest the possible role of Tax in utilizing lipid rafts as
signaling platform where it recruits IκB kinases and autophagy molecules and activates NFκB and
autophagy pathways (Ren T et al, 2015). They demonstrated that Tax activates the IκB kinase
93

a

b

c

d

e

94

Figure 20. HTLV-1 Tax recruits the IKK complex to lipid rafts. a. Immunoblots on SLB1 cells
lipid raft fractions showing the expression of Tax, p65RelA, IKKa, IKKb, IKKg and the lipid raft
marker Caveolin 1. b. Immunoblots on Jurkat T-cells lipid raft fractions showing the expression
of p65RelA, IKKg and the lipid raft marker Caveolin 1. A dot blot at the bottom of the panel shows
the expression of GM1 lipid raft marker. c and d. Confocal immunofluorescence images of 293
HEK cells transfected either with empty vector or HTLV-1 Tax and immunostained for IKKa
(Green) or IKKb (Green) and Beclin1(Red) (lipid raft marker) and DAPI nuclear stain. Inset shows
enlarged images to show Merge images of IKKa and Beclin1 on lipid rafts (shown with white
arrows). e. HT1080 cells were co-transfected with expression constructs for wt Tax and either a
CbS vector control or HTLV-1p30II-GFP and immunostained for Beclin1 (Red) and DAPI nuclear
stain. p30II-GFP was visualized by direct GFP fluorescence (Green).

complex which leads to recruitment of an autophagy molecular complex containing Beclin1 and
Bif-1 to lipid raft microdomains.
We used HTLV-1 +ve SLB1 cells for lipid raft fractionation and performed immunoblots to
detect the presence of various IKK complex components (IKKa, IKKb, IKKg), HTLV-1 Tax,
p65RelA and used Caveolin1 as a lipid raft marker. We observed that IKKa, IKKg, HTLV-1 Tax,
p65RelA and to a lesser extent IKKb were present in lipid raft fractions (fractions 4,5,6) (Fig. 20 a).
We compared SLB1 fractions to Jurkat T-cells lipid raft fractions, and we observed that much
lesser amount of IKKg and p65RelA was present in the lipid raft fractions (fractions 4-7) (Fig. 20
b). We also immunostained 293 HEK cells transfected with either HTLV-1 Tax or a CbS vector,
using Beclin1 (Rhodamine Red) and either IKKa or IKKb (Green) to visualize lipid rafts in the
presence or absence of Tax. We observed that there was a significant amount of colocalization of
the IKKa or IKKb with Beclin1 on lipid rafts in Tax-expressing cells and almost none in the other
group (Figs. 20 c and 20 d; the white arrows indicate lipid raft microdomains in the image). The
results in Fig. 20 a-d demonstrate that Tax indeed recruits the IKK complex components to lipid
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raft microdomains. We next wanted to study the effects of HTLV-1 p30II upon Tax induced lipid
rafts. We used HT1080 cells transfected with expression constructs for HTLV-1 Tax and a CbS
vector control or p30II-GFP and immunostained using Beclin1 (Red) and DAPI nuclear stain to
visualize the lipid rafts (Fig. 20 e). We observed that while Tax induced the presence of several
defined lipid raft microdomains in these cells, HTLV-1 p30II lead to disruption of or reduced lipid
rafts in Tax-expressing cells (Fig. 20 e). The results in figure 20 show promising preliminary data
that Tax recruits IKK complex signalosome components to lipid raft microdomains and that there
is a possibility that p30II disrupts Tax-lipid rafts which is probably another mechanism to suppress
Tax-induced NFkB activation and reduce Tax-induced cytotoxicity in order to promote cell
proliferation and survival. Further studies are required to deduce the exact mechanism of lipid
raft activation of NFkB by Tax and its implications on HTLV-1 associated carcinogenesis.
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CHAPTER III
DISCUSSION AND OUTLOOK

Viral infections are one of the major environmental factors that contribute to the etiology of
cancer. Several human viruses are associated with cancer including human papillomavirus
associated with cervical cancer, Hepatitis B and C viruses associated with hepatocellular cancer,
Epstein Barr virus causing Burkitt’s lymphoma and nasopharyngeal cancer, Kaposi’s sarcoma
herpesvirus causing Kaposi’s sarcoma and human T-cell leukemia virus (HTLV-1) being the
causative agent of adult T-cell leukemia/lymphoma (ATL). Of all these viruses, HTLV-1 is the
only virus directly linked to a human cancer. HTLV-1 infects approximately 20 million individuals
world-wide (Proietti et al, 2005). About 2–5% of these individuals develop ATL after a long latent
period, alluding to a multistage process of immortalization and transformation of T-lymphocytes.
Even though the mechanism of how HTLV-1 infection progresses from clinical latency to T-cell
malignancy is not well understood but it is certain that it involves the unique viral transactivator,
oncoprotein Tax. HTLV-1 Tax has been shown to be sufficient for immortalizing T-lymphocytes
(Grassmann R et al, 1989) and transforming rat fibroblasts (Tanaka A et al, 1990). Furthermore,
LTR-driven Tax transgenic mice expressing were found to develop neurofibromas - a tumor of
mesenchymal tissue (Nirenberg M et al, 1987) and the T-cell specific, granzyme B promoterdriven Tax transgenic mice developed large granular lymphocytic leukemia (Grossman et al,
1995). Together, these studies confirm that HTLV-1 transactivator Tax plays a crucial role in
cellular transformation and tumorigenesis. Tax is a 40kD nuclear phosphoprotein that has
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pleiotropic activities and is a potent activator of HTLV-1 transcription and NFκB signaling
pathways (Matsuoka M and Jeang KT, 2007). In response to immune stimuli, NFκB activation
occurs transiently in normal T-cells and functions to carry out antigen-stimulated T-cell
proliferation and survival. Contrarily, HTLV-1 Tax induces persistent activation of NFκB, causing
deregulated expression of a large number of cellular genes which may ultimately lead to initiation
of T-cell transformation. Tax activates NFκB pathway by signaling through the IKK complex (Sun
SC and Yamaoka S, 2005). Tax binds to IKKγ via lysine K63-linked polyubiquitin chains which
causes phosphorylation and activation of IKKα and IKKβ. This leads to phosphorylation and
subsequent degradation of IκBα and allows the NFκB/p65RelA subunit to be released and migrate
into the nucleus (Sun SC and Ballard DW, 1999). Tax can also activate the alternative NFκB
pathway by binding to an IKKα-IKKγ-p100 complex and inducing the processing of NFκB/p100
to its active form p52 (Sun SC, 2011). Despite its crucial role in oncogenesis, the constitutive
hyperactivation of NFκB signaling by Tax has been shown to be cytotoxic and triggers a
senescence and apoptosis response (Ho YK et al, 2012; Baydoun HH et al, 2015; Chaib-Mezrag
H et al, 2012). Previously it was shown that the HTLV-1 antisense protein HBZ can alleviate Taxinduced senescence by modulating the NFκB pathway (Zhi et al; 2011), we demonstrated in this
study that the other pX-encoded viral proteins HBZ and p30II that inhibit NFκB transactivation
cooperate with Tax and counter Tax-induced senescence and apoptosis (Hutchison T et al, 2018)
(Figs. 7, 8, 9, 15, 16 and 17). A hallmark of cancer is variable clastogenic DNA damage and/or
polyploid and aneuploid chromosomes (Loeb KR and Loeb LA, 2000). Clastogenic DNA changes
and aneuploidy are frequently seen in ATL or Tax-expressing cells (Marriott SJ et al, 2002), and
can be attributed to the abrogation of several cellular DNA-repair functions that monitor DNA
structural damage in HTLV-1 infection. Aneuploidy is the result of either improper chromosomal
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segregation during mitosis or from polyploidy created by failed cytokinesis. Aberrant centrosome
duplication can also lead to aneuploidy by multipolar mitotic spindle formations (Peloponese Jr.
JM et al, 2007). Tax has both clastogenic and aneuploidogenic effects in HTLV-1 infected cells.
Tax inactivates cell cycle checkpoint controls and inhibits cellular DNA repair allowing DNA
replication or chromosomal segregation to occur in the presence of damage and facilitates the
accumulation of such genetic lesions that contribute to cellular transformation (Marriott SJ et al,
2002).
Stathmin is a microtubule destabilizing protein which is transcriptionally repressed by wildtype p53 by formation of p53/HDAC1/mSin3a transcriptional repressor complexes (Murphy M et
al, 1999). One of the most frequent events in human cancers is the mutation or loss of p53 activity
(Hollstein et al, 1994). Unlike most cancers HTLV-1 positive ATL clinical isolates mostly have a
high level of wildtype p53 (Zane L et al, 2012), opening the possibility that in HTLV-1
pathogenesis the p53-target genes are subverted selectively to promote oncogenesis. The p53
tumor suppressor is the guardian of genome and functions in several cell signaling pathways
including those for proliferation, DNA-damage repair, and apoptosis. Our lab has previously
demonstrated the induction of p53 in p30II-expressing cells suggesting a role for p30II in
manipulating survival versus apoptosis pathways controlled by p53 (Romeo M et al; 2018).We
also recently demonstrated that the HTLV-1 latency protein p30II interacts with MYST-family
acetyltransferase TIP60 and inhibits the lysine K120-acetylation of the p53 protein (Romeo M et
al, 2018; Fig. 6b) which may lead to regulation and expression of p53 regulated pro-survival
signals such as TIGAR (Romeo M et al, 2018; Hutchison T et al, 2018). Lu et al showed a novel
oncogenic role of stathmin in aggressive pancreatic cancer by demonstrating that Stathmin binds
to and stabilizes the NFκB/p65RelA subunit (Lu et al, 2014). In the present study, our experiments
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demonstrate that the p30II protein dampens Tax-induced NFκB transcriptional activation by
suppressing Stathmin expression and destabilizing NFκB/p65RelA subunit possibly through a p53dependent pathway (Fig. 10). In consensus with Lu et al (2014), we saw robust interactions
between the Stathmin protein and NFκB/p65RelA by co-immunoprecipitation assays in 293 HEK
cells and HTLV-1 infected cell lines SLB1 and MJG11 (Fig. 9). To confirm the role of Stathmin
as p65RelA cofactor, we used a siRNA-stathmin oligonucleotide to deplete Stathmin protein
expression and indeed saw that Stathmin knockdown also destabilized p65RelA and inhibited Taxdependent NFkB transactivation (Fig. 9). The siRNA-knockdown of Stathmin also inhibited the
formation of p65RelA-Stathmin immune-complexes in the infectious HTLV-1 T-cell-line, SLB1
(Fig. 9). Since it is known that Stathmin is negatively regulated by p53 (Murphy M et al, 1999),
we used p53-R175H; a dominant-negative DNA-binding mutant of p53 in 293 HEK cels (Fig. 10)
and as expected we saw that the mutant p53 countered suppression of Stathmin by p30II-GFP.
Interestingly though, contrary to our expectation, the p53-R175H mutant inhibited Tax-dependent
NFkB transactivation from the E-selectin promoter (Fig. 10). One possible explanation could be
that the mutant p53-R175H sterically hinders the binding of Tax to IkKg subunit of the IkK
complex through direct p53-Tax interactions (Yamaoka S et al, 1998; Pise-Masison CA et al, 1998,
Pise-Masison CA et al, 2000a). It is also plausible that p53-R175H interferes with p65RelA
transcriptional activation since Tax-induced NFkB signaling is required for p65RelA and p53
interactions (Jeong SJ et al, 2004; Pise-Masison CA et al, 2000b).
In the mid-1990s, a major breakthrough in HTLV-1 research came with the development of
the ACH HTLV-1 molecular clones and its mutant clones, allowing for characterization of
mutations of key viral proteins in the context of the entire virus (Bartoe JT et al, 2000; Silverman
LR et al, 2004). We used the infectious HTLV-1 ACH.p30II mutant provirus, defective for p30II
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production and saw that in the absence of p30II these cells exhibited increased NFkB-dependent
transcription, aneuploidy, and multinucleation/genomic instability either in the absence or
presence of nocodozole-treatment, compared to the wildtype ACH clones (Figs. 12 and 13). The
higher levels of Stathmin expression and reduced levels of acetylated-Alpha-Tubulin detected by
immunoblotting in the ACH.p30II mutant proviral clones along with increased cytoplasmic tubulin
aggregates also correlated with increased MT-destabilization in the p30II deficient clones when
compared to the wild-type clones. These results allude towards the possibility of increased
genomic instability in the absence of p30II latency protein (Figs. 12 and 13). We also observed that
the repression of Stathmin either by the HTLV-1 latency factor p30II, or its targeted knockdown
using siRNA-stathmin was able to counter Tax-induced cellular senescence and apoptosis (Fig.
14; Ho YK et al, 2012; Baydoun HH et al, 2015; Chaib-Mezrag H et al, 2012). Additionally, the
use of Tax-G148V mutant defective for NFkB transactivation provided evidence for the
dependence of Tax-induced cytotoxicity (in the form of multinucleation, MT-destabilization and
cytoplasmic tubulin aggregates, senescence and apoptosis) upon Tax-induced NFkB
hyperactivation. We saw that the Tax-induced cytotoxicity was significantly reduced or countered
in the presence of p30II protein or in the NFkB-defective Tax-G148V mutant (Fig. 14).
HTLV-1 Tax induces genetic instability, in the form of multinucleation, chromatin bridges,
aneuploidy, telomere attrition, and clastogenic DNA damage (Baydoun HH et al, 2012). Tax plays
a crucial role in oncogenesis, but its expression is often silenced in the majority of ATL due to
genetic alterations or 5'-LTR DNA hypermethylation of the tax gene. Interestingly however,
despite the loss of Tax, NFκB activation was seen to be persistently active in ATL. The reason
behind this inconsistency can be contributed to somatic mutations in genes in the T/B-cell receptor
(T/BCR) and NFκB signaling pathways (Harhaj EW and Giam CZ, 2018).
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In addition to ATL leukemogenesis, studies of the HTLV viruses also provide an exceptional
model for understanding basic pathogenic mechanisms of virus-host interactions and human
oncogenesis. The persistent activation of the NFκB pathway maintained by certain viruses
contributes to oncogenic transformation (Hiscott J et al, 2001). Several reasons make the NFκB
pathway an attractive target to viral pathogens. NFκB activation is a rapid, immediate early (IE)
event that occurs within minutes after exposure to a relevant signal. Moreover, it does not require
de novo protein synthesis, and results in a strong transcriptional stimulation of several early viral
as well as cellular genes. Additionally, NFκB has many important target genes that profoundly
influence the host cell cycle, including growth factors, cytokines and cytokine receptors, and protooncogenes. NFκB contributes to DNA damage and induction of oncogenic mutations through
inflammation-mediated production of reactive oxygen and nitrogen species (ROS and RNS). The
Tax-induced constitutive activation of NFκB signaling results in increased expression of iNOS
and NO which causes double-strand DNA-breaks in HTLV-1-infected cells (Baydoun HH et al,
2015). Moreover, NFκB activates c-Myc and PI3K to induce expression of human telomerase
reverse transcriptase (hTERT) for the long-term proliferation and clonal expansion of HTLV-1infected cells that have acquired chromosomal abnormalities (Marriott SJ and Semmes OJ, 2005;
Sinha-Datta U et al, 2004). NF-kB also represses the tumor suppressor p53 at the protein level by
phosphorylation and degradation or by inducing the expression of p53-inhibitor MDM2 (Jeong SJ
et al, 2004). Tax also induces a physical interaction between RelA and p53, suggesting another
mechanism for NFκB-mediated p53 inactivation (Jeong SJ et al, 2004). Interestingly, the NFκB
pathway was shown to act as a barrier for tumor development by helping to maintain a senescent
state and regulating DNA damage-repair in primary mouse embryo fibroblast (MEF) cultures
(Wang J et al, 2009). Currently, it is largely unknown how the anti-tumor activity of NFκB is
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suppressed and converted to be pro-tumorigenic for ATL development. One suggestion on this
theory came from Wang et al (2009) who speculate that in pre-neoplastic cells undergoing stressinduced senescence, the NFκB functions as a tumor suppressor and maintains cells in a senescent
state. However, once these cells acquire sufficient genetic changes, activated oncogenes might
stimulate the tumor-promoting function of NFκB that mediates cell survival and proliferation.
Stathmin is frequently overexpressed in human cancers and Lu et al (2014) showed that
Stathmin activates NFκB dependent pathways to exert its oncogenic effects in pancreatic cancer
development (Lu et al, 2014). In this study, we demonstrated for the first time, the p65RelA/Stathmin
molecular interactions by viral transactivator Tax-induced NFκB hyperactivation. These
interactions may modulate the NFκB-pathway activity and its effector functions associated with
cellular transformation and oncogenesis including cell-cycle control, DNA damage and
chromosomal abnormalities, p53-dependent pathways, senescence and apoptosis. Additionally,
NFκB pathway has been shown to play a role in promoting cell motility and epithelial-tomesenchymal transition (EMT) (Maier HJ et al, 2010) which directly correlates to the MTremodeling function of Stathmin. In light of the p65RelA/Stathmin interactions observed in HTLV1 infected cells with Tax-induced NFκB activation, it is likely that the effects of these interactions
on MT-dynamics and remodeling can manifest in the form of angiogenesis, tumor invasion, cell
migration and metastasis promoting T-cell transformation and ATL disease progression.
These results demonstrate that the HTLV-1 latency maintenance factor p30II cooperates with
the viral transactivator Tax by repressing Stathmin/OP18 - a p53 dependent cofactor of
NFκB/p65RelA

and

suppresses

Tax-induced

NFκB

signaling,

apoptosis,

senescence,

multinucleation and genomic instability in HTLV-1-infected cells. Moreover, this study revealed
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a novel link between NFκB signaling and genomic instability mediated through p65RelAStathmin/Op-18 molecular interactions (Fig. 18).

Figure 21. Tax induced NFkB-signaling and genomic instability and cytotoxicity in HTLV1-infected cells. (A) In early stages of HTLV-1 infection, robust Tax expression hyperactivates
NFkB signaling through both the canonical and non-canonical IkK signaling pathways in the
cytoplasm. This allows the nuclear translocation of NFkB p65RelA/p50 heterodimers rendering
Stathmin/Op-18 free in the cytoplasm. As these cells progress into mitosis the free Stathmin can
destabilize MT spindle fibers resulting in aberrant chromosomal segregation, catastrophic genomic
instability, and cytotoxicity. (B) The viral latency-maintenance factor p30II cooperates with Tax
and activates p53. Since Stathmin is negatively regulated by p53/mSin3a/HDAC repressor
complexes, p30II activation of p53 leads to repression of stathmin gene expression leading to
destabilization of p65RelA protein and a dampened Tax-induced NFkB signaling –resulting in less
genomic instability and the enhanced survival of HTLV-1-infected cells.
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Presently, chemotherapies rely heavily on tumor suppressor p53 and p53-dependent apoptotic
pathways to block or remove malignant cells. Unfortunately, ATL responds poorly to most
prevalent chemotherapies. Also, p53 mutations are very rare in ATL patient isolates and those that
present with mutated p53 have been seen to have a short survival time and poor prognosis (Hatta
and Knoeffler, 2002). The majority of ATL patients present with acute or lymphomatous ATLL
leading to a median survival of only 0.5–2.0 years, despite intensive chemotherapy treatment
(Shimoyama M, 1991; Tsukasaki K et al, 2009). Host pathways that play an important part in cell
transformation can be used as chemotherapeutic targets. A constitutively activated NFκB pathway
represents such a target in the case of HTLV-1 mediated ATL. The NFκB pathway is a key
regulator of cell cycle, apoptosis, cell proliferation and genomic instability and accumulating
evidence supports the concept that NFκB targeted therapies sensitize ATL cells to apoptosis
(Raunch D and Ratner L, 2011). Bortezomib is a non-specific inhibitor of the NFκB pathway that
inhibits proliferation of Tax tumors cells ex vivo and sensitizes cells to apoptosis, however toxicity
constraints limited the efficacy of the treatment. Other inhibitors of NFκB such as Oridonin, NIK333, curcumin, fucoidan, histone-deacetylase inhibitors, have been reported to induce apoptosis in
ATL cells by repressing the NFκB pathway (Raunch D and Ratner L, 2011). These findings show
great promise to develop therapies for ATL that target NFκB. In fact, one plausible way to sensitize
these highly chemoresistant cancer cells to therapy could be to target p65RelA-Stathmin/Op-18
molecular interactions in ATL cells.
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CHAPTER IV
EXPERIMENTAL PROCEDURES AND METHODS

4.1 Cell Culture
293 Human embryonic kidney (HEK) cells (CRL-1573; ATCC, Manassas, VA) were cultured
in in a humidified incubator at 37◦C under 5% CO2 using Eagle’s Minimum Essential Medium
(EMEM), supplemented with 10% heat-inactivated fetal bovine serum (FBS; Biowest, Riverside,
MO), 100 U/ml penicillin, 100 µg/ml streptomycin-sulfate, and 20 µg/ml gentamycin-sulfate (Life
Technologies, Waltham, MA). HT-1080 fibrosarcoma cells (CCL-121; ATCC) were cultured in
DMEM, 10% FBS, 100 U/ml penicillin/streptomycin sulfate on collagen treated flasks at 37°C in
5% CO2. HeLa cells (CCL-2; ATCC) were cultured at 37◦C and 5% CO2 in Dulbecco’s Modified
Eagle’s Medium (DMEM), supplemented with 10% heat-inactivated FBS and 100 U/ml penicillin.
The Jurkat E6.1 T-lymphocytes (TIB-152; ATCC) were cultured in RPMI-1640 (ATCC), 20%
FBS, 100 U/ml penicillin/streptomycin sulfate at 37°C in 10% CO2. Primary human peripheral
blood mononuclear cells (hu-PBMCs) were isolated previously in the lab, after informed consent
obtained from enrolled donors by the SMU Memorial Health Center from whole blood samples
using

a

Ficoll

gradient

and

were

cultured

in

RPMI-1640,

20%

FBS,

100u/ml

penicillin/streptomycin sulfate, 50 U/ml hIL-2 at 37°C in 10% CO2. The HTLV-1-transformed
MJG11 T-cell-line (CRL-8294; ATCC) was cultured in RPMI-1640 medium, supplemented with
20% FBS and antibiotics, at 37◦C under 10% CO2. The HTLV-1-transformed SLB1 lymphoma Tcell-line (kindly provided by P. Green, The Ohio State University-Comprehensive Cancer Center)
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was cultured in Iscove’s Modified Dulbecco’s Medium (IMDM) with 10% FBS and antibiotics at
37◦C and 10% CO2 incubator. The infectious HTLV-1 ACH.wt or ACH.p30II mutant provirus
expressing transiently-amplified HT1080 cell clones, were generated and kindly provided by T.
Hutchison in the lab by transfecting 2x105 cells in 6-well tissue-culture plates with plasmids that
contain the full-length ACH.wt or ACH.p30II proviral nucleotide sequences (Hutchison T et al;
2018, Romeo M et al; 2018, Pise-Masison CA et al; 1998) and then seeding the transfected cultured
cells in 96-well microtiter plates followed by screening to quantify the amounts of extracellular
HTLV-1 p19Gag core antigen released into the culture supernatants by performing Anti-HTLV-1
p19Gag enzyme-linked immunosorbent assays (ELISAs; Zeptometrix, Buffalo, NY). The
supernatants were filtered using 0.22 µm cellulose acetate syringe filters (Sartorius, Goettingen,
Germany). The extracellular p19Gag levels were measured relative to a HTLV-1 p19Gag protein
standard using a Berthold Tristar microtiter plate-reader in Absorbance mode (Berthold
Technologies, Oak Ridge, TN). The virus-producing HT1080/HTLV-1 ACH.wt and ACH.p30II
clones were expanded and repeatedly passaged and the continuous production of infectious HTLV1 particles was confirmed by performing Anti-HTLV-1 p19Gag ELISAs (Romeo M et al; 2018,
Hutchison T et al; 2018). The HT1080/HTLV-1 ACH proviral clones were cultured in collagen
treated flasks using high glucose (4.5 g/L) EMEM and supplemented with 10% FBS and antibiotics
and incubated at 37◦C under 5% CO2. All cell-lines were negative for mycoplasma contamination.
4.2 Plasmids and Antibodies
Wild type Tax and Tax mutants were expressed using following plasmids that were kindly
provided by C.Z. Giam (The Uniformed Services University of the Health Sciences): the RcCMVwildtype HTLV-1 Tax (Harrod R et al; 1998, Harrod R et al; 2000), RcCMV-Tax-M22 and TaxM47 mutants –impaired for NFkB- and CREB-dependent transactivation, respectively (Smith MR
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and Greene WC; 1990), and the NFkB-defective Tax-G148V mutant (Yamaoka S et al; 1996).
The pEGFP-N3-HTLV-1 p30II-GFP and pMH-HTLV-1 p30II (HA-tagged) expression constructs
(Nicot C et al; 2004) were kindly provided by G. Franchini (NCI/NIH). J. Nyborg (Colorado State
University) kindly provided the pGL2-Basic-HTLV-1 TRE-luciferase reporter plasmid (Giebler
HA et al; 1997) and the pcDNA-HBZ-MycHis expression construct (Hiven P et al; 2005) was
provided by I. Lemasson (East Carolina University). The NFkB-responsive E-Selectin promoterluciferase reporter plasmid has been described by Hong S et al (2007). The kB responsive
luciferase construct pCV63-HIV-1kB-LTR (DTAR)-luciferase reporter construct contains
nucleotides 345-531 of the HIV-1LAI promoter, spanning the two kB-responsive elements and
three SP1-binding sites with a deletion of the trinucleotide bulge of the TAR, which were inserted
into pGL2-Basic (Promega, Madison, WI). pcDNA3.1-GFP was described by Nicot C and Harrod
R (2000). The pCDNA3-FLAG-IkKbD9 mutant and IkKbD34 mutant expression constructs were
described by Sylla BS et al (1998). The “super repressor” mutant of IkBa pRc-IkBa-S32A/S36A,
defective for Ser32/Ser36-phosphorylation and degradation (DiDonato et al; 1996), was kindly
provided by P. West (Texas A&M University). pCEP-wildtype p53 and the pCEP-p53-R175H
mutant expression constructs (Hermeking H et al; 1996) and were provided by B. Vogelstein
(Johns Hopkins University).
The following antibodies were used in this study for immunoblotting and immunofluorescence
experiments: Santa Cruz Biotechnology (Dallas, TX) antibodies include, mouse monoclonal AntiHTLV-1 Tax (1A3), rabbit polyclonal Anti-GFP (FL), mouse monoclonal Anti-NF-kappa-B
p65RelA (F-6), rabbit polyclonal Anti-Stathmin/Op-18 (FL-149), rabbit polyclonal Anti-IkBa (C15), mouse monoclonal Anti-p53 (DO-2), mouse monoclonal Anti-Alpha-Tubulin (TU-02), mouse
monoclonal Anti-Acetylated-Alpha-Tubulin (6-11B-1), mouse monoclonal Anti-c-Myc (9E10),
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and goat polyclonal Anti-Actin (C-11). Other antibodies used were: mouse monoclonal AntiFLAG

M2

(Sigma-Aldrich),

fluorescein

isothiocyanate

(FITC)-conjugated

Anti-

Bromodeoxyuridine (FITC-Anti-BrdU; BD-Pharmingen, San Diego, CA). The fluorescent
rhodamine red-conjugated Anti-Mouse IgG (H+L) secondary antibody and horseradish peroxidase
(HRP)-conjugated secondary antibodies (Anti-Mouse IgG [H+L]-HRP; Anti-Rabbit IgG [H+L]HRP; Anti-Goat IgG [H+L]-HRP) used for chemiluminescence-imaging and immunoblotting
were purchased from Jackson ImmunoResearch Laboratories (West Grove, PA).
4.3 Immunoblotting and co-immunoprecipitations
Immunoblotting/western-blotting was performed to detect protein expression. About 48-72 hrs
post-transfection, the transfected cells were harvested and pelleted by centrifugation for 7 min at
260 x g at 4◦C, washed 2X with PBS, pH 7.4, and the pellet was resuspended in 1X Reporter Lysis
Buffer (Promega). Cell lysis was performed by repeated freeze-thawing over dry-ice and passaging
through a 27-gauge tuberculin syringe needle. In order to resolve the protein lysates by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), the lysates were then
centrifuged for 2 min at 5,000 x g at 4◦C and mixed with 2X Laemmli Sample Buffer containing
2-mercaptoethanol (Biorad Laboratories, Hercules, CA) and heat-denatured at 95◦C for 3 min,
loaded on a 12.5% polyacrylamide gel with a 4% stacking layer. The proteins were transferred
onto a 0.2 µm nitrocellulose membrane (Whatman, Maidstone, UK) using a model TE 77 PWR
semi-dry blotting unit (Amersham Biosciences, Little Chalfont, UK). The membranes were
blocked using blocking buffer (3% w/v bovine serum albumin and 0.5% v/v Tween-20 in PBS,
pH 7.4) for 1 hour on a shaker and then incubated for 2 hrs in respective primary antibodies (diluted
1:1000 or 1:2000 in Blotto buffer: 50 mM Tris-Cl, pH 8.0, 2 mM CaCl2, 80 mM NaCl, 0.2% v/v
IGEPAL-CA630, 0.02% w/v sodium azide, and 5% w/v nonfat dry milk) with gentle shaking.
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Next, the membranes were washed 2X with blotto buffer for 10 min and incubated for 1 hr with
the relevant HRP-conjugated secondary antibodies (diluted 1:500). Finally the membrane was
washed 2X with blotto buffer and once with TMN solution (100 mM NaCl, 5 mM MgCl2, 100
mM Tris-Cl, pH 9.5) for 10 min, and developed by chemiluminescence-based detection using
Pierce ECL Western Blot Reagent (Thermo Scientific, Rockford, IL) on the ChemiDoc Touch
imaging system (BioRad Laboratories).
In order to study protein interactions and protein complexes, co-immunoprecipitations were
performed. For this the cells were lysed using 500 µl of RIPA buffer (0.15 M NaCl, 50 mM TrisCl, pH 7.4, 0.5% sodium deoxycholate, 0.5% Nonidet P-40, 0.1% SDS), containing 50 ng/ml each
of the protease inhibitors: pepstatin, leupeptin, chymostatin, bestatin, and antipain-dihydrochloride
(Roche Applied Science), by repeated freeze-thawing and either syringe-shearing or sonication
over an ice-bath using a microtip probe and Misonix S-4000 model instrument set at 70%
amplitude (for the HTLV-1-infected MJG11 and SLB1 ATLL cell-lines). Samples were
centrifuged for 5 min at 5,000 x g at 4◦C to remove the cell debris. For immunoprecipitation, 250
µl from each lysate was mixed with 20 µl of a 50% slurry of Protein-G-agarose and 3-5 µl of the
primary antibodies overnight at 4◦C with gentle rotation. These agarose-immune complexes were
then pelleted by centrifugation for 5 min at 5,000 x g at 4◦C followed by washing 2X with RIPA
buffer and resuspended in 30µl of 2X Laemmli Sample Buffer with 2-mercaptoethanol. These
samples were then heat denatured by incubating in a heat-block at 95◦C for 5 mins and then the
proteins were resolved and detected by SDS-PAGE and immunoblotting as described above.
4.4 Transactivations and luciferase reporter gene assays
Luciferase reporter plasmid constructs were used to study Tax-induced NFkB transcriptional
activation and the effect of HTLV-1 p30II on the same. For these experiments 293 HEK cells were
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co-transfected with either an E-Selectin promoter-luciferase reporter plasmid or HIV-1 kBLTRLAI (DTAR) promoter-luciferase reporter plasmid (0.25 µg), and RcCMV-HTLV-1 Tax
and/or an HTLV-1 p30II-GFP expression construct or empty CbS vector control. The cells were
harvested after 48 hours with 1X Reporter Lysis Buffer (Promega) and lysed with rapid freezethaw cycles and syringe shearing. The protein concentrations were determined using the Bradford
microassay and spectrophotometric analysis at 595 nm. Luciferase assays were carried out with
equivalent amounts of sample using luciferin (Promega) and read on a Berthold Lumat LB 9507
luminometer (Berthold Technologies), and the values were normalized to equivalent amounts of
total cellular protein. To study the transactivation using Tax mutants and the mechanism through
which HTLV-1 p30II repressed Tax-induced NFkB transcriptional activation, the cells were
transfected with expression constructs for the Tax-M22, Tax-M47, or Tax-G148V transactivation
mutants (Smith MR and Greene WC; 1990, Yamaoka S et al; 1996), or the dominant-negative p53
DNA-binding mutant, p53-R175H (Hermeking H et al; 1996), dominant-negative IkKb mutants,
IkKbD9 and IkKbD34 (Sylla BS et al; 1998), or a phosphorylation/degradation-defective IkBa
“super-repressor” mutant, IkBa-S32A/S36A (DiDonato J et al; 1996). In an alternate way to
induce NFkB transcriptional activation, 293 HEK cells were stimulated using 100 ng/ml of
phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich), and these cells were cotransfected with
an E-Selectin promoter-luciferase reporter plasmid and pEGFP-N3-HTLV-1 p30II-GFP. To study
the effects of Stathmin knockdown on Tax-induced NFkB activation, 293 cells were repeatedly
transfected with siRNA-stathmin to knockdown Stathmin/OP-18 expression or an nsRNA
oligonucleotide as a negative control. These cells were also co-transfected with E. Selectin
promoter and luciferase assays were carried out to measure NFkB transactivation. The CREBdependent transactivation of the HTLV-1 promoter by Tax was demonstrated by co-transfecting
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293 HEK cells with 0.25 µg of a pGL2-Basic-HTLV-1 TRE-luciferase reporter plasmid (Giebler
HA et al; 1997). Dual luciferase assays were conducted to compare the relative levels of NFkBdependent transactivation between the HT1080/HTLV-1 ACH.wt and HT1080/HTLV-1
ACH.p30II mutant proviral clones. These cells were cotransfected with E-Selectin promoterfirefly-luciferase (or HIV-1 kB-LTR (DTAR)-firefly-luciferase) and tk-renilla-luciferase reporter
plasmids and the dual-luciferase assays were performed using a Dual-Glo kit as recommended by
the manufacturer’s protocol (Promega). The RLU values from kB-dependent E-Selectin promoterdriven firefly-luciferase were normalized to equivalent tk-renilla-luciferase activities.
4.5 siRNA knockdown of Stathmin
Stathmin expression was inhibited using either a 2’-O-methyl-uridine-modified siRNAstathmin (#1) oligonucleotide with 5’ and 3’ terminal phosphorothioate linkages and the sequence:
5’-mUCCAGUUCUUUCACCUGGAUAUC-3’, or a bridged nucleic acid (BNA) siRNAstathmin (#2) oligonucleotide with phosphorothioate linkages at the 5’ and 3’ ends with the
sequence: 5’-AAUCAGCUCAAAGCCUGGCCU-3’ (Biosynthesis, Lewisville, TX), using the
HiPerFect transfection reagent (Qiagen, Germantown, MD) as per the manufacturer’s
recommended protocol. As a negative control, a 2’-O-methyl-uridine-modified non-specific RNA
(nsRNA)

oligonucleotide

with

the

sequence:

5’-UUACCGAGACCGUACGUAU-3’

(Biosynthesis) was used. Stathmin expression was inhibited in HTLV-1-transformed SLB1 Tlymphoblasts or 293 HEK cells by repeated transfections using using Qiagen Hi-perfect
transfection reagent. We used SDS-PAGE and immunoblotting using a rabbit polyclonal AntiStathmin/Op-18 primary antibody (Santa Cruz Biotechnology) to confirm the depletion of
Stathmin protein expression.
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4.6 Multinucleation and tubulin aggregates studies using confocal microscopy and flow
cytometry
Tax interacts with cell cycle components and often results in dysregulation causing cellular
abnormalities, aneuploidy and immortalization of T-cells which ultimately lead to ATL (Currer R
et al, 2012). In order to study the effects of Tax-induced NFkB signaling upon genomic instability
and the role of p30II expression in HTLV-1-infected cells I quantified multinucleation and tubulin
aggregates in HT1080 human fibrosarcoma cells, or the HT1080/HTLV-1 ACH.wt and
HT1080/HTLV-1 ACH.p30II mutant proviral clones (Hutchison T et al; 2018; Romeo M et al;
2018) which were treated with the microtubule-depolymerizing agent, nocodozole (400 ng/ml;
Sigma-Aldrich), for 24 hrs to induce metaphase (M-phase)-arrest. These cells were plated on
collagen treated sterile glass coverslips in 35 mm2 tissue-culture dishes, treated with 400ng/ml of
nocodazole and incubated at 37◦C and 5% CO2. After 24 hrs, the cells were fixed in 0.2%
glutaraldehyde-1% formaldehyde in PBS for 15 min, washed 2X with PBS, and then incubated in
Blocking buffer with gentle shaking. Immunostaining was performed, using a monoclonal AntiTubulin primary antibody (diluted 1:2000 in Blotto buffer) and a rhodamine red-conjugated AntiMouse IgG (H+L) secondary antibody (Jackson ImmunoResearch Laboratories; diluted 1:200)
and DAPI nuclear stain (4’,6-diamidine-2’-phenylindole dihydrochloride, DAPI; Invitrogen,
Carlsbad, CA). Confocal immunofluorescence-microscopy was performed to determine the
relative percentages of multinucleate cells, that had bypassed nocodozole-induced M-phase arrest,
per field by counting visual fields in triplicates. We used the Tax-G148V NFkB defective mutant
to determine whether it induces genomic instability compared to the wildtype Tax protein. For
this, 1x105 HT1080 cells were plated on glass coverslips and transfected with RcCMV expression
constructs for wildtype HTLV-1 Tax or the Tax-G148V mutant. We used nocodazole to induce
M-phase arrest. These slides were then fixed, blocked and immunostained, and confocal
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microscopy was performed as described above to quantify the relative percentages of
multinucleate cells per field.
I used flow cytometry to deduce the effects of HTLV-1 p30II on Tax-induced genomic
instability. The HT1080 fibrosarcoma cells and HT1080/HTLV-1 ACH.wt or ACH.p30II mutant
proviruses, were seeded at a density of 2x105 cells/well and co-transfected with a pLenti-6.2/V5DEST-HTLV-1 p30II (HA-tagged) expression construct or empty CbS vector control in 6-well
tissue culture plates for 72 hrs. Next, these cultures were labeled with 10 µM BrdU for 6 hrs in
EMEM supplemented with 20% FBS and immunostained using an Anti-BrdU antibody conjugated
with fluorescein isothiocyanate (FITC; BD-Pharmingen). Following BrdU labelling, the cells were
permeabilized and stained using the FITC-Anti-BrdU antibody; and the total genomic DNA
content was quantified by staining the cultures with 7-aminoactinomycin D (7-AAD; BDPharmingen). Flow cytometry was performed on a Becton Dickinson FACS Caliber instrument
(Becton Dickinson, Franklin Lakes, NJ). The samples were gated during acquisition to exclude
sub-G1 cellular debris and apoptotic fragments. The flow cytometry data were analyzed using
ModFit LT 3.0 software (Verity Software House, Topsham, ME).
The effects of NFkB-signaling induced by HTLV-1 Tax and the repression of Stathmin
expression by p30II upon tubulin dynamics and the MT network were determined by confocal
immunofluorescence

microscopy

in

immunostained

HT1080/HTLV-1

ACH.wt

and

HT1080/HTLV-1 ACH.p30II mutant proviral clones. These cells were plated on sterile glass
coverslips in collagen treated 35 mm2 tissue-culture dishes and then co-transfected using Qiagen
Superfect with pcDNA3.1-GFP or pEGFP-N3-HTLV-1 p30II-GFP and/or various expression
constructs for the dominant-negative IkKb deletion mutants: IkKbD9 and IkKbD34, or the IkBa
“super repressor” mutant, IkBa- S32A/S36A. After 72 hrs in culture in EMEM substituted with
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10% FBS at 37 C and 5% CO2, the samples were fixed with 0.2% glutaraldehyde-1%
formaldehyde in PBS for 15 min at room temperature, washed 2X with PBS, and incubated on
gentle shaker in blocking buffer for 1 hr. The samples were then immunostained with a monoclonal
Anti-Tubulin primary antibody and a rhodamine-red-conjugated Anti-Mouse IgG (H+L)
secondary antibody and DAPI nuclear-stain. Confocal immunofluorescence microscopy was
performed and the relative percentages of GFP-positive cells with cytoplasmic tubulin aggregates
were quantified by counting each slide in-triplicate. I also used the HT1080 cells co-transfected
with pcDNA3.1- GFP and wildtype HTLV-1 Tax or the Tax-G148V mutant which is NF-kB
transactivation defective mutant and followed the above protocol to quantify GFP-positive cells
with tubulin aggregates, to determine the effects of Tax-dependent NF-kB signaling on tubulin
polymer dynamics. The relative fluorescence-intensities of the DAPI, GFP, and Tubulin-specific
(red) signals were measured using the Zen 2.5D analysis tool (Carl Zeiss Microscopy, Jena,
Germany).
4.7 Senescence and Apoptosis
Detection of senescence associated β-galactosidase was done to determine the effects of
HTLV-1 p30II and HBZ upon Tax-induced cellular senescence (Ho YK et al; 2012). HeLa cells
were plated on 60 mm2 dishes (Grenier) and transfected with pRcCMV-HTLV-1 Tax, pEGFP-N3HTLV-1 p30II-GFP, pcDNA-HBZ-MycHis, or an empty CbS vector control. The transfected cells
were cultured for four days in DMEM substituted with 10% FBS and antibiotics at 37oC and 5%
CO2 followed by serum starvation (0.05% FBS) for 24 hrs. The cells were stained using an adapted
Cell Signaling Senescence β-galactosidase Cell Staining protocol using X-Gal (Sigma-Aldrich) to
detect senescence-associated Beta-galactosidase (SA-β-Gal) expression. The cells were fixed for
15 mins using fixative (PBS, 2% formaldehyde, 0.2% gluteraldeghyde) and then washed with PBS
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and stained using the β-galactosidase staining solution (930 μL 1X staining solution [40mM citric
acid/sodium phosphate (pH 6.0, 0.15 M NaCl, 2 mM MgCl2], 10 μL Staining Supplement A [500
mM potassium ferrocyanide], 10 μL Staining Supplement B [500 mM potassium ferricyanide], 50
μL 20 mg/mL X-gal in DMF). These stained plates were incubated at 37◦C overnight in a dry
incubator without CO2. The numbers of blue senescent cells were quantified by counting visual
fields in triplicates using a DIC filter on a Zeiss AxioImager Z2 fluorescence-microscope equipped
with AxioCam MRc color and HRm monochromatic cameras and a Plan-Apochromat 20x/0.8
objective lens. SDS-PAGE and immunoblotting were performed to confirm the expression of Tax,
HBZ (Myc-tagged), and p30IIGFP. Direct fluorescence was used to visualize the p30II-GFP fusion
and also to assess transfection control.
For apoptosis studies I used either Annexin staining or TUNEL staining in 293 HEK and Jurkat
T-cells. 293 HEK cells were plated on 8-well glass chamber slides and co-transfected with 0.25
µg of RcCMV-wildtype HTLV-1 Tax or the NFkB-defective Tax-G148V mutant, pMH-HTLV-1
p30II (HA-tagged), or a CβS empty vector in various combinations using Qiagen Superfect reagent.
To study the effects of inhibiting Stathmin expression on Tax-induced apoptosis, some cells were
co-transfected with 50 ng of a siRNA-stathmin (#2) oligonucleotide or nsRNA as a negative
control using Qiagen Hiperfect reagent along with wildtype Tax expression plasmid construct.
Cells were stained after 72 hrs in culture using Annexin V-FITC staining kit (BD-Pharmingen Annexin V conjugated to FITC) and propdium iodide (PI; BD-Pharmingen), and then using
confocal fluorescence-microscopy the relative percentages of apoptotic (i.e., Annexin V-FITC
and/or PI-positive) cells per well were quantified by counting in-triplicate. As a positive control,
staurosporine-treated cells (12 nM for 4 hrs; Sigma-Aldrich) were included.
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Apoptosis

studies

were

also

conducted

using

the

fluorescence-based,

terminal

deoxynucleotidyl transferase dUTP nick end-labeling (TUNEL) experiments. Jurkat T-cells were
grown in suspension in a T-75 flask in complete medium (RPMI with 20% FBS and antibiotics).
Cells were transfected by electroporation with 2.5 µg each of expression plasmids including CβS
vector, RcCMV-HTLV-1 Tax, pEGFP-N3-HTLV-1 p30II-GFP, and pcDNA-HBZ-MycHis
expression constructs or a CβS empty vector control using Bio-Rad Gene Pulser MXcell shock
pod. The cells were pelleted by centrifuging for 7 mins at 2100 rpm at 4◦C and washed with PBS.
2.5 x 106 cells were resuspended in 500 µl of ice-cold Bio-Rad Gene Pulser electroporation buffer
in 0.4 cm gap Bio-Rad Gene Pulser cuvettes along with respective plasmid DNA and pulsed 2X
for 10 microseconds duration at 250 Volts, 1,500 µF capacitance and 1000 Ohms resistance. The
cells from each cuvette were then transferred to six-well plates and fed with 2ml of RPMI media
substituted with 20% FBS and antibiotics and incubated for 48 hrs at 37◦C and 10% CO2. After 48
hrs, the cells were adhered on slides treated with a 0.1 mg/ml Concanavalin A (Sigma)/poly-Llysine by incubating for 30 minutes at 37◦C. The Click-iT® Plus TUNEL assay kit Alexa Fluor
594 Imaging Assay from Invitrogen was used to detect apoptotic cells. The cells were washed with
PBS and fixed (4% paraformaldehyde solution). 0.25% Triton X solution in PBS was used to
permeabilize the fixed cells by treating for 20 minutes at 37◦C. Cells were washed 2X with DI
water. DNAse I (Qiagen) solution (0.27U/µl) was used to treat cells for positive control. To
perform the Click-iT reaction, TUNEL reaction cocktail was used to incubate cells for 30 mins at
37◦C in dark. Cells were washed again with blocking buffer and treated with DAPI for 15 mins
and observed. The relative percentages of fluorescent TUNEL-positive apoptotic cells per field
were quantified by counting triplicate visual fields using confocal microscopy.
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4.8 Confocal microscopy
Confocal fluorescence-microscopy was used to visualize tubulin aggregates, multinucleation,
Annexin V-FITC/PI or Alexa Fluor 594 TUNEL-staining in HTLV-1 Tax-expressing cells. These
studies were performed on a Zeiss LSM800 instrument with an Airyscan super-resolution detector
and stage CO2 incubator (Carl Zeiss Microscopy). All images were taken using either PlanApochromat 40x/1.3 or Plan-Apochromat 63x/1.4 oil immersion objectives and Zeiss ZEN system
software. The expression of HTLV-1 p30II-GFP in co-transfected cells was visualized on an
inverted Nikon Eclipse TE2000-U microscope and D-Eclipse C1 confocal system (Nikon
Instruments, Melville, NY) equipped with 633 nm and 543 nm He/Ne and 488 nm Ar lasers using
a Plan Apo 20x/0.75 objective lens.
4.9 Lipid raft isolation
Lipid rafts are cholesterol and sphingolipid-rich structures or microdomains of the plasma
membrane, endoplasmic reticulum and golgi complex. I performed lipid raft isolation to study the
effect of Tax-induced NFkB activation on localization of the IKK complex components in lipid
raft microdomains (Ren T et al; 2015). Their isolation method is based on insolubility of lipids in
ice-cold Triton X-100 followed by their separation on an OptiPrep density gradient. I used the
Caveolae/Rafts isolation kit from Sigma-Aldrich. Jurkat T-cells or infectious HTLV-1 positive
SLB1 cells were cultured in RPMI or IMDM with 10% FBS and antibiotic and ~ 3-5X107 cells
were seeded in T-125 flasks. Cells were collected on ice in precooled 50 ml tubes and centrifuged
at 450 x g at 4◦C for 5 mins. The cell pellet was gently washed 2X with 10 ml ice cold PBS. Next,
the cell pellet was gently resuspended in 2ml of diluted CTB-HRP (cholera toxin B subunit from
Vibrio cholerae-peroxidase conjugate, Sigma C3741) solution and gently shaken on ice for 1 hr.
The cells are then centrifuged, and the cell pellet is washed 2X with ice cold PBS. Cell pellet is
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resuspended in 1ml lysis buffer containing 1% Triton X-100 and the cell lysate was transferred to
a pre-cooled microcentrifuge tube and incubated on ice in cold room for 30 mins. 50 µl of lysate
was kept aside as a positive control. Density gradient was prepared using different volumes of cell
lysate, lysis buffer and OptiPrep solution with final OptiPrep concentrations as follows: (from
bottom) 35%, 30%, 25%, 20%, 0% (top) and layered in precooled ultracentrifuge tubes. Balanced
ultracentrifuge tubes were centrifuged at ~200,000 x g ultracentrifuged in a Beckman 70.1 Ti rotor
for 4 hours at 4◦C and then each 1 ml fraction from top to bottom was collected in separate
microcentrifuge tubes. CTB-HRP was detected using dot blot analysis. Nitrocellulose membrane
was placed ona PBS soaked Whatman filter paper and 2-3 µl sample from each fraction was placed
along with original positive control lysate on the membrane. The membrane was allowed to air dry
and washed once briefly with PBS and developed by chemiluminescence-based detection using
Pierce ECL Western Blot Reagent (Thermo Scientific, Rockford, IL) on the ChemiDoc Touch
imaging system (BioRad Laboratories). Anti-Caveolin-1 primary antibody and anti-rabbit
secondary antibody was used for immunoblotting as a marker for lipid raft caveolae fractions.
HTLV-1 Tax, p65RelA, IKKa, IKKb, IKKγ were also detected using immunoblotting in lipid raft
fractions.
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APPENDIX A
Generation of lentiviral constructs
We use several different kinds of cell lines in our research studies and one of the most common
methods used in biological research is protein expression which is achieved by transfecting
plasmid DNAs in cells. Each cell line varies in its transfection efficiency, cell lines like HeLa
(ATCC CCL-2) and 293 HEK (ATCC CRL-1573) are known for their ease of transfection.
Contrary to this, cells that are not transformed by viruses or through cancer are generally more
difficult to transfect. These hard to transfect cells can be transduced using a lentivirus which will
infect individual cells and deliver the gene of interest with transduction efficiencies close to 100%.
By constructing lentiviral vectors, I will be able to transduce and express my proteins of interest
in primary hu-PBMCs which otherwise have extremely low transfection efficiency.
Method for lentiviral production: The lentiviral expression constructs were generated using the
Invitrogen (ThermoFischer Scientific) ViraPower Gateway Expression Kit. This Invitrogen kit
allows us to clone our gene of interest into a Gateway® entry vector to create an entry clone. An
expression clone is generated by LR recombination reaction between the entry clone and a
destination vector (pLenti6.2/V5-DEST). And finally, this expression clone is used ViraPower
lentiviral expression system to produce virus particles containing our gene of interest.
The HTLV-1 Tax insert was PCR-amplified, gel purified, and ligated into the Invitrogen
pCR8/GW/TOPO vector. The Tax insert was amplified from the plasmid RcCMV-wildtype
HTLV-1 Tax (provided by C.Z. Giam) using the Tax-F (5’ GGT ACC ACC ATG GCC CAC TTC
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CCA GGG TTT GGA 3’) and Tax-R (5’ GC GGC CGC TCA GAC TTC TGT TTC TCG GAA
ATG 3’) forward and reverse oligonucleotide primers. The ligation reaction was performed using
TOP10 E.coli strain (Invitrogen) and the Tax insert was ligated into the pCR8/GW/TOPO vector.
Screening of the clones was performed by EcoR1 (NEB) restriction enzyme digestion and PCRamplification was done to determine if the insert is present and also to ensure that the insert is in
the correct orientation within the pCR8 backbone. The Tax clones #B5 and #B9 were found to
have correct insert. To verify the orientation of the Tax insert, the Tax-F and GW2 (5’ GTT GCA
ACA AAT TGA TGA GCA ATT A 3’; Invitrogen) oligonucleotide primers were used. Clones B5
and B9 were then sequenced using the GW1 (5’-GTT GCA ACA AAT TGA TGA GCA ATG C3’; Invitrogen) and GW2 primers. Next, the selected clones were inserted into the Invitrogen
pLenti6.2/v5- DEST vector by homologous recombination using the provided Clonase II enzyme
mix to generate a lentiviral construct that contains the gene of interest. The lentiviral plasmid
construct which contains an insert will be transformed into StbI3 E. coli (designed for constructs
that contain direct repeats to help reduce unwanted recombinants). After transformation, the small
and large scale bacterial cultures were grown at 30°C. The lentiviral clones were verified using
restriction digestion with both XhoI and AflII. An XhoI site is present in the lentiviral backbone
at the 3’ end of the insert. AflII sites are present within the lentiviral LTRs and at the 3’ end of the
gene of interest. The clones with the highest expression were packaged into the pseudotyped
retrovirus. The 293FT (Invitrogen) packaging cell lines was co-transfected with 3 μg of lentiviral
construct and 9 μg of ViraPower Packaging Mix (Invitrogen) with Lipofectamine 2000
(Invitrogen) in 10 cm dishes. The pLenti6.2/V5-DEST vector contains the human CMV immediate
early promoter allowing high level constitutive expression of the gene of interest in most
mammalian cells. The residual cellular debris was removed by 0.45μm syringe filter. The
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supernatant containing the lentiviral particles was then ultracentrifuged in a Beckman 70.1 Ti rotor
at 44,000rpm for 24 hours at 4oC on a 20% sucrose-TSE cushion [10mM Tris-Cl (pH 7.5), 100mM
NaCl, 1mM EDTA]. The particles were resuspended in 600 μL of TNE buffer [10mM Tris-Cl (pH
7.4), 100mM NaCl, 1mM EDTA]. Small aliquots (100 μL) were stored at -80oC. The virus titer
was performed by plating 293 HEK cells on 6-well plates (Grenier) at approximately 30-50%
confluency. The next day, the lentiviral aliquots were diluted: mock, 1.5x10-4 and 3x10-4 in 1mL
of complete culture medium and added to the 6-well plate. After 24 hours, the media was removed
A

B

HTLV-1
Tax

Figure A1. The ability of the pLenti6.2/V5-DEST HTLV-1 Tax to transactivate the NFkBdependent transcription from the E-Selectin promoter-luciferase reporter plasmid was
demonstrated by cotransfecting 293 cells with 0.25 µg of E-Selectin promoter-luciferase reporter
plasmid and transduced with increasing amounts (150µl/mL and 300µl/mL) of unconcentrated
pLenti6.2/V5-DEST HTLV-1 Tax or pLenti6.2/V5-DEST empty vector control. Relative
luciferase activities were measured and normalized for equivalent total cellular protein levels. The
data represent the mean ± standard deviation (error bars) from three independent experiments. The
expression of HTLV-1 Tax was detected by SDS-PAGE and immunoblotting.

and the cells were cultured in 2mL of complete media without virus overnight. On Day 4, the cells
were harvested and detected by immunoblotting (Fig. A1.B). The viral supernatant was collected
after 72 hrs and centrifuged at 2150 rpm for 7 minutes.
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The pLenti6.2/V5-DEST HTLV-1 Tax was also used to study Tax-induced NFkB
transactivation in 293 HEK cells using the E-Selectin promoter-luciferase reporter plasmid and
was found to activate NFkB transcriptional activation (Fig. A1.A).
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APPENDIX B
Generation of SLB1-GFP cell line
The HTLV-1-transformed SLB1 lymphoma T-cells (kindly provided by P. Green, The Ohio
State University-Comprehensive Cancer Center). 2x106 cells were plated in a 10 cm tissue culture
plate in IMDM supplemented with 10% FBS and antibiotics, in a humidified incubator at 37◦C
under 10% CO2. pLenti6.2V5-DEST HTLV-1 GFP virus was prepared by Romeo M (Romeo et
al; 2018) and was used to transduce the SLB1 cells and were cultured for 48 hrs in media without
basticidin.
The pLenti6.2/V5-DEST vector backbone also contains a gene for resistance to the nucleoside
antibiotic Blasticidin (Invitrogen). Blasticidin was used to remove any cells that were not
transduced. A killing curve was used to determine the concentration of Blasticidin needed to kill
non-transduced cells and allow for the propagation of stably transduced cells and ~5 μg/mL
Blasticidin was determined to be optimal. The transduced SLB1-GFP cells were seeded in Poly
L/Con A coated 96 well plates in 200µl complete media containing 5 μg/mL blasticidin and
allowed to grow for 2 weeks. After 2 weeks, the 96 well plates were fed with 50µl complete media
containing blasticidin and GFP detected through direct fluorescence.
The cells were left in culture for 2 more weeks in 96 well plates. After the 4th week as a result
of blasticidin, the untransduced cells were eliminated, and the viable cell-wells were scaled up to
12 well plates with 500 µl complete media with 5 μg/mL blasticidin. The cells were allowed to
grow in culture for 2 weeks after which they were fed 500 µl complete media with 2.5 μg/mL
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blasticidin and allowed to grow for 2 more weeks. GFP was detected using direct fluorescence and
viable wells were scaled up to 6 well cell culture plates in 1ml complete media with 1 μg/mL
blasticidin and allowed to grow for 1 week. The cells were scaled up to T-25 flasks and cultured
in complete media with 1% blasticidin. After a week, the cells were pelleted by centrifugation at
2100 rpm at 4◦C for 7 mins and the cell pellet were washed 4x with PBS. The cells were then
resuspended in 7 ml IMDM supplemented with 10% FBS and antibiotics without blasticidin and
cultured for 3 days. GFP was detected using direct fluorescence and 2 ml cells were harvested and
lysed to get protein lysate. Immunoblotting was performed on the obtained lysate using rabbit
polyclonal Anti-GFP (FL) antibody (Santacruz) and a rabbit secondary antibody (Jackson). Out of
the 12 tested cell lines, 9 were positive for GFP on immunoblot detection (Fig. B1) and the
remaining cells of these 9 cell lines were frozen in liquid nitrogen for future use.

Figure B1. SLB1-GFP cell lines GFP was detected through direct fluorescence. In the figure, DIC
image (left) is shown and compared with green fluorescence (right) to show that over 90% cells
had GFP expression in culture. SLB1-GFP cells were then harvested for protein lysates and
immunoblotting was performed to detect the GFP protein. Relative Actin levels are shown by
immunoblotting.
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